,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1712050,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,501858,IFITM2-PS2,https://ctdbase.org/detail.go?type=gene&acc=501858,,,501858.0,Ifitm2-ps2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of IFITM2-PS2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1,1712051,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10410,IFITM3,https://ctdbase.org/detail.go?type=gene&acc=10410,,,10410.0,IFITM3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IFITM3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
2,1712052,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,213002,IFITM6,https://ctdbase.org/detail.go?type=gene&acc=213002,,,213002.0,Ifitm6,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of IFITM6 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
3,1712053,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,74482,IFITM7,https://ctdbase.org/detail.go?type=gene&acc=74482,,,74482.0,Ifitm7,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IFITM7 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4,1712466,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IGFBP3 mRNA,,,PMID:22504374|PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/22504374|https://www.ncbi.nlm.nih.gov/pubmed/24780913,22504374|24780913,,
5,1712590,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MSH2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
6,1712591,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4440,MSI1,https://ctdbase.org/detail.go?type=gene&acc=4440,,,4440.0,MSI1,8355.0,Xenopus laevis (African clawed frog),Propylthiouracil results in increased expression of MSI1 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
7,1712592,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55167,MSL2,https://ctdbase.org/detail.go?type=gene&acc=55167,,,55167.0,MSL2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MSL2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
8,1712649,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,347252,IGFBPL1,https://ctdbase.org/detail.go?type=gene&acc=347252,,,347252.0,IGFBPL1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IGFBPL1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
9,1712650,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,79713,IGFLR1,https://ctdbase.org/detail.go?type=gene&acc=79713,,,79713.0,IGFLR1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of IGFLR1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
10,1712651,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,500568,IGH-6L1,https://ctdbase.org/detail.go?type=gene&acc=500568,,,500568.0,Igh-6l1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of IGH-6L1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
11,1713073,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23255,MTCL1,https://ctdbase.org/detail.go?type=gene&acc=23255,,,23255.0,MTCL1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTCL1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
12,1713074,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,100380125,MT-CO1,https://ctdbase.org/detail.go?type=gene&acc=100380125,,,100380125.0,mt-co1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MT-CO1 mRNA,,,PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/36843608,36843608,,
13,1713075,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4515,MTCP1,https://ctdbase.org/detail.go?type=gene&acc=4515,,,4515.0,MTCP1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTCP1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
14,1713076,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9650,MTFR1,https://ctdbase.org/detail.go?type=gene&acc=9650,,,9650.0,MTFR1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTFR1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
15,1713077,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4522,MTHFD1,https://ctdbase.org/detail.go?type=gene&acc=4522,,,4522.0,MTHFD1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTHFD1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
16,1713078,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTHFD2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
17,1713079,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,441024,MTHFD2L,https://ctdbase.org/detail.go?type=gene&acc=441024,,,441024.0,MTHFD2L,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTHFD2L mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
18,1713080,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4524,MTHFR,https://ctdbase.org/detail.go?type=gene&acc=4524,,,4524.0,MTHFR,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTHFR mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
19,1713159,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,132014,IL17RE,https://ctdbase.org/detail.go?type=gene&acc=132014,,,132014.0,IL17RE,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IL17RE mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
20,1713160,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IL18 mRNA,,,PMID:37047793,https://www.ncbi.nlm.nih.gov/pubmed/37047793,37047793,,
21,1713161,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10068,IL18BP,https://ctdbase.org/detail.go?type=gene&acc=10068,,,10068.0,IL18BP,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IL18BP mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
22,1713162,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,8809,IL18R1,https://ctdbase.org/detail.go?type=gene&acc=8809,,,8809.0,IL18R1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of IL18R1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
23,1713163,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10116.0,Rattus norvegicus (Norway rat),[isoquercitrin analog co-treated with propylthiouracil] results in increased expression of IL1A mrna|[thioctic acid co-treated with propylthiouracil] results in increased expression of IL1A mRNA,,,PMID:31068541,https://www.ncbi.nlm.nih.gov/pubmed/31068541,31068541,,
24,1713164,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of IL1B mRNA,,,PMID:24780913|PMID:29796989|PMID:37047793,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/29796989|https://www.ncbi.nlm.nih.gov/pubmed/37047793,24780913|29796989|37047793,,
25,1713412,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4547,MTTP,https://ctdbase.org/detail.go?type=gene&acc=4547,,,4547.0,MTTP,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTTP mRNA,,,PMID:22504374,https://www.ncbi.nlm.nih.gov/pubmed/22504374,22504374,,
26,1713413,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,222166,MTURN,https://ctdbase.org/detail.go?type=gene&acc=222166,,,222166.0,MTURN,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTURN mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
27,1713414,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,222166,MTURN,https://ctdbase.org/detail.go?type=gene&acc=222166,,,222166.0,MTURN,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTURN mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
28,1713415,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,57509,MTUS1,https://ctdbase.org/detail.go?type=gene&acc=57509,,,57509.0,MTUS1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTUS1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
29,1713416,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23281,MTUS2,https://ctdbase.org/detail.go?type=gene&acc=23281,,,23281.0,MTUS2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MTUS2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
30,1713417,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10651,MTX2,https://ctdbase.org/detail.go?type=gene&acc=10651,,,10651.0,MTX2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTX2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
31,1713418,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,345778,MTX3,https://ctdbase.org/detail.go?type=gene&acc=345778,,,345778.0,MTX3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MTX3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
32,1713419,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4582,MUC1,https://ctdbase.org/detail.go?type=gene&acc=4582,,,4582.0,MUC1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MUC1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
33,1713420,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4582,MUC1,https://ctdbase.org/detail.go?type=gene&acc=4582,,,4582.0,MUC1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MUC1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
34,1713724,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,91663,MYADM,https://ctdbase.org/detail.go?type=gene&acc=91663,,,91663.0,MYADM,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of MYADM mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
35,1713725,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,91663,MYADM,https://ctdbase.org/detail.go?type=gene&acc=91663,,,91663.0,MYADM,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYADM mRNA,,,PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/25825206,25825206,,
36,1713779,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55765,INAVA,https://ctdbase.org/detail.go?type=gene&acc=55765,,,55765.0,INAVA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of INAVA mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
37,1713780,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3619,INCENP,https://ctdbase.org/detail.go?type=gene&acc=3619,,,3619.0,INCENP,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of INCENP mRNA,,,PMID:22504374|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/22504374|https://www.ncbi.nlm.nih.gov/pubmed/30047161,22504374|30047161,,
38,1713781,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3622,ING2,https://ctdbase.org/detail.go?type=gene&acc=3622,,,3622.0,ING2,8355.0,Xenopus laevis (African clawed frog),Propylthiouracil results in decreased expression of ING2 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
39,1713782,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,51147,ING4,https://ctdbase.org/detail.go?type=gene&acc=51147,,,51147.0,ING4,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of ING4 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
40,1713783,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3623,INHA,https://ctdbase.org/detail.go?type=gene&acc=3623,,,3623.0,INHA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of INHA mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
41,1714120,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,8821,INPP4B,https://ctdbase.org/detail.go?type=gene&acc=8821,,,8821.0,INPP4B,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of INPP4B mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
42,1714121,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,8821,INPP4B,https://ctdbase.org/detail.go?type=gene&acc=8821,,,8821.0,INPP4B,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of INPP4B mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
43,1714122,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,3635,INPP5D,https://ctdbase.org/detail.go?type=gene&acc=3635,,,3635.0,INPP5D,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of INPP5D mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
44,1714123,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,22876,INPP5F,https://ctdbase.org/detail.go?type=gene&acc=22876,,,22876.0,INPP5F,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of INPP5F mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
45,1714124,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,27124,INPP5J,https://ctdbase.org/detail.go?type=gene&acc=27124,,,27124.0,INPP5J,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of INPP5J mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
46,1714125,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,51763,INPP5K,https://ctdbase.org/detail.go?type=gene&acc=51763,,,51763.0,INPP5K,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of INPP5K mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
47,1714126,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),[fructose co-treated with propylthiouracil] results in increased expression of INS1 protein,,,PMID:25882089,https://www.ncbi.nlm.nih.gov/pubmed/25882089,25882089,,
48,1714127,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of INS1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
49,1714184,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4635,MYL4,https://ctdbase.org/detail.go?type=gene&acc=4635,,,4635.0,MYL4,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of MYL4 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
50,1714185,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10398,MYL9,https://ctdbase.org/detail.go?type=gene&acc=10398,,,10398.0,MYL9,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYL9 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
51,1714186,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10398,MYL9,https://ctdbase.org/detail.go?type=gene&acc=10398,,,10398.0,MYL9,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYL9 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
52,1714187,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,29116,MYLIP,https://ctdbase.org/detail.go?type=gene&acc=29116,,,29116.0,MYLIP,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYLIP mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
53,1714188,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4638,MYLK,https://ctdbase.org/detail.go?type=gene&acc=4638,,,4638.0,MYLK,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of MYLK mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
54,1714189,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,85366,MYLK2,https://ctdbase.org/detail.go?type=gene&acc=85366,,,85366.0,MYLK2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYLK2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
55,1714190,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55892,MYNN,https://ctdbase.org/detail.go?type=gene&acc=55892,,,55892.0,MYNN,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYNN mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
56,1714191,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,80022,MYO15B,https://ctdbase.org/detail.go?type=gene&acc=80022,,,80022.0,MYO15B,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYO15B mRNA,,,PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/25825206,25825206,,
57,1714341,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23026,MYO16,https://ctdbase.org/detail.go?type=gene&acc=23026,,,23026.0,MYO16,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYO16 mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
58,1714342,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,80179,MYO19,https://ctdbase.org/detail.go?type=gene&acc=80179,,,80179.0,MYO19,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYO19 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
59,1714343,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4430,MYO1B,https://ctdbase.org/detail.go?type=gene&acc=4430,,,4430.0,MYO1B,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYO1B mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
60,1714344,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4642,MYO1D,https://ctdbase.org/detail.go?type=gene&acc=4642,,,4642.0,MYO1D,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of MYO1D mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
61,1714345,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4642,MYO1D,https://ctdbase.org/detail.go?type=gene&acc=4642,,,4642.0,MYO1D,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYO1D mRNA,,,PMID:24780913|PMID:25825206|PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206|https://www.ncbi.nlm.nih.gov/pubmed/36843608,24780913|25825206|36843608,,
62,1714524,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55930,MYO5C,https://ctdbase.org/detail.go?type=gene&acc=55930,,,55930.0,MYO5C,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYO5C mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
63,1714525,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4646,MYO6,https://ctdbase.org/detail.go?type=gene&acc=4646,,,4646.0,MYO6,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYO6 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
64,1714526,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4647,MYO7A,https://ctdbase.org/detail.go?type=gene&acc=4647,,,4647.0,MYO7A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of MYO7A mRNA,,,PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/36843608,36843608,,
65,1714527,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4647,MYO7A,https://ctdbase.org/detail.go?type=gene&acc=4647,,,4647.0,MYO7A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYO7A mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
66,1714528,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,4653,MYOC,https://ctdbase.org/detail.go?type=gene&acc=4653,,,4653.0,MYOC,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of MYOC mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
67,1714692,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23138,N4BP3,https://ctdbase.org/detail.go?type=gene&acc=23138,,,23138.0,N4BP3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of N4BP3 mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
68,1714693,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,29104,N6AMT1,https://ctdbase.org/detail.go?type=gene&acc=29104,,,29104.0,N6AMT1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of N6AMT1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
69,1714694,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,51126,NAA20,https://ctdbase.org/detail.go?type=gene&acc=51126,,,51126.0,NAA20,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of NAA20 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
70,1714695,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,80018,NAA25,https://ctdbase.org/detail.go?type=gene&acc=80018,,,80018.0,NAA25,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of NAA25 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
71,1715183,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,24594658,NAPRT1,https://ctdbase.org/detail.go?type=gene&acc=24594658,,,24594658.0,,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of NAPRT1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
72,1715184,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9476,NAPSA,https://ctdbase.org/detail.go?type=gene&acc=9476,,,9476.0,NAPSA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of NAPSA mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
73,1710804,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Curcumin results in decreased expression of IL1B mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
74,1710805,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10036.0,Mesocricetus auratus (golden hamster),Curcumin results in decreased expression of IL1B mRNA,,,PMID:21256849,https://www.ncbi.nlm.nih.gov/pubmed/21256849,21256849,,
75,1710806,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Curcumin affects the expression of IL1B mRNA,,,PMID:18752423,https://www.ncbi.nlm.nih.gov/pubmed/18752423,18752423,,
76,1710807,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Curcumin analog inhibits the reaction [lipopolysaccharides results in increased expression of IL1B protein],,,PMID:36156276,https://www.ncbi.nlm.nih.gov/pubmed/36156276,36156276,,
77,1710808,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [aflatoxin B1 results in increased expression of IL1B mrna]|curcumin inhibits the reaction [aflatoxin B1 results in increased secretion of IL1B protein],,,PMID:35063475,https://www.ncbi.nlm.nih.gov/pubmed/35063475,35063475,,
78,1710809,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [chloranil results in increased expression of IL1B protein],,,PMID:25123790,https://www.ncbi.nlm.nih.gov/pubmed/25123790,25123790,,
79,1711725,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [IL6 protein results in increased expression of AR protein]|curcumin inhibits the reaction [IL6 protein results in increased expression of KLK3 protein]|curcumin inhibits the reaction [IL6 protein results in increased expression of KLK3 mrna]|curcumin inhibits the reaction [IL6 protein results in increased expression of AR mrna],,,PMID:18676361,https://www.ncbi.nlm.nih.gov/pubmed/18676361,18676361,,
80,1711726,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna],,,PMID:18209571,https://www.ncbi.nlm.nih.gov/pubmed/18209571,18209571,,
81,1711727,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein]|tin protoporphyrin IX inhibits the reaction [curcumin inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein]],,,PMID:18357586,https://www.ncbi.nlm.nih.gov/pubmed/18357586,18357586,,
82,1711728,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),"Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of IL6 protein]|mir125a mRNA inhibits the reaction [curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of IL6 protein]]|sirt6 protein promotes the reaction [curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of IL6 protein]]",,,PMID:33952798,https://www.ncbi.nlm.nih.gov/pubmed/33952798,33952798,,
83,1711729,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [nickel chloride results in increased expression of IL6 protein],,,PMID:30016632,https://www.ncbi.nlm.nih.gov/pubmed/30016632,30016632,,
84,1711730,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of IL6 mrna],,,PMID:17151092,https://www.ncbi.nlm.nih.gov/pubmed/17151092,17151092,,
85,1712166,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein],,,PMID:21811692,https://www.ncbi.nlm.nih.gov/pubmed/21811692,21811692,,
86,1712167,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [sodium arsenite affects the expression of IL6 mrna],,,PMID:34272803,https://www.ncbi.nlm.nih.gov/pubmed/34272803,34272803,,
87,1712346,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [acetaminophen results in increased expression of IL6 mrna],,,PMID:33350580,https://www.ncbi.nlm.nih.gov/pubmed/33350580,33350580,,
88,1712347,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [carbon tetrachloride results in increased expression of IL6 mrna],,,PMID:17383825|PMID:22683883,https://www.ncbi.nlm.nih.gov/pubmed/17383825|https://www.ncbi.nlm.nih.gov/pubmed/22683883,17383825|22683883,,
89,1712348,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [carbon tetrachloride results in increased expression of IL6 protein],,,PMID:18006644,https://www.ncbi.nlm.nih.gov/pubmed/18006644,18006644,,
90,1712528,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3572,IL6ST,https://ctdbase.org/detail.go?type=gene&acc=3572,,,3572.0,IL6ST,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [trichloroethylene results in increased expression of IL6ST protein],,,PMID:34233590,https://www.ncbi.nlm.nih.gov/pubmed/34233590,34233590,,
91,1712529,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of CEBPA mrna]]|curcumin inhibits the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mrna]|curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mrna]]|curcumin inhibits the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG mrna]|curcumin inhibits the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased abundance of triglycerides]|curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG mrna]]|curcumin inhibits the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of TNF mrna]|curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of TNF mrna]]|curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased abundance of triglycerides]]|curcumin inhibits the reaction [[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of CEBPA mrna],,,PMID:28595985,https://www.ncbi.nlm.nih.gov/pubmed/28595985,28595985,,
92,1712530,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [fructose results in increased expression of INS protein],,,PMID:25268984|PMID:26713546,https://www.ncbi.nlm.nih.gov/pubmed/25268984|https://www.ncbi.nlm.nih.gov/pubmed/26713546,25268984|26713546,,
93,1710903,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of IL1B,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
94,1710904,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,11009,IL24,https://ctdbase.org/detail.go?type=gene&acc=11009,,,11009.0,IL24,9606.0,Homo sapiens (human),Sulindac promotes the reaction [IL24 protein results in increased phosphorylation of MAPK8 protein]|[sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein|[sulindac results in increased expression of IL24 protein] which results in increased expression of CASP3 protein|sulindac results in increased expression of IL24 protein,,,PMID:15713900,https://www.ncbi.nlm.nih.gov/pubmed/15713900,15713900,,
95,1710905,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,9235,IL32,https://ctdbase.org/detail.go?type=gene&acc=9235,,,9235.0,IL32,9606.0,Homo sapiens (human),Sulindac inhibits the reaction [CDKN1A protein results in increased expression of IL32 mrna],,,PMID:15190207,https://www.ncbi.nlm.nih.gov/pubmed/15190207,15190207,,
96,1710906,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),"[sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IL6 mRNA",,,PMID:20371263,https://www.ncbi.nlm.nih.gov/pubmed/20371263,20371263,,
97,1710907,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of IL6,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
98,1710908,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,3611,ILK,https://ctdbase.org/detail.go?type=gene&acc=3611,,,3611.0,ILK,9606.0,Homo sapiens (human),Sulindac results in decreased activity of ILK protein,,,PMID:11593435,https://www.ncbi.nlm.nih.gov/pubmed/11593435,11593435,,
99,1710909,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,56623,INPP5E,https://ctdbase.org/detail.go?type=gene&acc=56623,,,56623.0,INPP5E,9606.0,Homo sapiens (human),Sulindac results in increased expression of INPP5E mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
100,1710910,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,253430,IPMK,https://ctdbase.org/detail.go?type=gene&acc=253430,,,253430.0,IPMK,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of IPMK mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
101,1711976,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,64951,MRPS24,https://ctdbase.org/detail.go?type=gene&acc=64951,,,64951.0,MRPS24,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of MRPS24 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
102,1711977,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,10240,MRPS31,https://ctdbase.org/detail.go?type=gene&acc=10240,,,10240.0,MRPS31,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of MRPS31 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
103,1711978,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,51650,MRPS33,https://ctdbase.org/detail.go?type=gene&acc=51650,,,51650.0,MRPS33,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of MRPS33 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
104,1711979,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,51081,MRPS7,https://ctdbase.org/detail.go?type=gene&acc=51081,,,51081.0,MRPS7,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of MRPS7 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
105,1711980,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,64965,MRPS9,https://ctdbase.org/detail.go?type=gene&acc=64965,,,64965.0,MRPS9,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of MRPS9 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
106,1711981,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,9606.0,Homo sapiens (human),Sulindac results in increased expression of MTHFD2 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
107,1712232,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,9,NAT1,https://ctdbase.org/detail.go?type=gene&acc=9,,,9.0,NAT1,9606.0,Homo sapiens (human),Sulindac results in decreased expression of NAT1 mRNA,,,PMID:11828994,https://www.ncbi.nlm.nih.gov/pubmed/11828994,11828994,,
108,1712233,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,9606.0,Homo sapiens (human),Sulindac results in increased expression of NDRG1 mRNA,,,PMID:16273229,https://www.ncbi.nlm.nih.gov/pubmed/16273229,16273229,,
109,1712234,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of NDRG1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
110,1712235,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,8509,NDST2,https://ctdbase.org/detail.go?type=gene&acc=8509,,,8509.0,NDST2,9606.0,Homo sapiens (human),Sulindac results in decreased expression of NDST2 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
111,1712236,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,4698,NDUFA5,https://ctdbase.org/detail.go?type=gene&acc=4698,,,4698.0,NDUFA5,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of NDUFA5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
112,1712237,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,4731,NDUFV3,https://ctdbase.org/detail.go?type=gene&acc=4731,,,4731.0,NDUFV3,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of NDUFV3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
113,1712238,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,140609,NEK7,https://ctdbase.org/detail.go?type=gene&acc=140609,,,140609.0,NEK7,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of NEK7 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
114,1712239,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,4758,NEU1,https://ctdbase.org/detail.go?type=gene&acc=4758,,,4758.0,NEU1,9606.0,Homo sapiens (human),Sulindac results in increased expression of NEU1 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
115,1712240,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,4779,NFE2L1,https://ctdbase.org/detail.go?type=gene&acc=4779,,,4779.0,NFE2L1,9606.0,Homo sapiens (human),Sulindac results in increased expression of NFE2L1 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
116,1712241,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,4779,NFE2L1,https://ctdbase.org/detail.go?type=gene&acc=4779,,,4779.0,NFE2L1,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of NFE2L1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
117,1712800,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5093,PCBP1,https://ctdbase.org/detail.go?type=gene&acc=5093,,,5093.0,PCBP1,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of PCBP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
118,1712801,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,9606.0,Homo sapiens (human),Sulindac results in decreased expression of PCDH17 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
119,1712802,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606.0,Homo sapiens (human),Sulindac results in increased expression of PCK2 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
120,1712803,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090.0,Mus musculus (house mouse),Sulindac results in decreased expression of PCNA protein,,,PMID:15020200,https://www.ncbi.nlm.nih.gov/pubmed/15020200,15020200,,
121,1712804,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116.0,Rattus norvegicus (Norway rat),"Kaempferol promotes the reaction [sulindac inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PCNA protein]]|sulindac inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PCNA protein]|epigallocatechin gallate promotes the reaction [sulindac inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PCNA protein]]",,,PMID:29999212,https://www.ncbi.nlm.nih.gov/pubmed/29999212,29999212,,
122,1712805,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5154,PDGFA,https://ctdbase.org/detail.go?type=gene&acc=5154,,,5154.0,PDGFA,10116.0,Rattus norvegicus (Norway rat),"[sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PDGFA mRNA",,,PMID:20371263,https://www.ncbi.nlm.nih.gov/pubmed/20371263,20371263,,
123,1712957,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5310,PKD1,https://ctdbase.org/detail.go?type=gene&acc=5310,,,5310.0,PKD1,9606.0,Homo sapiens (human),Sulindac results in increased expression of PKD1 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
124,1712958,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5319,PLA2G1B,https://ctdbase.org/detail.go?type=gene&acc=5319,,,5319.0,PLA2G1B,9823.0,Sus scrofa (pig),Sulindac promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mrna],,,PMID:10706128,https://www.ncbi.nlm.nih.gov/pubmed/10706128,10706128,,
125,1712959,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5321,PLA2G4A,https://ctdbase.org/detail.go?type=gene&acc=5321,,,5321.0,PLA2G4A,10090.0,Mus musculus (house mouse),Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein],,,PMID:15816863,https://www.ncbi.nlm.nih.gov/pubmed/15816863,15816863,,
126,1712960,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5321,PLA2G4A,https://ctdbase.org/detail.go?type=gene&acc=5321,,,5321.0,PLA2G4A,10090.0,Mus musculus (house mouse),Sulindac results in decreased expression of PLA2G4A mRNA,,,PMID:10706128,https://www.ncbi.nlm.nih.gov/pubmed/10706128,10706128,,
127,1714051,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Sulindac results in increased expression of RELA mRNA,,,PMID:16273229,https://www.ncbi.nlm.nih.gov/pubmed/16273229,16273229,,
128,1714052,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5972,REN,https://ctdbase.org/detail.go?type=gene&acc=5972,,,5972.0,REN,9606.0,Homo sapiens (human),Sulindac inhibits the reaction [furosemide results in increased expression of REN protein],,,PMID:4028619,https://www.ncbi.nlm.nih.gov/pubmed/4028619,4028619,,
129,1714053,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5972,REN,https://ctdbase.org/detail.go?type=gene&acc=5972,,,5972.0,REN,9606.0,Homo sapiens (human),Sulindac results in decreased activity of REN protein,,,PMID:2203262|PMID:3884224,https://www.ncbi.nlm.nih.gov/pubmed/2203262|https://www.ncbi.nlm.nih.gov/pubmed/3884224,2203262|3884224,,
130,1714054,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,19702,REN2,https://ctdbase.org/detail.go?type=gene&acc=19702,,,19702.0,Ren2,10116.0,Rattus norvegicus (Norway rat),[sulindac co-treated with REN2] results in increased expression of ALB protein,,,PMID:12586211,https://www.ncbi.nlm.nih.gov/pubmed/12586211,12586211,,
131,1714055,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,5979,RET,https://ctdbase.org/detail.go?type=gene&acc=5979,,,5979.0,RET,9606.0,Homo sapiens (human),Sulindac affects the expression of RET protein,,,PMID:12388792,https://www.ncbi.nlm.nih.gov/pubmed/12388792,12388792,,
132,1714056,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,301079,RGD1311745,https://ctdbase.org/detail.go?type=gene&acc=301079,,,301079.0,RGD1311745,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of RGD1311745 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
133,1714566,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,80349,SKIC8,https://ctdbase.org/detail.go?type=gene&acc=80349,,,80349.0,SKIC8,10116.0,Rattus norvegicus (Norway rat),Sulindac results in decreased expression of SKIC8 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
134,1714567,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,9120,SLC16A6,https://ctdbase.org/detail.go?type=gene&acc=9120,,,9120.0,SLC16A6,9606.0,Homo sapiens (human),Sulindac results in increased expression of SLC16A6 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
135,1714568,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,116843,SLC18B1,https://ctdbase.org/detail.go?type=gene&acc=116843,,,116843.0,SLC18B1,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of SLC18B1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
136,1714569,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),Sulindac results in decreased activity of SLC22A1 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
137,1714570,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,55867,SLC22A11,https://ctdbase.org/detail.go?type=gene&acc=55867,,,55867.0,SLC22A11,9606.0,Homo sapiens (human),Sulindac results in decreased activity of SLC22A11 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
138,1714571,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,9606.0,Homo sapiens (human),Sulindac results in decreased activity of SLC22A2 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
139,1715015,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,6813,STXBP2,https://ctdbase.org/detail.go?type=gene&acc=6813,,,6813.0,STXBP2,9606.0,Homo sapiens (human),Sulindac results in increased expression of STXBP2 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
140,1715016,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,8802,SUCLG1,https://ctdbase.org/detail.go?type=gene&acc=8802,,,8802.0,SUCLG1,10116.0,Rattus norvegicus (Norway rat),Sulindac results in increased expression of SUCLG1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
141,1715017,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,27284,SULT1B1,https://ctdbase.org/detail.go?type=gene&acc=27284,,,27284.0,SULT1B1,10116.0,Rattus norvegicus (Norway rat),"[sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT1B1 mRNA",,,PMID:20371263,https://www.ncbi.nlm.nih.gov/pubmed/20371263,20371263,,
142,1715018,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,6783,SULT1E1,https://ctdbase.org/detail.go?type=gene&acc=6783,,,6783.0,SULT1E1,9606.0,Homo sapiens (human),Sulindac results in decreased activity of SULT1E1 protein,,,PMID:17073578,https://www.ncbi.nlm.nih.gov/pubmed/17073578,17073578,,
143,1715019,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,6783,SULT1E1,https://ctdbase.org/detail.go?type=gene&acc=6783,,,6783.0,SULT1E1,10116.0,Rattus norvegicus (Norway rat),"[sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT1E1 mRNA",,,PMID:20371263,https://www.ncbi.nlm.nih.gov/pubmed/20371263,20371263,,
144,1711817,2724003,Toxin and Toxin Target Database (T3DB),Argentous cyanide,T3D0765,Silver cyanide,http://www.t3db.ca/toxins/T3D0765,BE0005012,"Cytochrome c oxidase subunit 6A1, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005012,P12074,"Cytochrome c oxidase subunit 6A1, mitochondrial",1337.0,COX6A1,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
145,1711818,2724003,Toxin and Toxin Target Database (T3DB),Argentous cyanide,T3D0765,Silver cyanide,http://www.t3db.ca/toxins/T3D0765,BE0003994,"Cytochrome c oxidase subunit 6A2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003994,Q02221,"Cytochrome c oxidase subunit 6A2, mitochondrial",1339.0,COX6A2,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
146,1711819,2724003,Toxin and Toxin Target Database (T3DB),Argentous cyanide,T3D0765,Silver cyanide,http://www.t3db.ca/toxins/T3D0765,BE0003995,Cytochrome c oxidase subunit 6B1,http://www.t3db.ca/biodb/bio_entities/BE0003995,P14854,Cytochrome c oxidase subunit 6B1,1340.0,COX6B1,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
147,1713672,2724144,Toxin and Toxin Target Database (T3DB),Cuprous cyanide,T3D0753,Copper(I) cyanide,http://www.t3db.ca/toxins/T3D0753,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
148,1713673,2724144,Toxin and Toxin Target Database (T3DB),Cuprous cyanide,T3D0753,Copper(I) cyanide,http://www.t3db.ca/toxins/T3D0753,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002252,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",6392.0,SDHD,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
149,1713674,2724144,Toxin and Toxin Target Database (T3DB),Cuprous cyanide,T3D0753,Copper(I) cyanide,http://www.t3db.ca/toxins/T3D0753,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
150,1713675,2724144,Toxin and Toxin Target Database (T3DB),Cuprous cyanide,T3D0753,Copper(I) cyanide,http://www.t3db.ca/toxins/T3D0753,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
151,1713676,2724350,Drug Gene Interaction database (DGIdb),6-Mercaptopurine monohydrate,,MERCAPTOPURINE,https://www.dgidb.org/drugs/rxcui:103,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
152,1713677,2724350,Drug Gene Interaction database (DGIdb),6-Mercaptopurine monohydrate,,MERCAPTOPURINE,https://www.dgidb.org/drugs/rxcui:103,,HBB,https://www.dgidb.org/genes/hgnc:4827,,,3043.0,HBB,9606.0,Homo sapiens (human),,,,,,,,
153,1713678,2724385,Drug Gene Interaction database (DGIdb),Digoxin,,DIGOXIN,https://www.dgidb.org/drugs/rxcui:3407,,ATP1A3,https://www.dgidb.org/genes/hgnc:801,,,478.0,ATP1A3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
154,1710810,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of GCLC mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
155,1712882,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PCNA mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
156,1712883,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,80003,PCNX2,https://ctdbase.org/detail.go?type=gene&acc=80003,,,80003.0,PCNX2,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of PCNX2 mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
157,1712884,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,255738,PCSK9,https://ctdbase.org/detail.go?type=gene&acc=255738,,,255738.0,PCSK9,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PCSK9 mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
158,1712885,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,5154,PDGFA,https://ctdbase.org/detail.go?type=gene&acc=5154,,,5154.0,PDGFA,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PDGFA mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased expression of PDGFA mrna|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[tetrachlorodibenzodioxin co-treated with IL1B protein] results in increased expression of PDGFA mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tetrachlorodibenzodioxin results in increased secretion of PDGFA protein]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased secretion of PDGFA protein,,,PMID:23625689,https://www.ncbi.nlm.nih.gov/pubmed/23625689,23625689,,
159,1713669,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein],,,PMID:36646296,https://www.ncbi.nlm.nih.gov/pubmed/36646296,36646296,,
160,1713670,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [isovitexin inhibits the reaction [TNF protein results in increased expression of RELA protein]],,,PMID:37263555,https://www.ncbi.nlm.nih.gov/pubmed/37263555,37263555,,
161,1713671,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,83695,RHNO1,https://ctdbase.org/detail.go?type=gene&acc=83695,,,83695.0,RHNO1,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [particulate matter results in decreased expression of RHNO1 mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [vehicle emissions results in decreased expression of RHNO1 mrna],,,PMID:28655636,https://www.ncbi.nlm.nih.gov/pubmed/28655636,28655636,,
162,1713844,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,257160,RNF214,https://ctdbase.org/detail.go?type=gene&acc=257160,,,257160.0,RNF214,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [vehicle emissions results in increased expression of RNF214 mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [particulate matter results in increased expression of RNF214 mrna],,,PMID:28655636,https://www.ncbi.nlm.nih.gov/pubmed/28655636,28655636,,
163,1713845,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,200312,RNF215,https://ctdbase.org/detail.go?type=gene&acc=200312,,,200312.0,RNF215,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of RNF215 mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
164,1711896,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607.0,Agtr1a,10116.0,Rattus norvegicus (Norway rat),Ovalbumin results in increased expression of AGTR1A mRNA,,,PMID:19080339,https://www.ncbi.nlm.nih.gov/pubmed/19080339,19080339,,
165,1711897,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,11608,AGTR1B,https://ctdbase.org/detail.go?type=gene&acc=11608,,,11608.0,Agtr1b,10116.0,Rattus norvegicus (Norway rat),Ovalbumin results in increased expression of AGTR1B mRNA,,,PMID:19080339,https://www.ncbi.nlm.nih.gov/pubmed/19080339,19080339,,
166,1711898,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,186,AGTR2,https://ctdbase.org/detail.go?type=gene&acc=186,,,186.0,AGTR2,10116.0,Rattus norvegicus (Norway rat),Ovalbumin results in decreased expression of AGTR2 mRNA,,,PMID:19080339,https://www.ncbi.nlm.nih.gov/pubmed/19080339,19080339,,
167,1711899,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),"MYD88 gene mutant form affects the reaction [[antigens, bacterial co-treated with ovalbumin] results in decreased expression of AHR mrna]|[antigens, bacterial co-treated with ovalbumin] results in decreased expression of AHR mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
168,1712340,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,10090.0,Mus musculus (house mouse),"[antigens, bacterial co-treated with ovalbumin] results in increased expression of BID mrna|myd88 gene mutant form affects the reaction [[antigens, bacterial co-treated with ovalbumin] results in increased expression of BID mrna]",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
169,1712341,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,640,BLK,https://ctdbase.org/detail.go?type=gene&acc=640,,,640.0,BLK,10090.0,Mus musculus (house mouse),Ovalbumin results in increased expression of BLK mRNA,,,PMID:32846909,https://www.ncbi.nlm.nih.gov/pubmed/32846909,32846909,,
170,1712342,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,651,BMP3,https://ctdbase.org/detail.go?type=gene&acc=651,,,651.0,BMP3,10116.0,Rattus norvegicus (Norway rat),[ovalbumin affects the susceptibility to particulate matter] which results in decreased expression of BMP3 mRNA,,,PMID:19176365,https://www.ncbi.nlm.nih.gov/pubmed/19176365,19176365,,
171,1712343,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,659,BMPR2,https://ctdbase.org/detail.go?type=gene&acc=659,,,659.0,BMPR2,10090.0,Mus musculus (house mouse),BMPR2 protein affects the susceptibility to ovalbumin|bmpr2 protein affects the reaction [ovalbumin results in increased expression of RETNLA mrna],,,PMID:23383100,https://www.ncbi.nlm.nih.gov/pubmed/23383100,23383100,,
172,1712344,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,659,BMPR2,https://ctdbase.org/detail.go?type=gene&acc=659,,,659.0,BMPR2,10090.0,Mus musculus (house mouse),[particulate matter co-treated with ovalbumin] results in decreased expression of BMPR2 mrna|[particulate matter co-treated with ovalbumin] results in decreased expression of BMPR2 protein,,,PMID:28415675,https://www.ncbi.nlm.nih.gov/pubmed/28415675,28415675,,
173,1712345,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,84312,BRMS1L,https://ctdbase.org/detail.go?type=gene&acc=84312,,,84312.0,BRMS1L,10116.0,Rattus norvegicus (Norway rat),[ovalbumin affects the susceptibility to particulate matter] which results in decreased expression of BRMS1L mRNA,,,PMID:19176365,https://www.ncbi.nlm.nih.gov/pubmed/19176365,19176365,,
174,1712652,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090.0,Mus musculus (house mouse),"[dexamethasone co-treated with curcumin] inhibits the reaction [[ovalbumin co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased cleavage of CASP1 protein]|curcumin inhibits the reaction [[ovalbumin co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased cleavage of CASP1 protein]|curcumin inhibits the reaction [[ovalbumin co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased expression of CASP1 mrna]|[dexamethasone co-treated with curcumin] inhibits the reaction [[ovalbumin co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased expression of CASP1 mrna]|[ovalbumin co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased expression of CASP1 mrna|[ovalbumin co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased cleavage of CASP1 protein",,,PMID:34998855,https://www.ncbi.nlm.nih.gov/pubmed/34998855,34998855,,
175,1712653,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090.0,Mus musculus (house mouse),"[MYD88 gene mutant form affects the susceptibility to [antigens, bacterial co-treated with ovalbumin]] which affects the expression of CASP1 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
176,1712654,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with ovalbumin] results in increased expression of CCL3 mRNA,,,PMID:31788436,https://www.ncbi.nlm.nih.gov/pubmed/31788436,31788436,,
177,1712655,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090.0,Mus musculus (house mouse),Ovalbumin results in increased cleavage of CASP1 protein|particulate matter promotes the reaction [ovalbumin results in increased cleavage of CASP1 protein]|tlr2 protein affects the reaction [particulate matter promotes the reaction [ovalbumin results in increased cleavage of CASP1 protein]],,,PMID:31836503,https://www.ncbi.nlm.nih.gov/pubmed/31836503,31836503,,
178,1712656,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),"[MYD88 gene mutant form affects the susceptibility to [antigens, bacterial co-treated with ovalbumin]] which affects the expression of CASP3 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
179,1712657,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),TLR2 protein affects the reaction [ovalbumin results in increased cleavage of CASP3 protein],,,PMID:31836503,https://www.ncbi.nlm.nih.gov/pubmed/31836503,31836503,,
180,1713261,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6369,CCL24,https://ctdbase.org/detail.go?type=gene&acc=6369,,,6369.0,CCL24,10090.0,Mus musculus (house mouse),"[MYD88 gene mutant form affects the susceptibility to [antigens, bacterial co-treated with ovalbumin]] which affects the expression of CCL24 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
181,1713262,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),"MYD88 gene mutant form affects the reaction [[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL3 mrna]|[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL3 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
182,1713263,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),[ovalbumin co-treated with dust] results in increased expression of CCL3 protein|myd88 gene mutant form promotes the reaction [[ovalbumin co-treated with dust] results in increased expression of CCL3 protein]|polymyxin B inhibits the reaction [[ovalbumin co-treated with dust] results in increased expression of CCL3 protein],,,PMID:26882889,https://www.ncbi.nlm.nih.gov/pubmed/26882889,26882889,,
183,1713264,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351.0,CCL4,10090.0,Mus musculus (house mouse),"MYD88 gene mutant form affects the reaction [[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL4 mrna]|[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL4 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
184,1713265,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,10090.0,Mus musculus (house mouse),"MYD88 gene mutant form affects the reaction [[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL5 mrna]|[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL5 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
185,1713266,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,10090.0,Mus musculus (house mouse),[bisphenol A affects the susceptibility to ovalbumin] which results in increased expression of and results in increased secretion of CCL5 protein,,,PMID:29737898,https://www.ncbi.nlm.nih.gov/pubmed/29737898,29737898,,
186,1713267,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,10090.0,Mus musculus (house mouse),[ovalbumin co-treated with dust] results in increased expression of CCL5 protein|myd88 gene mutant form inhibits the reaction [[ovalbumin co-treated with dust] results in increased expression of CCL5 protein]|polymyxin B inhibits the reaction [[ovalbumin co-treated with dust] results in increased expression of CCL5 protein],,,PMID:26882889,https://www.ncbi.nlm.nih.gov/pubmed/26882889,26882889,,
187,1713268,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10090.0,Mus musculus (house mouse),"MYD88 gene mutant form affects the reaction [[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL6 mrna]|[antigens, bacterial co-treated with ovalbumin] results in increased expression of CCL6 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
188,1714563,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,1293,COL6A3,https://ctdbase.org/detail.go?type=gene&acc=1293,,,1293.0,COL6A3,10090.0,Mus musculus (house mouse),Ovalbumin results in increased expression of COL6A3 mRNA,,,PMID:32846909,https://www.ncbi.nlm.nih.gov/pubmed/32846909,32846909,,
189,1714564,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,1359,CPA3,https://ctdbase.org/detail.go?type=gene&acc=1359,,,1359.0,CPA3,10090.0,Mus musculus (house mouse),Ovalbumin results in increased expression of CPA3 mRNA,,,PMID:32846909,https://www.ncbi.nlm.nih.gov/pubmed/32846909,32846909,,
190,1714565,3342298,ChEMBL,4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide,CHEMBL440498,CTS-1027,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL440498/,CHEMBL283,Matrix metalloproteinase 3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL283/,P08254,Stromelysin-1,4314.0,MMP3,9606.0,Homo sapiens (human),Matrix metalloproteinase 3 inhibitor,,,PMID:19624765,https://www.ncbi.nlm.nih.gov/pubmed/19624765,19624765,,
191,1711796,4286311,Therapeutic Target Database (TTD),4-butyl-N-pyridin-3-ylbenzamide,D00XZZ,4-butyl-N-(pyridin-3-yl)benzamide,https://idrblab.net/ttd/data/drug/details/D00XZZ,T83193,Transient receptor potential cation channel V1 (TRPV1),https://idrblab.net/ttd/data/target/details/T83193,Q8NER1,Transient receptor potential cation channel subfamily V member 1,7442.0,TRPV1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
192,1712392,4329839,IUPHAR/BPS Guide to PHARMACOLOGY,3-[[2-[[2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[(1-amino-1-oxo-3-phenylpropan-2-yl)amino]-4-oxobutanoic acid,861,CCK-4,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=861,76,CCK1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=76,P30551,Cholecystokinin receptor type A,24889.0,Cckar,10116.0,Rattus norvegicus (Norway rat),Full agonist,pIC50,5.3,PMID:1975695,https://www.ncbi.nlm.nih.gov/pubmed/1975695,1975695,,
193,1712393,4329839,IUPHAR/BPS Guide to PHARMACOLOGY,3-[[2-[[2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[(1-amino-1-oxo-3-phenylpropan-2-yl)amino]-4-oxobutanoic acid,861,CCK-4,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=861,77,CCK2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=77,P32239,Gastrin/cholecystokinin type B receptor,887.0,CCKBR,9606.0,Homo sapiens (human),Full agonist,pIC50,7.5,PMID:8349705,https://www.ncbi.nlm.nih.gov/pubmed/8349705,8349705,,
194,1710878,4331799,IUPHAR/BPS Guide to PHARMACOLOGY,"N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N'-[4-(dimethylamino)phenyl]urea",1704,SB-408124,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1704,321,OX1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=321,P56718,Orexin receptor type 1,25593.0,Hcrtr1,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,6.4,PMID:25583879,https://www.ncbi.nlm.nih.gov/pubmed/25583879,25583879,,
195,1710879,4338240,BindingDB,"1-[(4-Bromoanilino)methyl]indole-2,3-dione",22805,"1-{[(4-bromophenyl)amino]methyl}-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22805,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
196,1710880,4350924,BindingDB,"1-(2-chloroacetyl)-2,3-dihydro-1H-indole-2,3-dione",22788,"1-(2-chloroacetyl)-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22788,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
197,1711797,4369935,BindingDB,"1,2-Bis(4-ethoxyphenyl)ethane-1,2-dione",22847,"1,2-Dione-Based Compound, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22847,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),1420,PMID:17941623|DOI:10.1021/jm0706867,https://www.ncbi.nlm.nih.gov/pubmed/17941623|https://doi.org/10.1021/jm0706867,17941623,10.1021/jm0706867,
198,1711798,4369935,BindingDB,"1,2-Bis(4-ethoxyphenyl)ethane-1,2-dione",22847,"1,2-Dione-Based Compound, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22847,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17941623|DOI:10.1021/jm0706867,https://www.ncbi.nlm.nih.gov/pubmed/17941623|https://doi.org/10.1021/jm0706867,17941623,10.1021/jm0706867,
199,1712054,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,100101467,ZSCAN30,https://ctdbase.org/detail.go?type=gene&acc=100101467,,,100101467.0,ZSCAN30,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN30 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN30 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
200,1712055,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,64288,ZSCAN31,https://ctdbase.org/detail.go?type=gene&acc=64288,,,64288.0,ZSCAN31,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN31 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN31 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN31 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
201,1712056,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,7746,ZSCAN9,https://ctdbase.org/detail.go?type=gene&acc=7746,,,7746.0,ZSCAN9,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN9 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
202,1712057,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,57643,ZSWIM5,https://ctdbase.org/detail.go?type=gene&acc=57643,,,57643.0,ZSWIM5,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSWIM5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
203,1712058,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,79364,ZXDC,https://ctdbase.org/detail.go?type=gene&acc=79364,,,79364.0,ZXDC,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZXDC mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
204,1712059,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,440590,ZYG11A,https://ctdbase.org/detail.go?type=gene&acc=440590,,,440590.0,ZYG11A,9606.0,Homo sapiens (human),"[NOG protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZYG11A mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZYG11A mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZYG11A mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZYG11A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
205,1712797,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,8991,SELENBP1,https://ctdbase.org/detail.go?type=gene&acc=8991,,,8991.0,SELENBP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENBP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
206,1712798,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,280636,SELENOH,https://ctdbase.org/detail.go?type=gene&acc=280636,,,280636.0,SELENOH,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SELENOH protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
207,1712799,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,85465,SELENOI,https://ctdbase.org/detail.go?type=gene&acc=85465,,,85465.0,SELENOI,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SELENOI mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SELENOI mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SELENOI mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
208,1713610,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,92482,BBIP1,https://ctdbase.org/detail.go?type=gene&acc=92482,,,92482.0,BBIP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BBIP1 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BBIP1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BBIP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
209,1713611,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,79738,BBS10,https://ctdbase.org/detail.go?type=gene&acc=79738,,,79738.0,BBS10,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BBS10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
210,1713612,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,9532,BAG2,https://ctdbase.org/detail.go?type=gene&acc=9532,,,9532.0,BAG2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mrna|[nog protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
211,1713613,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,9606.0,Homo sapiens (human),"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mrna|[nog protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
212,1713784,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10458,BAIAP2,https://ctdbase.org/detail.go?type=gene&acc=10458,,,10458.0,BAIAP2,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BAIAP2 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
213,1713785,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,440465,BAIAP2-DT,https://ctdbase.org/detail.go?type=gene&acc=440465,,,440465.0,BAIAP2-DT,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAIAP2-DT mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAIAP2-DT mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAIAP2-DT mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAIAP2-DT mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
214,1713786,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,55971,BAIAP2L1,https://ctdbase.org/detail.go?type=gene&acc=55971,,,55971.0,BAIAP2L1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAIAP2L1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
215,1713787,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,55210,ATAD3A,https://ctdbase.org/detail.go?type=gene&acc=55210,,,55210.0,ATAD3A,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATAD3A protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
216,1713788,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,79915,ATAD5,https://ctdbase.org/detail.go?type=gene&acc=79915,,,79915.0,ATAD5,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD5 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
217,1714118,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RORA mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
218,1714119,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,6096,RORB,https://ctdbase.org/detail.go?type=gene&acc=6096,,,6096.0,RORB,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RORB mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RORB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
219,1712394,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,1845,DUSP3,https://ctdbase.org/detail.go?type=gene&acc=1845,,,1845.0,DUSP3,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of DUSP3 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
220,1712395,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,1846,DUSP4,https://ctdbase.org/detail.go?type=gene&acc=1846,,,1846.0,DUSP4,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of DUSP4 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
221,1712396,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,1847,DUSP5,https://ctdbase.org/detail.go?type=gene&acc=1847,,,1847.0,DUSP5,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of DUSP5 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
222,1712397,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,1852,DUSP9,https://ctdbase.org/detail.go?type=gene&acc=1852,,,1852.0,DUSP9,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of DUSP9 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
223,1712398,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,1780,DYNC1I1,https://ctdbase.org/detail.go?type=gene&acc=1780,,,1780.0,DYNC1I1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of DYNC1I1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
224,1712399,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,13586,EAR1,https://ctdbase.org/detail.go?type=gene&acc=13586,,,13586.0,Ear1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of EAR1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
225,1712886,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,9413,ENTREP1,https://ctdbase.org/detail.go?type=gene&acc=9413,,,9413.0,ENTREP1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of ENTREP1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
226,1712887,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,2034,EPAS1,https://ctdbase.org/detail.go?type=gene&acc=2034,,,2034.0,EPAS1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of EPAS1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
227,1712888,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,23136,EPB41L3,https://ctdbase.org/detail.go?type=gene&acc=23136,,,23136.0,EPB41L3,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of EPB41L3 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
228,1712889,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,64097,EPB41L4A,https://ctdbase.org/detail.go?type=gene&acc=64097,,,64097.0,EPB41L4A,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of EPB41L4A mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
229,1712890,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of EPHA2 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
230,1713846,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,3756,KCNH1,https://ctdbase.org/detail.go?type=gene&acc=3756,,,3756.0,KCNH1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of KCNH1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
231,1713847,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,3776,KCNK2,https://ctdbase.org/detail.go?type=gene&acc=3776,,,3776.0,KCNK2,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of KCNK2 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
232,1713848,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,9424,KCNK6,https://ctdbase.org/detail.go?type=gene&acc=9424,,,9424.0,KCNK6,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of KCNK6 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
233,1713849,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,79047,KCTD15,https://ctdbase.org/detail.go?type=gene&acc=79047,,,79047.0,KCTD15,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of KCTD15 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
234,1713850,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,10116.0,Rattus norvegicus (Norway rat),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of KDR mRNA,,,PMID:24475139,https://www.ncbi.nlm.nih.gov/pubmed/24475139,24475139,,
235,1713851,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,55083,KIF26B,https://ctdbase.org/detail.go?type=gene&acc=55083,,,55083.0,KIF26B,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of KIF26B mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
236,1713852,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,3799,KIF5B,https://ctdbase.org/detail.go?type=gene&acc=3799,,,3799.0,KIF5B,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of KIF5B mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
237,1713853,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,83855,KLF16,https://ctdbase.org/detail.go?type=gene&acc=83855,,,83855.0,KLF16,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of KLF16 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
238,1714336,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,4060,LUM,https://ctdbase.org/detail.go?type=gene&acc=4060,,,4060.0,LUM,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of LUM mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
239,1714337,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,116372,LYPD1,https://ctdbase.org/detail.go?type=gene&acc=116372,,,116372.0,LYPD1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of LYPD1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
240,1714338,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MAFB mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
241,1714339,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of MAFF mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
242,1714340,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,260425,MAGI3,https://ctdbase.org/detail.go?type=gene&acc=260425,,,260425.0,MAGI3,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MAGI3 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
243,1714832,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,4233,MET,https://ctdbase.org/detail.go?type=gene&acc=4233,,,4233.0,MET,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MET mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
244,1714833,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,4234,METTL1,https://ctdbase.org/detail.go?type=gene&acc=4234,,,4234.0,METTL1,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of METTL1 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
245,1714834,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,155368,METTL27,https://ctdbase.org/detail.go?type=gene&acc=155368,,,155368.0,METTL27,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of METTL27 mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
246,1714835,4668801,Comparative Toxicogenomics Database (CTD),methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C548651,84206,MEX3B,https://ctdbase.org/detail.go?type=gene&acc=84206,,,84206.0,MEX3B,10090.0,Mus musculus (house mouse),2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MEX3B mRNA,,,PMID:19933214,https://www.ncbi.nlm.nih.gov/pubmed/19933214,19933214,,
247,1711820,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,483,ATP1B3,https://ctdbase.org/detail.go?type=gene&acc=483,,,483.0,ATP1B3,9606.0,Homo sapiens (human),Quercetin results in increased expression of ATP1B3 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
248,1711821,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,91419,ATP23,https://ctdbase.org/detail.go?type=gene&acc=91419,,,91419.0,ATP23,9606.0,Homo sapiens (human),Quercetin results in decreased expression of ATP23 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
249,1711822,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,487,ATP2A1,https://ctdbase.org/detail.go?type=gene&acc=487,,,487.0,ATP2A1,9606.0,Homo sapiens (human),Quercetin results in increased expression of ATP2A1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
250,1711823,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,488,ATP2A2,https://ctdbase.org/detail.go?type=gene&acc=488,,,488.0,ATP2A2,10090.0,Mus musculus (house mouse),Quercetin promotes the reaction [dietary fats results in decreased expression of ATP2A2 mrna],,,PMID:27260466,https://www.ncbi.nlm.nih.gov/pubmed/27260466,27260466,,
251,1711824,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,498,ATP5F1A,https://ctdbase.org/detail.go?type=gene&acc=498,,,498.0,ATP5F1A,9606.0,Homo sapiens (human),Quercetin analog binds to ATP5F1A protein,,,PMID:21798748,https://www.ncbi.nlm.nih.gov/pubmed/21798748,21798748,,
252,1711825,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,9606.0,Homo sapiens (human),Quercetin analog binds to ATP5F1B protein,,,PMID:21798748,https://www.ncbi.nlm.nih.gov/pubmed/21798748,21798748,,
253,1713155,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),[quercetin results in increased susceptibility to cisplatin] which results in increased expression of BAX protein,,,PMID:16619537,https://www.ncbi.nlm.nih.gov/pubmed/16619537,16619537,,
254,1713156,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10036.0,Mesocricetus auratus (golden hamster),"Quercetin inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]|quercetin inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX mrna]",,,PMID:21294050,https://www.ncbi.nlm.nih.gov/pubmed/21294050,21294050,,
255,1713157,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [benzo(a)pyrene results in decreased expression of BAX protein]|[curcumin co-treated with quercetin] inhibits the reaction [benzo(a)pyrene results in decreased expression of BAX protein],,,PMID:28681665,https://www.ncbi.nlm.nih.gov/pubmed/28681665,28681665,,
256,1713158,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [4-nitro-3-cresol results in increased expression of BAX protein],,,PMID:22467373,https://www.ncbi.nlm.nih.gov/pubmed/22467373,22467373,,
257,1713345,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [4-nitrophenol results in increased expression of BAX protein],,,PMID:23997041,https://www.ncbi.nlm.nih.gov/pubmed/23997041,23997041,,
258,1713346,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [cadmium chloride results in increased expression of BAX protein],,,PMID:21337715,https://www.ncbi.nlm.nih.gov/pubmed/21337715,21337715,,
259,1713347,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [diethylnitrosamine results in decreased expression of BAX protein],,,PMID:34726822,https://www.ncbi.nlm.nih.gov/pubmed/34726822,34726822,,
260,1713348,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [okadaic acid results in increased expression of BAX protein],,,PMID:27050422,https://www.ncbi.nlm.nih.gov/pubmed/27050422,27050422,,
261,1713349,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin results in increased expression of BAX mRNA,,,PMID:25543474,https://www.ncbi.nlm.nih.gov/pubmed/25543474,25543474,,
262,1713350,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Quercetin results in increased expression of BAX protein,,,PMID:17039455|PMID:25543474,https://www.ncbi.nlm.nih.gov/pubmed/17039455|https://www.ncbi.nlm.nih.gov/pubmed/25543474,17039455|25543474,,
263,1713351,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [vincristine results in increased expression of BAX mrna],,,PMID:33038355,https://www.ncbi.nlm.nih.gov/pubmed/33038355,33038355,,
264,1713513,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of BAX mrna],,,PMID:19466539,https://www.ncbi.nlm.nih.gov/pubmed/19466539,19466539,,
265,1713514,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [aluminum lactate results in increased expression of BAX protein],,,PMID:26944603,https://www.ncbi.nlm.nih.gov/pubmed/26944603,26944603,,
266,1713515,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cadmium chloride results in increased expression of BAX protein],,,PMID:27389774,https://www.ncbi.nlm.nih.gov/pubmed/27389774,27389774,,
267,1713516,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [chlorodiphenyl (54% chlorine) results in increased expression of BAX protein]|quercetin results in decreased expression of BAX mRNA,,,PMID:23281070,https://www.ncbi.nlm.nih.gov/pubmed/23281070,23281070,,
268,1713517,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [chlorpyrifos results in increased expression of BAX protein],,,PMID:30990955,https://www.ncbi.nlm.nih.gov/pubmed/30990955,30990955,,
269,1713717,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [thioacetamide affects the expression of BAX protein modified form],,,PMID:21885874,https://www.ncbi.nlm.nih.gov/pubmed/21885874,21885874,,
270,1713718,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein],,,PMID:23138875,https://www.ncbi.nlm.nih.gov/pubmed/23138875,23138875,,
271,1713719,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [triptolide affects the expression of BAX protein],,,PMID:26277538,https://www.ncbi.nlm.nih.gov/pubmed/26277538,26277538,,
272,1713720,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9823.0,Sus scrofa (pig),Quercetin inhibits the reaction [[antimycin A co-treated with deoxyglucose] results in increased expression of BAX protein],,,PMID:25087994,https://www.ncbi.nlm.nih.gov/pubmed/25087994,25087994,,
273,1713721,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,11177,BAZ1A,https://ctdbase.org/detail.go?type=gene&acc=11177,,,11177.0,BAZ1A,9606.0,Homo sapiens (human),Quercetin results in increased expression of BAZ1A mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
274,1713722,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,29994,BAZ2B,https://ctdbase.org/detail.go?type=gene&acc=29994,,,29994.0,BAZ2B,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BAZ2B mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
275,1713723,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,166379,BBS12,https://ctdbase.org/detail.go?type=gene&acc=166379,,,166379.0,BBS12,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BBS12 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
276,1713935,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,583,BBS2,https://ctdbase.org/detail.go?type=gene&acc=583,,,583.0,BBS2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BBS2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
277,1713936,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,585,BBS4,https://ctdbase.org/detail.go?type=gene&acc=585,,,585.0,BBS4,9606.0,Homo sapiens (human),Quercetin results in increased expression of BBS4 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
278,1713937,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,129880,BBS5,https://ctdbase.org/detail.go?type=gene&acc=129880,,,129880.0,BBS5,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BBS5 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
279,1713938,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,27241,BBS9,https://ctdbase.org/detail.go?type=gene&acc=27241,,,27241.0,BBS9,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BBS9 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
280,1713939,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4059,BCAM,https://ctdbase.org/detail.go?type=gene&acc=4059,,,4059.0,BCAM,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BCAM mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
281,1713940,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,9564,BCAR1,https://ctdbase.org/detail.go?type=gene&acc=9564,,,9564.0,BCAR1,9606.0,Homo sapiens (human),Quercetin results in increased expression of BCAR1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
282,1713941,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8412,BCAR3,https://ctdbase.org/detail.go?type=gene&acc=8412,,,8412.0,BCAR3,9606.0,Homo sapiens (human),Quercetin results in increased expression of BCAR3 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
283,1713942,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,586,BCAT1,https://ctdbase.org/detail.go?type=gene&acc=586,,,586.0,BCAT1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BCAT1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
284,1713943,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9796.0,Equus caballus (horse),Quercetin binds to and results in decreased activity of BCHE protein,,,PMID:19596285,https://www.ncbi.nlm.nih.gov/pubmed/19596285,19596285,,
285,1713944,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cadmium chloride results in increased activity of BCHE protein],,,PMID:25064450,https://www.ncbi.nlm.nih.gov/pubmed/25064450,25064450,,
286,1714272,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[pterostilbene co-treated with quercetin] results in decreased expression of BCL2 protein|rela protein affects the reaction [[pterostilbene co-treated with quercetin] results in decreased expression of BCL2 protein],,,PMID:18852136,https://www.ncbi.nlm.nih.gov/pubmed/18852136,18852136,,
287,1714273,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin affects the expression of BCL2 protein,,,PMID:15975156,https://www.ncbi.nlm.nih.gov/pubmed/15975156,15975156,,
288,1714274,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[quercetin analog co-treated with gold analog] results in decreased expression of BCL2 protein,,,PMID:27470402,https://www.ncbi.nlm.nih.gov/pubmed/27470402,27470402,,
289,1714275,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[quercetin analog co-treated with nickel] results in decreased expression of BCL2 protein,,,PMID:20577783,https://www.ncbi.nlm.nih.gov/pubmed/20577783,20577783,,
290,1714276,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin analog results in decreased expression of BCL2 protein,,,PMID:25289772,https://www.ncbi.nlm.nih.gov/pubmed/25289772,25289772,,
291,1714277,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [glucose results in increased degradation of and results in decreased expression of BCL2 protein],,,PMID:19557821,https://www.ncbi.nlm.nih.gov/pubmed/19557821,19557821,,
292,1714278,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [hydrogen peroxide results in decreased expression of BCL2 protein],,,PMID:12672908|PMID:25108166,https://www.ncbi.nlm.nih.gov/pubmed/12672908|https://www.ncbi.nlm.nih.gov/pubmed/25108166,12672908|25108166,,
293,1714455,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin metabolite results in decreased expression of BCL2 protein,,,PMID:16280456,https://www.ncbi.nlm.nih.gov/pubmed/16280456,16280456,,
294,1714456,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin promotes the reaction [TNFSF10 protein results in decreased expression of BCL2 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
295,1714457,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BCL2,,,PMID:21867607,https://www.ncbi.nlm.nih.gov/pubmed/21867607,21867607,,
296,1714458,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BCL2 mRNA,,,PMID:10437144|PMID:22200874|PMID:30639267,https://www.ncbi.nlm.nih.gov/pubmed/10437144|https://www.ncbi.nlm.nih.gov/pubmed/22200874|https://www.ncbi.nlm.nih.gov/pubmed/30639267,10437144|22200874|30639267,,
297,1714459,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of BCL2 protein,,,PMID:10437144|PMID:14688022|PMID:15741050|PMID:16049707|PMID:16082193|PMID:16898267|PMID:18787224|PMID:19623560|PMID:20386985|PMID:20438634|PMID:20803121|PMID:22222411|PMID:22431435|PMID:22447039|PMID:22555976|PMID:22983795|PMID:24612139|PMID:25293876|PMID:25339540|PMID:25481090|PMID:25830055|PMID:25896339|PMID:28811126|PMID:30152185|PMID:30639267|PMID:33070227,https://www.ncbi.nlm.nih.gov/pubmed/10437144|https://www.ncbi.nlm.nih.gov/pubmed/14688022|https://www.ncbi.nlm.nih.gov/pubmed/15741050|https://www.ncbi.nlm.nih.gov/pubmed/16049707|https://www.ncbi.nlm.nih.gov/pubmed/16082193|https://www.ncbi.nlm.nih.gov/pubmed/16898267|https://www.ncbi.nlm.nih.gov/pubmed/18787224|https://www.ncbi.nlm.nih.gov/pubmed/19623560|https://www.ncbi.nlm.nih.gov/pubmed/20386985|https://www.ncbi.nlm.nih.gov/pubmed/20438634|https://www.ncbi.nlm.nih.gov/pubmed/20803121|https://www.ncbi.nlm.nih.gov/pubmed/22222411|https://www.ncbi.nlm.nih.gov/pubmed/22431435|https://www.ncbi.nlm.nih.gov/pubmed/22447039|https://www.ncbi.nlm.nih.gov/pubmed/22555976|https://www.ncbi.nlm.nih.gov/pubmed/22983795|https://www.ncbi.nlm.nih.gov/pubmed/24612139|https://www.ncbi.nlm.nih.gov/pubmed/25293876|https://www.ncbi.nlm.nih.gov/pubmed/25339540|https://www.ncbi.nlm.nih.gov/pubmed/25481090|https://www.ncbi.nlm.nih.gov/pubmed/25830055|https://www.ncbi.nlm.nih.gov/pubmed/25896339|https://www.ncbi.nlm.nih.gov/pubmed/28811126|https://www.ncbi.nlm.nih.gov/pubmed/30152185|https://www.ncbi.nlm.nih.gov/pubmed/30639267|https://www.ncbi.nlm.nih.gov/pubmed/33070227,10437144|14688022|15741050|16049707|16082193|16898267|18787224|19623560|20386985|20438634|20803121|22222411|22431435|22447039|22555976|22983795|24612139|25293876|25339540|25481090|25830055|25896339|28811126|30152185|30639267|33070227,,
298,1714460,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin results in increased expression of BCL2 mRNA,,,PMID:23727915,https://www.ncbi.nlm.nih.gov/pubmed/23727915,23727915,,
299,1714461,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Quercetin results in increased phosphorylation of BCL2 protein,,,PMID:16059641,https://www.ncbi.nlm.nih.gov/pubmed/16059641,16059641,,
300,1714636,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[quercetin results in increased susceptibility to cisplatin] which results in decreased expression of BCL2 protein,,,PMID:16619537,https://www.ncbi.nlm.nih.gov/pubmed/16619537,16619537,,
301,1714637,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10036.0,Mesocricetus auratus (golden hamster),"Quercetin inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 mrna]|quercetin inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]",,,PMID:21294050,https://www.ncbi.nlm.nih.gov/pubmed/21294050,21294050,,
302,1714827,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Quercetin affects the expression of BCL2 protein,,,PMID:22000973,https://www.ncbi.nlm.nih.gov/pubmed/22000973,22000973,,
303,1714828,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Quercetin affects the reaction [glucose affects the expression of BCL2 protein],,,PMID:22524206,https://www.ncbi.nlm.nih.gov/pubmed/22524206,22524206,,
304,1714829,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [aluminum lactate affects the localization of BCL2 protein],,,PMID:26944603,https://www.ncbi.nlm.nih.gov/pubmed/26944603,26944603,,
305,1714830,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cadmium chloride results in decreased expression of BCL2 protein],,,PMID:27389774,https://www.ncbi.nlm.nih.gov/pubmed/27389774,27389774,,
306,1714831,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Quercetin results in decreased expression of BCL2 protein|quercetin inhibits the reaction [chlorodiphenyl (54% chlorine) results in increased expression of BCL2 protein]|quercetin results in increased expression of BCL2 mrna|quercetin inhibits the reaction [chlorodiphenyl (54% chlorine) results in increased expression of BCL2 mrna],,,PMID:23281070,https://www.ncbi.nlm.nih.gov/pubmed/23281070,23281070,,
307,1711789,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9606.0,Homo sapiens (human),Linoleic acid results in decreased activity of DIO2 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
308,1711790,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,9606.0,Homo sapiens (human),Linoleic acid results in decreased activity of DIO3 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
309,1711791,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606.0,Homo sapiens (human),Linoleic acid results in decreased expression of EDN1 mrna|linoleic acid results in decreased expression of EDN1 protein,,,PMID:16895544,https://www.ncbi.nlm.nih.gov/pubmed/16895544,16895544,,
310,1711792,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),Linoleic acid results in decreased expression of FABP1 mRNA,,,PMID:15708366,https://www.ncbi.nlm.nih.gov/pubmed/15708366,15708366,,
311,1711793,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,2170,FABP3,https://ctdbase.org/detail.go?type=gene&acc=2170,,,2170.0,FABP3,9606.0,Homo sapiens (human),Linoleic acid results in decreased expression of FABP3 mRNA,,,PMID:15708366,https://www.ncbi.nlm.nih.gov/pubmed/15708366,15708366,,
312,1711794,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,2170,FABP3,https://ctdbase.org/detail.go?type=gene&acc=2170,,,2170.0,FABP3,9606.0,Homo sapiens (human),FABP3 protein results in increased uptake of linoleic acid analog,,,PMID:27939595,https://www.ncbi.nlm.nih.gov/pubmed/27939595,27939595,,
313,1711795,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),Linoleic acid analog affects the localization of FABP4 protein,,,PMID:27939595,https://www.ncbi.nlm.nih.gov/pubmed/27939595,27939595,,
314,1712961,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166.0,PDK4,10116.0,Rattus norvegicus (Norway rat),Linoleic acid results in increased expression of PDK4 mRNA,,,PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/23056435,23056435,,
315,1712962,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,9606.0,Homo sapiens (human),PLD2 protein inhibits the reaction [linoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]],,,PMID:16118212,https://www.ncbi.nlm.nih.gov/pubmed/16118212,16118212,,
316,1712963,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090.0,Mus musculus (house mouse),Linoleic acid analog results in increased expression of PLIN1 mRNA,,,PMID:27939595,https://www.ncbi.nlm.nih.gov/pubmed/27939595,27939595,,
317,1712964,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),Linoleic acid inhibits the reaction [PON1 protein results in increased hydrolysis of paraoxon]|linoleic acid inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid],,,PMID:15375178,https://www.ncbi.nlm.nih.gov/pubmed/15375178,15375178,,
318,1712965,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),Linoleic acid results in decreased activity of PON1 protein,,,PMID:12871208|PMID:15375178,https://www.ncbi.nlm.nih.gov/pubmed/12871208|https://www.ncbi.nlm.nih.gov/pubmed/15375178,12871208|15375178,,
319,1712966,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),"Linoleic acid inhibits the reaction [9,11-linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]]|linoleic acid inhibits the reaction [trans-10,cis-12-conjugated linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of PON1]]",,,PMID:12934671,https://www.ncbi.nlm.nih.gov/pubmed/12934671,12934671,,
320,1713508,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Linoleic acid results in increased expression of PTGS2 mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
321,1713509,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9823.0,Sus scrofa (pig),Linoleic acid promotes the reaction [[polychlorinated biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of dinoprostone]|prolinedithiocarbamate inhibits the reaction [[linoleic acid co-treated with polychlorinated biphenyls] results in increased expression of PTGS2 mrna]|linoleic acid promotes the reaction [polychlorinated biphenyls results in increased expression of PTGS2 protein]|linoleic acid promotes the reaction [polychlorinated biphenyls results in increased expression of PTGS2 mrna]|polychlorinated biphenyls promotes the reaction [[linoleic acid results in increased activity of PTGS2 protein] which results in increased chemical synthesis of dinoprostone]|prolinedithiocarbamate inhibits the reaction [linoleic acid results in increased expression of PTGS2 mrna]|linoleic acid results in increased expression of PTGS2 mRNA,,,PMID:18155686,https://www.ncbi.nlm.nih.gov/pubmed/18155686,18155686,,
322,1713510,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9823.0,Sus scrofa (pig),"PPARG protein promotes the reaction [linoleic acid results in increased activity of RELA protein]|2,4-thiazolidinedione inhibits the reaction [linoleic acid results in increased activity of RELA protein]|linoleic acid results in increased activity of RELA protein",,,PMID:14519784,https://www.ncbi.nlm.nih.gov/pubmed/14519784,14519784,,
323,1713511,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Linoleic acid binds to and results in increased activity of RXRA protein,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
324,1713512,5280450,Comparative Toxicogenomics Database (CTD),Linoleic Acid,D019787,Linoleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019787,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Linoleic acid binds to RXRA protein,,,PMID:16258897,https://www.ncbi.nlm.nih.gov/pubmed/16258897,16258897,,
325,1714270,5280644,Comparative Toxicogenomics Database (CTD),Bovinic acid,C503589,"cis-9, trans-11-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C503589,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116.0,Rattus norvegicus (Norway rat),"[trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in increased activity of SOD2 protein",,,PMID:17408517,https://www.ncbi.nlm.nih.gov/pubmed/17408517,17408517,,
326,1714271,5280644,Comparative Toxicogenomics Database (CTD),Bovinic acid,C503589,"cis-9, trans-11-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C503589,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10090.0,Mus musculus (house mouse),"Cis-9, trans-11-conjugated linoleic acid affects the expression of SREBF1 mRNA",,,PMID:17327424,https://www.ncbi.nlm.nih.gov/pubmed/17327424,17327424,,
327,1714628,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,5733,PTGER3,https://ctdbase.org/detail.go?type=gene&acc=5733,,,5733.0,PTGER3,9913.0,Bos taurus (cattle),Alprostadil results in increased expression of PTGER3 mRNA,,,PMID:22120546,https://www.ncbi.nlm.nih.gov/pubmed/22120546,22120546,,
328,1714629,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,5734,PTGER4,https://ctdbase.org/detail.go?type=gene&acc=5734,,,5734.0,PTGER4,9913.0,Bos taurus (cattle),Alprostadil results in decreased expression of PTGER4 mRNA,,,PMID:22120546,https://www.ncbi.nlm.nih.gov/pubmed/22120546,22120546,,
329,1714630,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606.0,Homo sapiens (human),Silymarin inhibits the reaction [alprostadil promotes the reaction [ABCC4 protein results in increased hydrolysis of adenosine triphosphate]]|quercetin inhibits the reaction [alprostadil promotes the reaction [ABCC4 protein results in increased hydrolysis of adenosine triphosphate]],,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
330,1714631,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),Alprostadil results in increased phosphorylation of ADRB2 protein,,,PMID:14722251,https://www.ncbi.nlm.nih.gov/pubmed/14722251,14722251,,
331,1714632,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606.0,Homo sapiens (human),Alprostadil results in increased expression of AGT protein,,,PMID:9195357,https://www.ncbi.nlm.nih.gov/pubmed/9195357,9195357,,
332,1714633,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Alprostadil inhibits the reaction [galactosamine results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:15565661,https://www.ncbi.nlm.nih.gov/pubmed/15565661,15565661,,
333,1714634,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Alprostadil inhibits the reaction [carbamazepine results in increased expression of CXCL2 mrna],,,PMID:22790970,https://www.ncbi.nlm.nih.gov/pubmed/22790970,22790970,,
334,1714635,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Alprostadil inhibits the reaction [[phenytoin co-treated with buthionine sulfoximine] results in increased expression of CXCL2 mrna],,,PMID:23986454,https://www.ncbi.nlm.nih.gov/pubmed/23986454,23986454,,
335,1715020,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,5737,PTGFR,https://ctdbase.org/detail.go?type=gene&acc=5737,,,5737.0,PTGFR,9913.0,Bos taurus (cattle),Alprostadil results in increased expression of PTGFR mRNA,,,PMID:22120546,https://www.ncbi.nlm.nih.gov/pubmed/22120546,22120546,,
336,1715021,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Alprostadil results in increased localization of and results in increased activity of RELA protein,,,PMID:15189274,https://www.ncbi.nlm.nih.gov/pubmed/15189274,15189274,,
337,1715022,5280723,Comparative Toxicogenomics Database (CTD),Alprostadil,D000527,Alprostadil,https://ctdbase.org/detail.go?type=chem&acc=D000527,4879,NPPB,https://ctdbase.org/detail.go?type=gene&acc=4879,,,4879.0,NPPB,9606.0,Homo sapiens (human),Alprostadil results in decreased expression of NPPB protein,,,PMID:16084762,https://www.ncbi.nlm.nih.gov/pubmed/16084762,16084762,,
338,1715023,5280793,Drug Gene Interaction database (DGIdb),Ergocalciferol,,ERGOCALCIFEROL,https://www.dgidb.org/drugs/rxcui:4018,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
339,1715024,5280862,Drug Gene Interaction database (DGIdb),Isokaempferide,,ISOKAEMPFERIDE,https://www.dgidb.org/drugs/chembl:CHEMBL165064,,WRN,https://www.dgidb.org/genes/hgnc:12791,,,7486.0,WRN,9606.0,Homo sapiens (human),,,,,,,,
340,1711658,5280953,Comparative Toxicogenomics Database (CTD),Harmine,D006247,Harmine,https://ctdbase.org/detail.go?type=chem&acc=D006247,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Harmine promotes the reaction [erlotinib hydrochloride results in increased cleavage of PARP1 protein],,,PMID:30171258,https://www.ncbi.nlm.nih.gov/pubmed/30171258,30171258,,
341,1711659,5280953,Comparative Toxicogenomics Database (CTD),Harmine,D006247,Harmine,https://ctdbase.org/detail.go?type=chem&acc=D006247,3651,PDX1,https://ctdbase.org/detail.go?type=gene&acc=3651,,,3651.0,PDX1,9606.0,Homo sapiens (human),Harmine results in increased expression of PDX1 mrna|harmine results in increased expression of PDX1 protein,,,PMID:25751815,https://www.ncbi.nlm.nih.gov/pubmed/25751815,25751815,,
342,1711660,5280953,Comparative Toxicogenomics Database (CTD),Harmine,D006247,Harmine,https://ctdbase.org/detail.go?type=chem&acc=D006247,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Harmine results in increased expression of PPARG protein,,,PMID:27805061,https://www.ncbi.nlm.nih.gov/pubmed/27805061,27805061,,
343,1711664,5280953,Comparative Toxicogenomics Database (CTD),Harmine,D006247,Harmine,https://ctdbase.org/detail.go?type=chem&acc=D006247,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10090.0,Mus musculus (house mouse),"Harmine results in increased expression of UCP1 protein|harmine inhibits the reaction [CHD4 protein binds to UCP1 promoter]|harmine affects the reaction [dietary fats affects the expression of UCP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [harmine results in increased expression of UCP1 mrna]|harmine results in increased expression of UCP1 mrna|n4-(9-ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-ylpropyl)-pyrimidine-2,4-diamine inhibits the reaction [harmine results in increased expression of UCP1 mrna]|harmine inhibits the reaction [CHD4 protein affects the expression of UCP1 mrna]|azd 6244 inhibits the reaction [harmine results in increased expression of UCP1 mrna]",,,PMID:27805061,https://www.ncbi.nlm.nih.gov/pubmed/27805061,27805061,,
344,1710735,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,84329,HVCN1,https://ctdbase.org/detail.go?type=gene&acc=84329,,,84329.0,HVCN1,10090.0,Mus musculus (house mouse),Genistein results in increased expression of HVCN1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
345,1710736,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,8372,HYAL3,https://ctdbase.org/detail.go?type=gene&acc=8372,,,8372.0,HYAL3,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of HYAL3 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
346,1710737,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,74409,HYAL6,https://ctdbase.org/detail.go?type=gene&acc=74409,,,74409.0,Hyal6,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of HYAL6 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
347,1710881,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3397,ID1,https://ctdbase.org/detail.go?type=gene&acc=3397,,,3397.0,ID1,9606.0,Homo sapiens (human),Genistein results in increased expression of ID1 mRNA,,,PMID:22228119,https://www.ncbi.nlm.nih.gov/pubmed/22228119,22228119,,
348,1710882,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3397,ID1,https://ctdbase.org/detail.go?type=gene&acc=3397,,,3397.0,ID1,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of ID1 mrna|[genistein co-treated with methoxychlor] results in decreased expression of ID1 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
349,1710883,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3399,ID3,https://ctdbase.org/detail.go?type=gene&acc=3399,,,3399.0,ID3,9606.0,Homo sapiens (human),Genistein results in decreased expression of ID3 mRNA,,,PMID:16474171|PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/16474171|https://www.ncbi.nlm.nih.gov/pubmed/26865669,16474171|26865669,,
350,1710884,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3399,ID3,https://ctdbase.org/detail.go?type=gene&acc=3399,,,3399.0,ID3,9606.0,Homo sapiens (human),Genistein results in increased expression of ID3 mRNA,,,PMID:22228119,https://www.ncbi.nlm.nih.gov/pubmed/22228119,22228119,,
351,1710885,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3400,ID4,https://ctdbase.org/detail.go?type=gene&acc=3400,,,3400.0,ID4,9606.0,Homo sapiens (human),Genistein results in increased expression of ID4 mRNA,,,PMID:22228119,https://www.ncbi.nlm.nih.gov/pubmed/22228119,22228119,,
352,1710886,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,9606.0,Homo sapiens (human),Genistein results in increased expression of IDI1 mRNA,,,PMID:15378649,https://www.ncbi.nlm.nih.gov/pubmed/15378649,15378649,,
353,1711665,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of IGFBP5 mRNA,,,PMID:22504913,https://www.ncbi.nlm.nih.gov/pubmed/22504913,22504913,,
354,1711666,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3489,IGFBP6,https://ctdbase.org/detail.go?type=gene&acc=3489,,,3489.0,IGFBP6,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in decreased expression of IGFBP6 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
355,1712400,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3605,IL17A,https://ctdbase.org/detail.go?type=gene&acc=3605,,,3605.0,IL17A,10090.0,Mus musculus (house mouse),[genistein results in increased activity of RORC protein] which results in increased expression of IL17A mrna|[genistein results in increased activity of RORA protein] which results in increased expression of IL17A mrna|genistein promotes the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of IL17A mrna],,,PMID:25583575,https://www.ncbi.nlm.nih.gov/pubmed/25583575,25583575,,
356,1712401,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,27190,IL17B,https://ctdbase.org/detail.go?type=gene&acc=27190,,,27190.0,IL17B,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of IL17B mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
357,1712733,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in increased expression of IL1R1 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
358,1712734,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7850,IL1R2,https://ctdbase.org/detail.go?type=gene&acc=7850,,,7850.0,IL1R2,9606.0,Homo sapiens (human),Genistein results in increased expression of IL1R2 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
359,1712735,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3557,IL1RN,https://ctdbase.org/detail.go?type=gene&acc=3557,,,3557.0,IL1RN,10090.0,Mus musculus (house mouse),Genistein results in increased expression of IL1RN mRNA,,,PMID:22553218,https://www.ncbi.nlm.nih.gov/pubmed/22553218,22553218,,
360,1712736,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in increased expression of IL2 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
361,1712737,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,50615,IL21R,https://ctdbase.org/detail.go?type=gene&acc=50615,,,50615.0,IL21R,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of IL21R mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
362,1712738,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,90865,IL33,https://ctdbase.org/detail.go?type=gene&acc=90865,,,90865.0,IL33,10090.0,Mus musculus (house mouse),Genistein results in increased expression of IL33 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
363,1712739,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,146433,IL34,https://ctdbase.org/detail.go?type=gene&acc=146433,,,146433.0,IL34,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of IL34 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
364,1712740,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,56300,IL36G,https://ctdbase.org/detail.go?type=gene&acc=56300,,,56300.0,IL36G,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of IL36G mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
365,1712741,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Genistein results in increased expression of IL4 mRNA,,,PMID:16169028|PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/16169028|https://www.ncbi.nlm.nih.gov/pubmed/32186404,16169028|32186404,,
366,1714519,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,83473,KATNAL2,https://ctdbase.org/detail.go?type=gene&acc=83473,,,83473.0,KATNAL2,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of KATNAL2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
367,1714520,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,23254,KAZN,https://ctdbase.org/detail.go?type=gene&acc=23254,,,23254.0,KAZN,9606.0,Homo sapiens (human),Genistein results in increased expression of KAZN mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
368,1714521,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,84541,KBTBD8,https://ctdbase.org/detail.go?type=gene&acc=84541,,,84541.0,KBTBD8,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of KBTBD8 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
369,1714522,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3736,KCNA1,https://ctdbase.org/detail.go?type=gene&acc=3736,,,3736.0,KCNA1,10090.0,Mus musculus (house mouse),Genistein results in increased expression of KCNA1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
370,1714523,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,3737,KCNA2,https://ctdbase.org/detail.go?type=gene&acc=3737,,,3737.0,KCNA2,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of KCNA2 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
371,1715175,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,79047,KCTD15,https://ctdbase.org/detail.go?type=gene&acc=79047,,,79047.0,KCTD15,10090.0,Mus musculus (house mouse),Genistein results in increased expression of KCTD15 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
372,1715176,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,23510,KCTD2,https://ctdbase.org/detail.go?type=gene&acc=23510,,,23510.0,KCTD2,9606.0,Homo sapiens (human),Genistein results in decreased expression of KCTD2 mRNA,,,PMID:16705744,https://www.ncbi.nlm.nih.gov/pubmed/16705744,16705744,,
373,1715177,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,222658,KCTD20,https://ctdbase.org/detail.go?type=gene&acc=222658,,,222658.0,KCTD20,9606.0,Homo sapiens (human),Genistein results in increased expression of KCTD20 mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
374,1715178,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,386617,KCTD8,https://ctdbase.org/detail.go?type=gene&acc=386617,,,386617.0,KCTD8,10090.0,Mus musculus (house mouse),Genistein results in increased expression of KCTD8 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
375,1715179,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,10945,KDELR1,https://ctdbase.org/detail.go?type=gene&acc=10945,,,10945.0,KDELR1,9606.0,Homo sapiens (human),Genistein results in decreased expression of KDELR1 mRNA,,,PMID:16705744,https://www.ncbi.nlm.nih.gov/pubmed/16705744,16705744,,
376,1715180,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,11014,KDELR2,https://ctdbase.org/detail.go?type=gene&acc=11014,,,11014.0,KDELR2,9606.0,Homo sapiens (human),Genistein results in increased expression of KDELR2 mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
377,1715181,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9682,KDM4A,https://ctdbase.org/detail.go?type=gene&acc=9682,,,9682.0,KDM4A,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of KDM4A protein,,,PMID:24552547,https://www.ncbi.nlm.nih.gov/pubmed/24552547,24552547,,
378,1715182,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,5927,KDM5A,https://ctdbase.org/detail.go?type=gene&acc=5927,,,5927.0,KDM5A,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
379,1712467,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,384,ARG2,https://ctdbase.org/detail.go?type=gene&acc=384,,,384.0,ARG2,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of ARG2 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
380,1712468,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,26084,ARHGEF26,https://ctdbase.org/detail.go?type=gene&acc=26084,,,26084.0,ARHGEF26,9606.0,Homo sapiens (human),Amphotericin B results in increased expression of ARHGEF26 mRNA,,,PMID:20849824,https://www.ncbi.nlm.nih.gov/pubmed/20849824,20849824,,
381,1712469,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Amphotericin B inhibits the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer],,,PMID:16189267,https://www.ncbi.nlm.nih.gov/pubmed/16189267,16189267,,
382,1712470,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,408,ARRB1,https://ctdbase.org/detail.go?type=gene&acc=408,,,408.0,ARRB1,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of ARRB1 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
383,1712471,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,64422,ATG3,https://ctdbase.org/detail.go?type=gene&acc=64422,,,64422.0,ATG3,9606.0,Homo sapiens (human),Amphotericin B results in decreased expression of ATG3 mRNA,,,PMID:20849824,https://www.ncbi.nlm.nih.gov/pubmed/20849824,20849824,,
384,1712472,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,23120,ATP10B,https://ctdbase.org/detail.go?type=gene&acc=23120,,,23120.0,ATP10B,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of ATP10B mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
385,1712473,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,79369,B3GNT4,https://ctdbase.org/detail.go?type=gene&acc=79369,,,79369.0,B3GNT4,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of B3GNT4 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
386,1712474,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,9530,BAG4,https://ctdbase.org/detail.go?type=gene&acc=9530,,,9530.0,BAG4,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of BAG4 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
387,1713011,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,79094,CHAC1,https://ctdbase.org/detail.go?type=gene&acc=79094,,,79094.0,CHAC1,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of CHAC1 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
388,1713012,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,1116,CHI3L1,https://ctdbase.org/detail.go?type=gene&acc=1116,,,1116.0,CHI3L1,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of CHI3L1 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
389,1713013,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,10752,CHL1,https://ctdbase.org/detail.go?type=gene&acc=10752,,,10752.0,CHL1,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of CHL1 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
390,1713014,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,11261,CHP1,https://ctdbase.org/detail.go?type=gene&acc=11261,,,11261.0,CHP1,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of CHP1 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
391,1713015,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,1142,CHRNB3,https://ctdbase.org/detail.go?type=gene&acc=1142,,,1142.0,CHRNB3,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of CHRNB3 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
392,1713016,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of CLU mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
393,1713604,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10090.0,Mus musculus (house mouse),[sodium selenite results in increased abundance of selenium] inhibits the reaction [[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in decreased expression of CYP7A1 mrna]|[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in decreased expression of CYP7A1 mRNA,,,PMID:36464106,https://www.ncbi.nlm.nih.gov/pubmed/36464106,36464106,,
394,1713605,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,10090.0,Mus musculus (house mouse),[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in decreased expression of CYP7B1 mRNA,,,PMID:36464106,https://www.ncbi.nlm.nih.gov/pubmed/36464106,36464106,,
395,1713606,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,1582,CYP8B1,https://ctdbase.org/detail.go?type=gene&acc=1582,,,1582.0,CYP8B1,10090.0,Mus musculus (house mouse),[sodium selenite results in increased abundance of selenium] inhibits the reaction [[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in decreased expression of CYP8B1 mrna]|[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in decreased expression of CYP8B1 mRNA,,,PMID:36464106,https://www.ncbi.nlm.nih.gov/pubmed/36464106,36464106,,
396,1713607,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,27128,CYTH4,https://ctdbase.org/detail.go?type=gene&acc=27128,,,27128.0,CYTH4,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of CYTH4 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
397,1713608,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of DCLK1 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
398,1713609,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,81501,DCSTAMP,https://ctdbase.org/detail.go?type=gene&acc=81501,,,81501.0,DCSTAMP,9606.0,Homo sapiens (human),Amphotericin B analog results in increased expression of DCSTAMP mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
399,1714922,5280965,Comparative Toxicogenomics Database (CTD),Amphotericin B,D000666,Amphotericin B,https://ctdbase.org/detail.go?type=chem&acc=D000666,3233,HOXD4,https://ctdbase.org/detail.go?type=gene&acc=3233,,,3233.0,HOXD4,9606.0,Homo sapiens (human),Amphotericin B analog results in decreased expression of HOXD4 mRNA,,,PMID:28534445,https://www.ncbi.nlm.nih.gov/pubmed/28534445,28534445,,
400,1775037,5281872,Toxin and Toxin Target Database (T3DB),"2-Methylbiphenyl-3-ylmethyl (Z)-(1RS,3RS)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate",T3D1843,Bifenthrin,http://www.t3db.ca/toxins/T3D1843,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
401,1775038,5281872,Toxin and Toxin Target Database (T3DB),"2-Methylbiphenyl-3-ylmethyl (Z)-(1RS,3RS)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate",T3D1843,Bifenthrin,http://www.t3db.ca/toxins/T3D1843,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
402,1711900,5282360,Comparative Toxicogenomics Database (CTD),4-Hydroxyestradiol,C014036,4-hydroxyestradiol,https://ctdbase.org/detail.go?type=chem&acc=C014036,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10090.0,Mus musculus (house mouse),4-hydroxyestradiol results in increased expression of PGR mRNA,,,PMID:9607801,https://www.ncbi.nlm.nih.gov/pubmed/9607801,9607801,,
403,1711901,5282360,Comparative Toxicogenomics Database (CTD),4-Hydroxyestradiol,C014036,4-hydroxyestradiol,https://ctdbase.org/detail.go?type=chem&acc=C014036,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,9606.0,Homo sapiens (human),4-hydroxyestradiol promotes the reaction [[medroxyprogesterone acetate co-treated with cyclic AMP] results in increased expression of PRL mrna]|4-hydroxyestradiol results in increased expression of PRL mRNA,,,PMID:32781018,https://www.ncbi.nlm.nih.gov/pubmed/32781018,32781018,,
404,1711902,5282361,Comparative Toxicogenomics Database (CTD),4-Hydroxychalcone,C451019,4-hydroxychalcone,https://ctdbase.org/detail.go?type=chem&acc=C451019,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,10116.0,Rattus norvegicus (Norway rat),4-hydroxychalcone binds to AFP protein,,,PMID:23013281|PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/23013281|https://www.ncbi.nlm.nih.gov/pubmed/25349334,23013281|25349334,,
405,1711903,5282361,Comparative Toxicogenomics Database (CTD),4-Hydroxychalcone,C451019,4-hydroxychalcone,https://ctdbase.org/detail.go?type=chem&acc=C451019,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10116.0,Rattus norvegicus (Norway rat),4-hydroxychalcone binds to AR protein,,,PMID:14565775,https://www.ncbi.nlm.nih.gov/pubmed/14565775,14565775,,
406,1711904,5282361,Comparative Toxicogenomics Database (CTD),4-Hydroxychalcone,C451019,4-hydroxychalcone,https://ctdbase.org/detail.go?type=chem&acc=C451019,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),4-hydroxychalcone binds to AR protein,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,
407,1711905,5282361,Comparative Toxicogenomics Database (CTD),4-Hydroxychalcone,C451019,4-hydroxychalcone,https://ctdbase.org/detail.go?type=chem&acc=C451019,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),4-hydroxychalcone results in decreased activity of CYP1A1 protein,,,PMID:15596260,https://www.ncbi.nlm.nih.gov/pubmed/15596260,15596260,,
408,1713071,5283204,Comparative Toxicogenomics Database (CTD),"11,12-Epoxyeicosatrienoic acid",C046783,"11,12-epoxy-5,8,14-eicosatrienoic acid",https://ctdbase.org/detail.go?type=chem&acc=C046783,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,10090.0,Mus musculus (house mouse),"[mercuric chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid",,,PMID:24472606,https://www.ncbi.nlm.nih.gov/pubmed/24472606,24472606,,
409,1713072,5283204,Comparative Toxicogenomics Database (CTD),"11,12-Epoxyeicosatrienoic acid",C046783,"11,12-epoxy-5,8,14-eicosatrienoic acid",https://ctdbase.org/detail.go?type=chem&acc=C046783,2230,FDX1,https://ctdbase.org/detail.go?type=gene&acc=2230,,,2230.0,FDX1,9606.0,Homo sapiens (human),"[CYP2C8 protein modified form co-treated with FDX1 protein co-treated with FDXR protein] results in increased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid",,,PMID:25160618,https://www.ncbi.nlm.nih.gov/pubmed/25160618,25160618,,
410,1713411,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,6453,ITSN1,https://ctdbase.org/detail.go?type=gene&acc=6453,,,6453.0,ITSN1,9606.0,Homo sapiens (human),4-hydroxy-2-nonenal results in decreased expression of ITSN1 mRNA,,,PMID:12419474,https://www.ncbi.nlm.nih.gov/pubmed/12419474,12419474,,
411,1714048,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,84232,MAF1,https://ctdbase.org/detail.go?type=gene&acc=84232,,,84232.0,MAF1,10090.0,Mus musculus (house mouse),4-hydroxy-2-nonenal results in increased expression of MAF1 mRNA,,,PMID:19191707,https://www.ncbi.nlm.nih.gov/pubmed/19191707,19191707,,
412,1714049,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,10090.0,Mus musculus (house mouse),4-hydroxy-2-nonenal results in decreased expression of MAFB mRNA,,,PMID:19191707,https://www.ncbi.nlm.nih.gov/pubmed/19191707,19191707,,
413,1714050,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,4097,MAFG,https://ctdbase.org/detail.go?type=gene&acc=4097,,,4097.0,MAFG,10090.0,Mus musculus (house mouse),4-hydroxy-2-nonenal results in increased expression of MAFG mRNA,,,PMID:19191707,https://www.ncbi.nlm.nih.gov/pubmed/19191707,19191707,,
414,1714192,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10090.0,Mus musculus (house mouse),4-hydroxy-2-nonenal results in increased expression of MAP1LC3B mRNA,,,PMID:19191707,https://www.ncbi.nlm.nih.gov/pubmed/19191707,19191707,,
415,1714193,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,5607,MAP2K5,https://ctdbase.org/detail.go?type=gene&acc=5607,,,5607.0,MAP2K5,9606.0,Homo sapiens (human),4-hydroxy-2-nonenal results in decreased expression of MAP2K5 mRNA,,,PMID:12419474,https://www.ncbi.nlm.nih.gov/pubmed/12419474,12419474,,
416,1713017,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,5260,PHKG1,https://ctdbase.org/detail.go?type=gene&acc=5260,,,5260.0,PHKG1,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of PHKG1 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
417,1713018,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of PHLDA2 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
418,1713019,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,90102,PHLDB2,https://ctdbase.org/detail.go?type=gene&acc=90102,,,90102.0,PHLDB2,9606.0,Homo sapiens (human),Licochalcone B results in decreased expression of PHLDB2 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
419,1714696,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,10110,SGK2,https://ctdbase.org/detail.go?type=gene&acc=10110,,,10110.0,SGK2,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SGK2 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
420,1714697,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,27352,SGSM3,https://ctdbase.org/detail.go?type=gene&acc=27352,,,27352.0,SGSM3,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SGSM3 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
421,1714698,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,79729,SH3D21,https://ctdbase.org/detail.go?type=gene&acc=79729,,,79729.0,SH3D21,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SH3D21 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
422,1714699,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,9644,SH3PXD2A,https://ctdbase.org/detail.go?type=gene&acc=9644,,,9644.0,SH3PXD2A,9606.0,Homo sapiens (human),Licochalcone B results in decreased expression of SH3PXD2A mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
423,1714700,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SHBG mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
424,1714923,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,220963,SLC16A9,https://ctdbase.org/detail.go?type=gene&acc=220963,,,220963.0,SLC16A9,9606.0,Homo sapiens (human),Licochalcone B results in decreased expression of SLC16A9 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
425,1714924,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,57030,SLC17A7,https://ctdbase.org/detail.go?type=gene&acc=57030,,,57030.0,SLC17A7,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SLC17A7 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
426,1714925,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,9606.0,Homo sapiens (human),Licochalcone B results in decreased expression of SLC22A2 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
427,1714926,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,114789,SLC25A25,https://ctdbase.org/detail.go?type=gene&acc=114789,,,114789.0,SLC25A25,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SLC25A25 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
428,1714927,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,55630,SLC39A4,https://ctdbase.org/detail.go?type=gene&acc=55630,,,55630.0,SLC39A4,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SLC39A4 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
429,1714928,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,80736,SLC44A4,https://ctdbase.org/detail.go?type=gene&acc=80736,,,80736.0,SLC44A4,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SLC44A4 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
430,1714929,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,6528,SLC5A5,https://ctdbase.org/detail.go?type=gene&acc=6528,,,6528.0,SLC5A5,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SLC5A5 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
431,1714930,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,6540,SLC6A13,https://ctdbase.org/detail.go?type=gene&acc=6540,,,6540.0,SLC6A13,9606.0,Homo sapiens (human),Licochalcone B results in increased expression of SLC6A13 mRNA,,,PMID:33647349,https://www.ncbi.nlm.nih.gov/pubmed/33647349,33647349,,
432,1710901,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,389816,LRRC26,https://ctdbase.org/detail.go?type=gene&acc=389816,,,389816.0,LRRC26,9606.0,Homo sapiens (human),Arsenicals results in decreased expression of LRRC26 mRNA,,,PMID:28625800,https://www.ncbi.nlm.nih.gov/pubmed/28625800,28625800,,
433,1710902,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,55631,LRRC40,https://ctdbase.org/detail.go?type=gene&acc=55631,,,55631.0,LRRC40,9606.0,Homo sapiens (human),Arsenicals results in increased methylation of LRRC40 promoter,,,PMID:26039340,https://www.ncbi.nlm.nih.gov/pubmed/26039340,26039340,,
434,1711731,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,79680,RTL10,https://ctdbase.org/detail.go?type=gene&acc=79680,,,79680.0,RTL10,9606.0,Homo sapiens (human),Arsenicals results in decreased expression of RTL10 mRNA,,,PMID:28625800,https://www.ncbi.nlm.nih.gov/pubmed/28625800,28625800,,
435,1711732,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,7356,SCGB1A1,https://ctdbase.org/detail.go?type=gene&acc=7356,,,7356.0,SCGB1A1,9606.0,Homo sapiens (human),Arsenicals results in decreased expression of SCGB1A1 mRNA,,,PMID:28625800,https://www.ncbi.nlm.nih.gov/pubmed/28625800,28625800,,
436,1711733,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,266629,SEC14L3,https://ctdbase.org/detail.go?type=gene&acc=266629,,,266629.0,SEC14L3,9606.0,Homo sapiens (human),Arsenicals results in decreased expression of SEC14L3 mRNA,,,PMID:28625800,https://www.ncbi.nlm.nih.gov/pubmed/28625800,28625800,,
437,1712158,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,140870,WFDC6,https://ctdbase.org/detail.go?type=gene&acc=140870,,,140870.0,WFDC6,9606.0,Homo sapiens (human),Arsenicals results in decreased expression of WFDC6 mRNA,,,PMID:28625800,https://www.ncbi.nlm.nih.gov/pubmed/28625800,28625800,,
438,1712159,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,7474,WNT5A,https://ctdbase.org/detail.go?type=gene&acc=7474,,,7474.0,WNT5A,9606.0,Homo sapiens (human),Arsenicals affects the acetylation of WNT5A promoter,,,PMID:19061910,https://www.ncbi.nlm.nih.gov/pubmed/19061910,19061910,,
439,1712160,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,374887,YJEFN3,https://ctdbase.org/detail.go?type=gene&acc=374887,,,374887.0,YJEFN3,9606.0,Homo sapiens (human),Arsenicals results in increased methylation of YJEFN3 promoter,,,PMID:26039340,https://www.ncbi.nlm.nih.gov/pubmed/26039340,26039340,,
440,1712161,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,9880,ZBTB39,https://ctdbase.org/detail.go?type=gene&acc=9880,,,9880.0,ZBTB39,9606.0,Homo sapiens (human),Arsenicals results in increased methylation of ZBTB39 promoter,,,PMID:26039340,https://www.ncbi.nlm.nih.gov/pubmed/26039340,26039340,,
441,1712162,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,7561,ZNF14,https://ctdbase.org/detail.go?type=gene&acc=7561,,,7561.0,ZNF14,9606.0,Homo sapiens (human),Arsenicals results in increased methylation of ZNF14 promoter,,,PMID:26039340,https://www.ncbi.nlm.nih.gov/pubmed/26039340,26039340,,
442,1712163,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001152,Arsenicals,https://ctdbase.org/detail.go?type=chem&acc=D001152,84627,ZNF469,https://ctdbase.org/detail.go?type=gene&acc=84627,,,84627.0,ZNF469,9606.0,Homo sapiens (human),Arsenicals results in increased expression of ZNF469 mRNA,,,PMID:28625800,https://www.ncbi.nlm.nih.gov/pubmed/28625800,28625800,,
443,1712164,5360315,Comparative Toxicogenomics Database (CTD),Magnesium Chloride,D015636,Magnesium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D015636,368,ABCC6,https://ctdbase.org/detail.go?type=gene&acc=368,,,368.0,ABCC6,10116.0,Rattus norvegicus (Norway rat),Magnesium chloride promotes the reaction [beryllium fluoride promotes the reaction [8-azidoadenosine 5'-triphosphate binds to ABCC6 protein]]|magnesium chloride promotes the reaction [8-azidoadenosine 5'-triphosphate binds to ABCC6 protein],,,PMID:12069597,https://www.ncbi.nlm.nih.gov/pubmed/12069597,12069597,,
444,1712165,5360315,Comparative Toxicogenomics Database (CTD),Magnesium Chloride,D015636,Magnesium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D015636,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,7788.0,Torpedo marmorata (marbled electric ray),Magnesium chloride results in increased activity of ACHE protein,,,PMID:3075,https://www.ncbi.nlm.nih.gov/pubmed/3075,3075,,
445,1712593,5360315,Comparative Toxicogenomics Database (CTD),Magnesium Chloride,D015636,Magnesium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D015636,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Magnesium chloride affects the reaction [nickel binds to SERPINE1 protein],,,PMID:21280128,https://www.ncbi.nlm.nih.gov/pubmed/21280128,21280128,,
446,1712594,5360315,Comparative Toxicogenomics Database (CTD),Magnesium Chloride,D015636,Magnesium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D015636,55512,SMPD3,https://ctdbase.org/detail.go?type=gene&acc=55512,,,55512.0,SMPD3,10090.0,Mus musculus (house mouse),[magnesium chloride co-treated with phosphatidylserines] promotes the reaction [SMPD3 protein results in increased degradation of sphingomyelins],,,PMID:12566438,https://www.ncbi.nlm.nih.gov/pubmed/12566438,12566438,,
447,1712595,5360315,Comparative Toxicogenomics Database (CTD),Magnesium Chloride,D015636,Magnesium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D015636,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),Magnesium chloride promotes the reaction [ITIH2 protein binds to TNFAIP6 protein]|magnesium chloride promotes the reaction [ITIH1 protein binds to TNFAIP6 protein],,,PMID:16768462,https://www.ncbi.nlm.nih.gov/pubmed/16768462,16768462,,
448,1712596,5360315,Comparative Toxicogenomics Database (CTD),Magnesium Chloride,D015636,Magnesium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D015636,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Magnesium chloride affects the expression of TP53 mRNA,,,PMID:10506531,https://www.ncbi.nlm.nih.gov/pubmed/10506531,10506531,,
449,1712597,5360373,Toxin and Toxin Target Database (T3DB),Bleomycin,T3D2738,Bleomycin,http://www.t3db.ca/toxins/T3D2738,BE0000199,DNA ligase 1,http://www.t3db.ca/biodb/bio_entities/BE0000199,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),"Although the exact mechanism of action of bleomycin is unknown, available evidence would seem to indicate that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis.",,,PMID:17202402,https://www.ncbi.nlm.nih.gov/pubmed/17202402,17202402,,
450,1712598,5360373,Toxin and Toxin Target Database (T3DB),Bleomycin,T3D2738,Bleomycin,http://www.t3db.ca/toxins/T3D2738,BE0000167,DNA ligase 3,http://www.t3db.ca/biodb/bio_entities/BE0000167,P49916,DNA ligase 3,3980.0,LIG3,9606.0,Homo sapiens (human),"Although the exact mechanism of action of bleomycin is unknown, available evidence would seem to indicate that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis.",,,PMID:17202402,https://www.ncbi.nlm.nih.gov/pubmed/17202402,17202402,,
451,1713269,5362440,Comparative Toxicogenomics Database (CTD),Indinavir,D019469,Indinavir,https://ctdbase.org/detail.go?type=chem&acc=D019469,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10090.0,Mus musculus (house mouse),[zidovudine co-treated with lamivudine co-treated with indinavir] results in decreased expression of CD36 mRNA,,,PMID:16931933,https://www.ncbi.nlm.nih.gov/pubmed/16931933,16931933,,
452,1713270,5362440,Comparative Toxicogenomics Database (CTD),Indinavir,D019469,Indinavir,https://ctdbase.org/detail.go?type=chem&acc=D019469,63924,CIDEC,https://ctdbase.org/detail.go?type=gene&acc=63924,,,63924.0,CIDEC,10090.0,Mus musculus (house mouse),[zidovudine co-treated with lamivudine co-treated with indinavir] results in decreased expression of CIDEC mRNA,,,PMID:16931933,https://www.ncbi.nlm.nih.gov/pubmed/16931933,16931933,,
453,1714462,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,126969,SLC44A3,https://ctdbase.org/detail.go?type=gene&acc=126969,,,126969.0,SLC44A3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of SLC44A3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
454,1714463,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,55652,SLC48A1,https://ctdbase.org/detail.go?type=gene&acc=55652,,,55652.0,SLC48A1,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of SLC48A1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
455,2009698,11598848,BindingDB,"1-(4-(2-(Thiazol-2-yl)thieno[3,2-b]pyridin-7-yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea",24504,"3-(3-fluoro-4-{[2-(1,3-thiazol-2-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24504,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,IC50 (nM),65,PMID:18434145|DOI:10.1016/j.bmcl.2008.04.009,https://www.ncbi.nlm.nih.gov/pubmed/18434145|https://doi.org/10.1016/j.bmcl.2008.04.009,18434145,10.1016/j.bmcl.2008.04.009,
456,2009699,11599241,BindingDB,"3-(3-Fluoro-4-{[2-(morpholin-4-ylcarbonyl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea",24495,"3-(3-fluoro-4-{[2-(morpholin-4-ylcarbonyl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24495,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,IC50 (nM),125,PMID:18434145|DOI:10.1016/j.bmcl.2008.04.009,https://www.ncbi.nlm.nih.gov/pubmed/18434145|https://doi.org/10.1016/j.bmcl.2008.04.009,18434145,10.1016/j.bmcl.2008.04.009,
457,2009700,11599241,BindingDB,"3-(3-Fluoro-4-{[2-(morpholin-4-ylcarbonyl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea",24495,"3-(3-fluoro-4-{[2-(morpholin-4-ylcarbonyl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24495,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),289,PMID:18434145|DOI:10.1016/j.bmcl.2008.04.009,https://www.ncbi.nlm.nih.gov/pubmed/18434145|https://doi.org/10.1016/j.bmcl.2008.04.009,18434145,10.1016/j.bmcl.2008.04.009,
458,2009701,11603462,BindingDB,"(5-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}-2-fluorophenyl) sulfamate",24335,"(5-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}-2-fluorophenyl) sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24335,1024,Aromatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1024,P11511,Aromatase,1588.0,CYP19A1,9606.0,Homo sapiens (human),,IC50 (nM),0.77,PMID:17580845|DOI:10.1021/jm061462b,https://www.ncbi.nlm.nih.gov/pubmed/17580845|https://doi.org/10.1021/jm061462b,17580845,10.1021/jm061462b,
459,2009702,11603462,BindingDB,"(5-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}-2-fluorophenyl) sulfamate",24335,"(5-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}-2-fluorophenyl) sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24335,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),590,PMID:17580845|DOI:10.1021/jm061462b,https://www.ncbi.nlm.nih.gov/pubmed/17580845|https://doi.org/10.1021/jm061462b,17580845,10.1021/jm061462b,
460,2009703,11604217,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 15",35566,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35566,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),130,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
461,2009704,11604217,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 15",35566,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35566,4292,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4292,P26661,Genome polyprotein,,,11115.0,Hepatitis C virus isolate HC-J8,,IC50 (nM),90,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
462,2009842,11604802,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 16",35567,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35567,4292,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4292,P26661,Genome polyprotein,,,11115.0,Hepatitis C virus isolate HC-J8,,IC50 (nM),120,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
463,2009843,11604802,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 16",35567,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35567,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),66,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
464,2009844,11607738,Drug Gene Interaction database (DGIdb),Vinorelbine Tartrate,,VINORELBINE TARTRATE,https://www.dgidb.org/drugs/rxcui:114527,,TUBA3C,https://www.dgidb.org/genes/hgnc:12408,,,7278.0,TUBA3C,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
465,2009845,11607738,Drug Gene Interaction database (DGIdb),Vinorelbine Tartrate,,VINORELBINE TARTRATE,https://www.dgidb.org/drugs/rxcui:114527,,TUBB4B,https://www.dgidb.org/genes/hgnc:20771,,,10383.0,TUBB4B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
466,2009846,11607781,Drug Gene Interaction database (DGIdb),Murucoidin V,,MURUCOIDIN V,https://www.dgidb.org/drugs/chembl:CHEMBL505000,,ABCB1,https://www.dgidb.org/genes/hgnc:40,,,5243.0,ABCB1,9606.0,Homo sapiens (human),,,,,,,,
467,2009847,11609955,Drug Gene Interaction database (DGIdb),Resminostat,,RESMINOSTAT,https://www.dgidb.org/drugs/ncit:C84856,,HDAC10,https://www.dgidb.org/genes/hgnc:18128,,,83933.0,HDAC10,9606.0,Homo sapiens (human),,,,,,,,
468,2009848,11609955,Drug Gene Interaction database (DGIdb),Resminostat,,RESMINOSTAT,https://www.dgidb.org/drugs/ncit:C84856,,HDAC11,https://www.dgidb.org/genes/hgnc:19086,,,79885.0,HDAC11,9606.0,Homo sapiens (human),,,,,,,,
469,2009849,11609955,Drug Gene Interaction database (DGIdb),Resminostat,,RESMINOSTAT,https://www.dgidb.org/drugs/ncit:C84856,,HDAC5,https://www.dgidb.org/genes/hgnc:14068,,,10014.0,HDAC5,9606.0,Homo sapiens (human),,,,,,,,
470,2009850,11611589,BindingDB,"(3-{[3-(sulfamoyloxy)phenyl](1H-1,2,4-triazol-1-yl)methyl}phenyl) sulfamate",24300,"(3-{[3-(sulfamoyloxy)phenyl](1H-1,2,4-triazol-1-yl)methyl}phenyl) sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24300,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,,,PMID:18590272|DOI:10.1021/jm800168s,https://www.ncbi.nlm.nih.gov/pubmed/18590272|https://doi.org/10.1021/jm800168s,18590272,10.1021/jm800168s,
471,2009851,11611589,BindingDB,"(3-{[3-(sulfamoyloxy)phenyl](1H-1,2,4-triazol-1-yl)methyl}phenyl) sulfamate",24300,"(3-{[3-(sulfamoyloxy)phenyl](1H-1,2,4-triazol-1-yl)methyl}phenyl) sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24300,1024,Aromatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1024,P11511,Aromatase,1588.0,CYP19A1,9606.0,Homo sapiens (human),,IC50 (nM),99,PMID:18590272|DOI:10.1021/jm800168s,https://www.ncbi.nlm.nih.gov/pubmed/18590272|https://doi.org/10.1021/jm800168s,18590272,10.1021/jm800168s,
472,2009852,11612910,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 20",35571,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 20",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35571,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),42,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
473,2009853,11612910,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 20",35571,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 20",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35571,4292,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4292,P26661,Genome polyprotein,,,11115.0,Hepatitis C virus isolate HC-J8,,IC50 (nM),110,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
474,2009854,11624303,BindingDB,"3-ethyl-1-[6-methoxy-5-(2-methoxypyrimidin-5-yl)-1H-1,3-benzodiazol-2-yl]urea",24613,"3-ethyl-1-[6-methoxy-5-(2-methoxypyrimidin-5-yl)-1H-1,3-benzodiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24613,207,DNA topoisomerase 4 subunit A/B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=207,P0AFI2,DNA topoisomerase 4 subunit A,947499.0,parC,83333.0,Escherichia coli K-12,,Ki (nM),680,PMID:18690678|DOI:10.1021/jm800318d,https://www.ncbi.nlm.nih.gov/pubmed/18690678|https://doi.org/10.1021/jm800318d,18690678,10.1021/jm800318d,
475,2009855,11624303,BindingDB,"3-ethyl-1-[6-methoxy-5-(2-methoxypyrimidin-5-yl)-1H-1,3-benzodiazol-2-yl]urea",24613,"3-ethyl-1-[6-methoxy-5-(2-methoxypyrimidin-5-yl)-1H-1,3-benzodiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24613,208,DNA gyrase subunit A/B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=208,P0AES4,DNA gyrase subunit A,946614.0,gyrA,83333.0,Escherichia coli K-12,,Ki (nM),15,PMID:18690678|DOI:10.1021/jm800318d,https://www.ncbi.nlm.nih.gov/pubmed/18690678|https://doi.org/10.1021/jm800318d,18690678,10.1021/jm800318d,
476,2009856,11624303,BindingDB,"3-ethyl-1-[6-methoxy-5-(2-methoxypyrimidin-5-yl)-1H-1,3-benzodiazol-2-yl]urea",24613,"3-ethyl-1-[6-methoxy-5-(2-methoxypyrimidin-5-yl)-1H-1,3-benzodiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24613,206,DNA gyrase subunit A/B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=206,P20831,DNA gyrase subunit A,,,1280.0,Staphylococcus aureus,,Ki (nM),44,PMID:18690678|DOI:10.1021/jm800318d,https://www.ncbi.nlm.nih.gov/pubmed/18690678|https://doi.org/10.1021/jm800318d,18690678,10.1021/jm800318d,
477,2009857,11625374,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 7",35558,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35558,4292,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4292,P26661,Genome polyprotein,,,11115.0,Hepatitis C virus isolate HC-J8,,IC50 (nM),185,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
478,2009858,11625374,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 7",35558,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35558,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),29,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
479,2009859,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2L1 protein]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [idelalisib inhibits the reaction [FASLG protein results in increased phosphorylation of RELA protein]]|[faslg protein co-treated with idelalisib] results in increased cleavage of BID protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[idelalisib co-treated with FASLG protein] results in decreased phosphorylation of AKT1 protein]|[faslg protein co-treated with idelalisib] results in increased expression of and affects the localization of BAX protein|[faslg protein co-treated with idelalisib] results in decreased expression of BCL2L1 protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in increased cleavage of BID protein]|[faslg protein co-treated with idelalisib] results in decreased expression of CFLAR protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein]|[idelalisib co-treated with FASLG protein] results in decreased phosphorylation of AKT1 protein|idelalisib promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [idelalisib promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in increased expression of and affects the localization of BAX protein]|idelalisib inhibits the reaction [FASLG protein results in increased phosphorylation of RELA protein]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of CFLAR protein]|[faslg protein co-treated with idelalisib] results in decreased expression of BCL2 protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
480,2009920,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Idelalisib affects the expression of GPT protein,,,PMID:31501888,https://www.ncbi.nlm.nih.gov/pubmed/31501888,31501888,,
481,2009921,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Idelalisib inhibits the reaction [lipopolysaccharides results in increased expression of HIF1A protein]|idelalisib results in increased expression of HIF1A protein,,,PMID:34978009,https://www.ncbi.nlm.nih.gov/pubmed/34978009,34978009,,
482,2009922,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,406906,MIR122,https://ctdbase.org/detail.go?type=gene&acc=406906,,,406906.0,MIR122,10090.0,Mus musculus (house mouse),Idelalisib affects the expression of MIR122 mRNA,,,PMID:31501888,https://www.ncbi.nlm.nih.gov/pubmed/31501888,31501888,,
483,2009923,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Idelalisib inhibits the reaction [lipopolysaccharides results in increased expression of MMP9 mrna]|idelalisib results in decreased expression of MMP9 protein,,,PMID:34978009,https://www.ncbi.nlm.nih.gov/pubmed/34978009,34978009,,
484,2009924,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9606.0,Homo sapiens (human),Idelalisib promotes the reaction [lipopolysaccharides results in increased expression of MTOR mrna]|idelalisib inhibits the reaction [lipopolysaccharides results in increased phosphorylation of MTOR protein],,,PMID:34978009,https://www.ncbi.nlm.nih.gov/pubmed/34978009,34978009,,
485,2009925,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,55226,NAT10,https://ctdbase.org/detail.go?type=gene&acc=55226,,,55226.0,NAT10,9606.0,Homo sapiens (human),Idelalisib results in increased expression of NAT10 mRNA,,,PMID:35877022,https://www.ncbi.nlm.nih.gov/pubmed/35877022,35877022,,
486,2009926,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[palbociclib results in increased susceptibility to idelalisib] which results in increased cleavage of PARP1 protein,,,PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/23676220,23676220,,
487,2009927,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,5290,PIK3CA,https://ctdbase.org/detail.go?type=gene&acc=5290,,,5290.0,PIK3CA,10090.0,Mus musculus (house mouse),Idelalisib inhibits the reaction [TGFB1 protein results in increased expression of PIK3CA mrna]|idelalisib results in increased expression of PIK3CA mRNA,,,PMID:31522336,https://www.ncbi.nlm.nih.gov/pubmed/31522336,31522336,,
488,2009928,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,5291,PIK3CB,https://ctdbase.org/detail.go?type=gene&acc=5291,,,5291.0,PIK3CB,10090.0,Mus musculus (house mouse),Idelalisib results in increased expression of PIK3CB mrna|idelalisib inhibits the reaction [TGFB1 protein results in increased expression of PIK3CB mrna],,,PMID:31522336,https://www.ncbi.nlm.nih.gov/pubmed/31522336,31522336,,
489,2009929,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,5293,PIK3CD,https://ctdbase.org/detail.go?type=gene&acc=5293,,,5293.0,PIK3CD,10090.0,Mus musculus (house mouse),Idelalisib inhibits the reaction [TGFB1 protein results in decreased expression of PIK3CD mrna]|idelalisib results in increased expression of PIK3CD mRNA,,,PMID:31522336,https://www.ncbi.nlm.nih.gov/pubmed/31522336,31522336,,
490,2009988,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,5293,PIK3CD,https://ctdbase.org/detail.go?type=gene&acc=5293,,,5293.0,PIK3CD,9606.0,Homo sapiens (human),Idelalisib results in decreased activity of PIK3CD protein,,,PMID:22801959|PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/22801959|https://www.ncbi.nlm.nih.gov/pubmed/23676220,22801959|23676220,,
491,2009989,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,5294,PIK3CG,https://ctdbase.org/detail.go?type=gene&acc=5294,,,5294.0,PIK3CG,10090.0,Mus musculus (house mouse),Idelalisib results in decreased expression of PIK3CG mRNA,,,PMID:31522336,https://www.ncbi.nlm.nih.gov/pubmed/31522336,31522336,,
492,2009990,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Idelalisib results in increased susceptibility to TNF protein|[tnf protein co-treated with idelalisib] results in increased activity of CASP8 protein|[tnf protein co-treated with idelalisib] results in decreased expression of CFLAR protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[TNF protein co-treated with idelalisib] results in increased activity of CASP8 protein]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[TNF protein co-treated with idelalisib] results in decreased expression of CFLAR protein],,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
493,2009991,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Idelalisib inhibits the reaction [lipopolysaccharides results in increased expression of VEGFA mrna]|idelalisib inhibits the reaction [lipopolysaccharides results in increased expression of VEGFA protein]|idelalisib promotes the reaction [lipopolysaccharides results in increased expression of VEGFA mrna],,,PMID:34978009,https://www.ncbi.nlm.nih.gov/pubmed/34978009,34978009,,
494,2009992,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[idelalisib co-treated with FASLG protein] results in decreased phosphorylation of AKT1 protein]|[idelalisib co-treated with FASLG protein] results in decreased phosphorylation of AKT1 protein|idelalisib results in decreased phosphorylation of AKT1 protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
495,2009993,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Idelalisib results in decreased phosphorylation of AKT1 protein,,,PMID:23676220|PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/23676220|https://www.ncbi.nlm.nih.gov/pubmed/31445927,23676220|31445927,,
496,2009994,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Palbociclib promotes the reaction [idelalisib results in decreased phosphorylation of AKT1 protein],,,PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/23676220,23676220,,
497,2009995,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,42127,ALT,https://ctdbase.org/detail.go?type=gene&acc=42127,,,42127.0,alt,10090.0,Mus musculus (house mouse),Idelalisib results in increased expression of ALT protein|[galactosamine co-treated with lipopolysaccharides] promotes the reaction [idelalisib results in increased expression of ALT protein]|fas protein affects the reaction [idelalisib results in increased expression of ALT protein],,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
498,2009996,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in increased expression of and affects the localization of BAX protein]|[faslg protein co-treated with idelalisib] results in increased expression of and affects the localization of BAX protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
499,2010037,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein]|[faslg protein co-treated with idelalisib] results in decreased expression of BCL2 protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
500,2010038,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2L1 protein]|[faslg protein co-treated with idelalisib] results in decreased expression of BCL2L1 protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
501,2010039,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in increased cleavage of BID protein]|[faslg protein co-treated with idelalisib] results in increased cleavage of BID protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
502,2010040,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[palbociclib results in increased susceptibility to idelalisib] which results in increased cleavage of CASP3 protein,,,PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/23676220,23676220,,
503,2010041,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [idelalisib promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]]|[tnf protein co-treated with idelalisib] results in increased activity of CASP8 protein|idelalisib promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[TNF protein co-treated with idelalisib] results in increased activity of CASP8 protein],,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
504,2010042,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,8837,CFLAR,https://ctdbase.org/detail.go?type=gene&acc=8837,,,8837.0,CFLAR,9606.0,Homo sapiens (human),[FASLG protein co-treated with idelalisib] results in decreased expression of CFLAR protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of CFLAR protein]|[tnf protein co-treated with idelalisib] results in decreased expression of CFLAR protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[TNF protein co-treated with idelalisib] results in decreased expression of CFLAR protein],,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
505,2010043,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Idelalisib affects the susceptibility to FAS protein|fas protein affects the reaction [idelalisib results in increased expression of ALT protein],,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
506,2010044,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,113791,PIK3IP1,https://ctdbase.org/detail.go?type=gene&acc=113791,,,113791.0,PIK3IP1,9606.0,Homo sapiens (human),Idelalisib results in increased expression of PIK3IP1 mRNA,,,PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/23676220,23676220,,
507,2010128,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Idelalisib inhibits the reaction [FASLG protein results in increased phosphorylation of RELA protein]|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [idelalisib inhibits the reaction [FASLG protein results in increased phosphorylation of RELA protein]],,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
508,2010129,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Idelalisib inhibits the reaction [TGFB1 protein results in decreased expression of PIK3CD mrna]|idelalisib inhibits the reaction [TGFB1 protein results in increased expression of PIK3CA mrna]|idelalisib inhibits the reaction [TGFB1 protein results in increased expression of PIK3CB mrna],,,PMID:31522336,https://www.ncbi.nlm.nih.gov/pubmed/31522336,31522336,,
509,2010130,11626560,Drug Gene Interaction database (DGIdb),Crizotinib,,CRIZOTINIB,https://www.dgidb.org/drugs/rxcui:1148495,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
510,2010131,11626560,Drug Gene Interaction database (DGIdb),Crizotinib,,CRIZOTINIB,https://www.dgidb.org/drugs/rxcui:1148495,,ROS1,https://www.dgidb.org/genes/hgnc:10261,,,6098.0,ROS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
511,2010132,11626560,Drug Gene Interaction database (DGIdb),Crizotinib,,CRIZOTINIB,https://www.dgidb.org/drugs/rxcui:1148495,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
512,2010133,11626560,Drug Gene Interaction database (DGIdb),Crizotinib,,CRIZOTINIB,https://www.dgidb.org/drugs/rxcui:1148495,,ROS1,https://www.dgidb.org/genes/hgnc:10261,,,6098.0,ROS1,9606.0,Homo sapiens (human),,,,,,,,
513,2010134,11634725,BindingDB,4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide,35657,"pyrimidylpyrrole, 11e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35657,2239,Mitogen-activated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2239,P28482,Mitogen-activated protein kinase 1,5594.0,MAPK1,9606.0,Homo sapiens (human),,Ki (nM),<2,PMID:19827834|DOI:10.1021/jm900630q,https://www.ncbi.nlm.nih.gov/pubmed/19827834|https://doi.org/10.1021/jm900630q,19827834,10.1021/jm900630q,
514,2010135,11634725,BindingDB,4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide,35657,"pyrimidylpyrrole, 11e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35657,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,Ki (nM),395,PMID:19827834|DOI:10.1021/jm900630q,https://www.ncbi.nlm.nih.gov/pubmed/19827834|https://doi.org/10.1021/jm900630q,19827834,10.1021/jm900630q,
515,2010136,11634725,BindingDB,4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide,35657,"pyrimidylpyrrole, 11e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35657,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,Ki (nM),852,PMID:19827834|DOI:10.1021/jm900630q,https://www.ncbi.nlm.nih.gov/pubmed/19827834|https://doi.org/10.1021/jm900630q,19827834,10.1021/jm900630q,
516,2010137,11634725,BindingDB,4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide,35657,"pyrimidylpyrrole, 11e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35657,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,Ki (nM),540,PMID:19827834|DOI:10.1021/jm900630q,https://www.ncbi.nlm.nih.gov/pubmed/19827834|https://doi.org/10.1021/jm900630q,19827834,10.1021/jm900630q,
517,2009678,12311312,Comparative Toxicogenomics Database (CTD),Marliolide,C000626884,marliolide,https://ctdbase.org/detail.go?type=chem&acc=C000626884,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),NFE2L2 protein affects the reaction [marliolide results in increased expression of HMOX1 protein]|marliolide results in increased expression of HMOX1 mrna|nfe2l2 protein affects the reaction [marliolide results in increased expression of HMOX1 mrna]|marliolide results in increased expression of HMOX1 protein,,,PMID:31319135,https://www.ncbi.nlm.nih.gov/pubmed/31319135,31319135,,
518,2009679,12311312,Comparative Toxicogenomics Database (CTD),Marliolide,C000626884,marliolide,https://ctdbase.org/detail.go?type=chem&acc=C000626884,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),NFE2L2 protein affects the reaction [marliolide results in increased expression of HMOX1 protein]|nfe2l2 protein affects the reaction [marliolide results in increased expression of HMOX1 mrna]|nfe2l2 protein affects the reaction [marliolide results in increased expression of NQO1 protein],,,PMID:31319135,https://www.ncbi.nlm.nih.gov/pubmed/31319135,31319135,,
519,2009680,12311312,Comparative Toxicogenomics Database (CTD),Marliolide,C000626884,marliolide,https://ctdbase.org/detail.go?type=chem&acc=C000626884,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Marliolide results in increased expression of NQO1 protein|nfe2l2 protein affects the reaction [marliolide results in increased expression of NQO1 protein],,,PMID:31319135,https://www.ncbi.nlm.nih.gov/pubmed/31319135,31319135,,
520,2009681,12358972,Drug Gene Interaction database (DGIdb),Dexmecamylamine,,DEXMECAMYLAMINE,https://www.dgidb.org/drugs/chembl:CHEMBL2103881,,CHRNB2,https://www.dgidb.org/genes/hgnc:1962,,,1141.0,CHRNB2,9606.0,Homo sapiens (human),,,,,,,,
521,2009682,12358972,Drug Gene Interaction database (DGIdb),Dexmecamylamine,,DEXMECAMYLAMINE,https://www.dgidb.org/drugs/chembl:CHEMBL2103881,,CHRNA4,https://www.dgidb.org/genes/hgnc:1958,,,1137.0,CHRNA4,9606.0,Homo sapiens (human),,,,,,,,
522,2009589,12645347,BindingDB,"1-(Carboxymethyl)cyclopenta-2,4-dien-1-ide cyclopentane-1,2,3,4,5-pentaide iron",16432,"1-(carboxymethyl)cyclopenta-2,4-dien-1-ide cyclopentane-1,2,3,4,5-pentaide iron",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16432,8450,Aldo-keto reductase family 1 member B1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8450,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),,Ki (nM),37700,PMID:17083960|DOI:10.1016/j.bioorg.2006.09.004,https://www.ncbi.nlm.nih.gov/pubmed/17083960|https://doi.org/10.1016/j.bioorg.2006.09.004,17083960,10.1016/j.bioorg.2006.09.004,
523,2009590,12688004,BindingDB,[Methyl(phenyl)amino](oxo)acetic acid,93306,"Oxamic Acid/Ester, 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=93306,5434,L-lactate dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5434,,,,,,,,IC50 (nM),>2.00e+5,PMID:17316052|DOI:10.1021/cc060110n,https://www.ncbi.nlm.nih.gov/pubmed/17316052|https://doi.org/10.1021/cc060110n,17316052,10.1021/cc060110n,
524,2009591,12688004,BindingDB,[Methyl(phenyl)amino](oxo)acetic acid,93306,"Oxamic Acid/Ester, 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=93306,5433,L-lactate dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5433,,,,,,,,IC50 (nM),>2.00e+5,PMID:17316052|DOI:10.1021/cc060110n,https://www.ncbi.nlm.nih.gov/pubmed/17316052|https://doi.org/10.1021/cc060110n,17316052,10.1021/cc060110n,
525,2009683,12743703,BindingDB,4-Methyl-benzocoumarin,248070,4-Methyl-2H-benzo[g]chromen-2-one (5),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=248070,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),8.2e+3,PMID:23488741|DOI:10.3109/14756366.2013.777334,https://www.ncbi.nlm.nih.gov/pubmed/23488741|https://doi.org/10.3109/14756366.2013.777334,23488741,10.3109/14756366.2013.777334,
526,2009684,12743703,BindingDB,4-Methyl-benzocoumarin,248070,4-Methyl-2H-benzo[g]chromen-2-one (5),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=248070,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),>2.00e+5,PMID:23488741|DOI:10.3109/14756366.2013.777334,https://www.ncbi.nlm.nih.gov/pubmed/23488741|https://doi.org/10.3109/14756366.2013.777334,23488741,10.3109/14756366.2013.777334,
527,2009685,12743703,BindingDB,4-Methyl-benzocoumarin,248070,4-Methyl-2H-benzo[g]chromen-2-one (5),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=248070,1363,Carbonic anhydrase 12,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1363,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),,Ki (nM),3.3e+3,PMID:23488741|DOI:10.3109/14756366.2013.777334,https://www.ncbi.nlm.nih.gov/pubmed/23488741|https://doi.org/10.3109/14756366.2013.777334,23488741,10.3109/14756366.2013.777334,
528,2009686,12743703,BindingDB,4-Methyl-benzocoumarin,248070,4-Methyl-2H-benzo[g]chromen-2-one (5),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=248070,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),,Ki (nM),2.0e+2,PMID:23488741|DOI:10.3109/14756366.2013.777334,https://www.ncbi.nlm.nih.gov/pubmed/23488741|https://doi.org/10.3109/14756366.2013.777334,23488741,10.3109/14756366.2013.777334,
529,2009817,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Ginsenoside rh1 results in increased expression of FOS mRNA,,,PMID:16204943,https://www.ncbi.nlm.nih.gov/pubmed/16204943,16204943,,
530,2009818,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of ICAM1 protein],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
531,2009819,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Ginsenoside rh1 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of IL1B mrna]|ginsenoside rh1 inhibits the reaction [oxazolone results in increased expression of IL1B mrna],,,PMID:16557482,https://www.ncbi.nlm.nih.gov/pubmed/16557482,16557482,,
532,2009820,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Ginsenoside rh1 results in decreased expression of IL4,,,PMID:22855946,https://www.ncbi.nlm.nih.gov/pubmed/22855946,22855946,,
533,2009821,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [galactose results in increased secretion of IL6 protein],,,PMID:29412148,https://www.ncbi.nlm.nih.gov/pubmed/29412148,29412148,,
534,2009822,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3676,ITGA4,https://ctdbase.org/detail.go?type=gene&acc=3676,,,3676.0,ITGA4,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of [ITGA4 protein binds to ITGB1 protein]],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
535,2009823,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3683,ITGAL,https://ctdbase.org/detail.go?type=gene&acc=3683,,,3683.0,ITGAL,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
536,2009824,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3688,ITGB1,https://ctdbase.org/detail.go?type=gene&acc=3688,,,3688.0,ITGB1,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of [ITGA4 protein binds to ITGB1 protein]],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
537,2009825,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3689,ITGB2,https://ctdbase.org/detail.go?type=gene&acc=3689,,,3689.0,ITGB2,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
538,2009826,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090.0,Mus musculus (house mouse),Ginsenoside rh1 results in decreased activity of JUN protein,,,PMID:22855946,https://www.ncbi.nlm.nih.gov/pubmed/22855946,22855946,,
539,2009896,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10090.0,Mus musculus (house mouse),Ginsenoside rh1 results in increased secretion of LPL protein,,,PMID:8988629,https://www.ncbi.nlm.nih.gov/pubmed/8988629,8988629,,
540,2009897,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),Ginsenoside rh1 results in increased expression of PGR protein,,,PMID:16204943,https://www.ncbi.nlm.nih.gov/pubmed/16204943,16204943,,
541,2009898,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Ginsenoside rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mrna]|ginsenoside rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein],,,PMID:32623698,https://www.ncbi.nlm.nih.gov/pubmed/32623698,32623698,,
542,2009899,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Ginsenoside rh1 inhibits the reaction [oxazolone results in increased expression of PTGS2 mrna]|ginsenoside rh1 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of PTGS2 mrna],,,PMID:16557482,https://www.ncbi.nlm.nih.gov/pubmed/16557482,16557482,,
543,2009900,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of SELE protein],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
544,2009901,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),Ginsenoside rh1 results in increased expression of TFF1 mRNA,,,PMID:16204943,https://www.ncbi.nlm.nih.gov/pubmed/16204943,16204943,,
545,2009902,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of [ITGA4 protein binds to ITGB1 protein]]|ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]|ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]]|ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of SELE protein]|ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]|ginsenoside rh1 results in decreased susceptibility to TNF protein,,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
546,2009903,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Ginsenoside rh1 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of TNF mrna]|ginsenoside rh1 inhibits the reaction [oxazolone results in increased expression of TNF mrna],,,PMID:16557482,https://www.ncbi.nlm.nih.gov/pubmed/16557482,16557482,,
547,2009904,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Ginsenoside rh1 results in decreased expression of TNF,,,PMID:22855946,https://www.ncbi.nlm.nih.gov/pubmed/22855946,22855946,,
548,2010045,12855920,Comparative Toxicogenomics Database (CTD),Ginsenoside Rh1,C425564,ginsenoside Rh1,https://ctdbase.org/detail.go?type=chem&acc=C425564,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606.0,Homo sapiens (human),Ginsenoside rh1 inhibits the reaction [TNF protein results in increased expression of VCAM1 protein],,,PMID:21875580,https://www.ncbi.nlm.nih.gov/pubmed/21875580,21875580,,
549,2010046,13081071,BindingDB,"4-Thiazolol, 2-mercapto-",7818,"2-sulfanylidene-1,3-thiazolidin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7818,862,Glycogen synthase kinase-3 beta [7-25],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=862,G1T8E2,[tau protein] kinase ,,,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),100000,PMID:16279768|DOI:10.1021/jm040895g,https://www.ncbi.nlm.nih.gov/pubmed/16279768|https://doi.org/10.1021/jm040895g,16279768,10.1021/jm040895g,
550,2010047,13104826,BindingDB,"Imidazole-dioxolane, 30",31680,"imidazole-dioxolane, 30",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31680,3888,Heme oxygenase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3888,P23711,Heme oxygenase 2,79239.0,Hmox2,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),>100000,PMID:19268600|DOI:10.1016/j.bmc.2009.01.078,https://www.ncbi.nlm.nih.gov/pubmed/19268600|https://doi.org/10.1016/j.bmc.2009.01.078,19268600,10.1016/j.bmc.2009.01.078,
551,2010048,13104826,BindingDB,"Imidazole-dioxolane, 30",31680,"imidazole-dioxolane, 30",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31680,3885,Heme oxygenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3885,P06762,Heme oxygenase 1 ,24451.0,Hmox1,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),12000,PMID:19268600|DOI:10.1016/j.bmc.2009.01.078,https://www.ncbi.nlm.nih.gov/pubmed/19268600|https://doi.org/10.1016/j.bmc.2009.01.078,19268600,10.1016/j.bmc.2009.01.078,
552,2010049,13104852,BindingDB,"Imidazole-dioxolane, 26",31674,"imidazole-dioxolane, 26",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31674,3885,Heme oxygenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3885,P06762,Heme oxygenase 1 ,24451.0,Hmox1,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),2000,PMID:19268600|DOI:10.1016/j.bmc.2009.01.078,https://www.ncbi.nlm.nih.gov/pubmed/19268600|https://doi.org/10.1016/j.bmc.2009.01.078,19268600,10.1016/j.bmc.2009.01.078,
553,2010050,13104852,BindingDB,"Imidazole-dioxolane, 26",31674,"imidazole-dioxolane, 26",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31674,3888,Heme oxygenase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3888,P23711,Heme oxygenase 2,79239.0,Hmox2,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),43000,PMID:19268600|DOI:10.1016/j.bmc.2009.01.078,https://www.ncbi.nlm.nih.gov/pubmed/19268600|https://doi.org/10.1016/j.bmc.2009.01.078,19268600,10.1016/j.bmc.2009.01.078,
554,2010051,13104875,BindingDB,"Imidazole-dioxolane, 12",31660,"imidazole-dioxolane, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31660,3888,Heme oxygenase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3888,P23711,Heme oxygenase 2,79239.0,Hmox2,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),12000,PMID:19268600|DOI:10.1016/j.bmc.2009.01.078,https://www.ncbi.nlm.nih.gov/pubmed/19268600|https://doi.org/10.1016/j.bmc.2009.01.078,19268600,10.1016/j.bmc.2009.01.078,
555,2010052,13104875,BindingDB,"Imidazole-dioxolane, 12",31660,"imidazole-dioxolane, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31660,3885,Heme oxygenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3885,P06762,Heme oxygenase 1 ,24451.0,Hmox1,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),2800,PMID:19268600|DOI:10.1016/j.bmc.2009.01.078,https://www.ncbi.nlm.nih.gov/pubmed/19268600|https://doi.org/10.1016/j.bmc.2009.01.078,19268600,10.1016/j.bmc.2009.01.078,
556,2010527,13145364,BindingDB,Isothiochroman-3-one,23986,"3,4-dihydro-1H-2-benzothiopyran-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23986,2445,Cytosol aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2445,P00727,Cytosol aminopeptidase,781648.0,LAP3,9913.0,Bos taurus (cattle),,IC50 (nM),>1000000,PMID:16844380|DOI:10.1016/j.bmc.2006.06.050,https://www.ncbi.nlm.nih.gov/pubmed/16844380|https://doi.org/10.1016/j.bmc.2006.06.050,16844380,10.1016/j.bmc.2006.06.050,
557,2010528,13145364,BindingDB,Isothiochroman-3-one,23986,"3,4-dihydro-1H-2-benzothiopyran-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23986,50003122,Bacterial leucyl aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003122,Q01693,Bacterial leucyl aminopeptidase,,,671.0,Vibrio proteolyticus,,Ki (nM),4000,PMID:16844380|DOI:10.1016/j.bmc.2006.06.050,https://www.ncbi.nlm.nih.gov/pubmed/16844380|https://doi.org/10.1016/j.bmc.2006.06.050,16844380,10.1016/j.bmc.2006.06.050,
558,2010529,13145364,BindingDB,Isothiochroman-3-one,23986,"3,4-dihydro-1H-2-benzothiopyran-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23986,8356,Aminopeptidase N,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8356,P15145,Aminopeptidase N,397520.0,ANPEP,9823.0,Sus scrofa (pig),,IC50 (nM),>1000000,PMID:16844380|DOI:10.1016/j.bmc.2006.06.050,https://www.ncbi.nlm.nih.gov/pubmed/16844380|https://doi.org/10.1016/j.bmc.2006.06.050,16844380,10.1016/j.bmc.2006.06.050,
559,2010530,13145364,BindingDB,Isothiochroman-3-one,23986,"3,4-dihydro-1H-2-benzothiopyran-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23986,2448,Leukotriene A-4 hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2448,P09960,Leukotriene A-4 hydrolase,4048.0,LTA4H,9606.0,Homo sapiens (human),,IC50 (nM),>1000000,PMID:16844380|DOI:10.1016/j.bmc.2006.06.050,https://www.ncbi.nlm.nih.gov/pubmed/16844380|https://doi.org/10.1016/j.bmc.2006.06.050,16844380,10.1016/j.bmc.2006.06.050,
560,2009737,15508240,Therapeutic Target Database (TTD),1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine,D07UUQ,1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine,https://idrblab.net/ttd/data/drug/details/D07UUQ,T02551,Dopamine D3 receptor (D3R),https://idrblab.net/ttd/data/target/details/T02551,P35462,D(3) dopamine receptor,1814.0,DRD3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
561,2009738,15508243,Therapeutic Target Database (TTD),1-Benzyl-4-(2-iodo-1H-pyrrol-1-yl)piperidine,D0B9DR,1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine,https://idrblab.net/ttd/data/drug/details/D0B9DR,T22118,Dopamine D1 receptor (D1R),https://idrblab.net/ttd/data/target/details/T22118,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
562,2009739,15508243,Therapeutic Target Database (TTD),1-Benzyl-4-(2-iodo-1H-pyrrol-1-yl)piperidine,D0B9DR,1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine,https://idrblab.net/ttd/data/drug/details/D0B9DR,T24983,Dopamine D4 receptor (D4R),https://idrblab.net/ttd/data/target/details/T24983,P21917,D(4) dopamine receptor,1815.0,DRD4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
563,2009740,15508243,Therapeutic Target Database (TTD),1-Benzyl-4-(2-iodo-1H-pyrrol-1-yl)piperidine,D0B9DR,1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine,https://idrblab.net/ttd/data/drug/details/D0B9DR,T67162,Dopamine D2 receptor (D2R),https://idrblab.net/ttd/data/target/details/T67162,P14416,D(2) dopamine receptor,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
564,2009741,15508243,Therapeutic Target Database (TTD),1-Benzyl-4-(2-iodo-1H-pyrrol-1-yl)piperidine,D0B9DR,1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine,https://idrblab.net/ttd/data/drug/details/D0B9DR,T02551,Dopamine D3 receptor (D3R),https://idrblab.net/ttd/data/target/details/T02551,P35462,D(3) dopamine receptor,1814.0,DRD3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
565,2009742,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0000820,Epididymal secretory glutathione peroxidase,http://www.t3db.ca/biodb/bio_entities/BE0000820,O75715,Epididymal secretory glutathione peroxidase,2880.0,GPX5,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
566,2009743,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0000816,Glutathione peroxidase 1,http://www.t3db.ca/biodb/bio_entities/BE0000816,P07203,Glutathione peroxidase 1,2876.0,GPX1,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
567,2009744,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0000817,Glutathione peroxidase 2,http://www.t3db.ca/biodb/bio_entities/BE0000817,P18283,Glutathione peroxidase 2,2877.0,GPX2,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
568,2009745,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0000821,Glutathione peroxidase 3,http://www.t3db.ca/biodb/bio_entities/BE0000821,P22352,Glutathione peroxidase 3,2878.0,GPX3,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
569,2009746,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0002286,Glutathione peroxidase 6,http://www.t3db.ca/biodb/bio_entities/BE0002286,P59796,Glutathione peroxidase 6,257202.0,GPX6,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
570,2009860,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0002289,Glutathione peroxidase 7,http://www.t3db.ca/biodb/bio_entities/BE0002289,Q96SL4,Glutathione peroxidase 7,2882.0,GPX7,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
571,2009861,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879.0,GPX4,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
572,2009862,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
573,2009863,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000732,P05023,Sodium/potassium-transporting ATPase subunit alpha-1 ,476.0,ATP1A1,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
574,2009864,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0005034,P50993,Sodium/potassium-transporting ATPase subunit alpha-2,477.0,ATP1A2,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
575,2009865,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0005047,P13637,Sodium/potassium-transporting ATPase subunit alpha-3,478.0,ATP1A3,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
576,2009866,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0005031,Sodium/potassium-transporting ATPase subunit alpha-4,http://www.t3db.ca/biodb/bio_entities/BE0005031,Q13733,Sodium/potassium-transporting ATPase subunit alpha-4,480.0,ATP1A4,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
577,2009867,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0004994,P05026,Sodium/potassium-transporting ATPase subunit beta-1,481.0,ATP1B1,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
578,2009930,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,http://www.t3db.ca/biodb/bio_entities/BE0005018,P14415,Sodium/potassium-transporting ATPase subunit beta-2,482.0,ATP1B2,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
579,2009931,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0005026,P54709,Sodium/potassium-transporting ATPase subunit beta-3,483.0,ATP1B3,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
580,2009932,15520661,Toxin and Toxin Target Database (T3DB),Silver selenite,T3D1838,Silver selenite,http://www.t3db.ca/toxins/T3D1838,BE0000229,Sodium/potassium-transporting ATPase subunit gamma,http://www.t3db.ca/biodb/bio_entities/BE0000229,P54710,Sodium/potassium-transporting ATPase subunit gamma,486.0,FXYD2,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
581,2009933,15541506,Comparative Toxicogenomics Database (CTD),1-[5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl]-4-methylpiperazine,C525468,1-(5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)-4-methylpiperazine,https://ctdbase.org/detail.go?type=chem&acc=C525468,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9615.0,Canis lupus familiaris (dog),1-(5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)-4-methylpiperazine results in decreased activity of MAPK14 protein,,,PMID:20448081,https://www.ncbi.nlm.nih.gov/pubmed/20448081,20448081,,
582,2009934,15552206,Therapeutic Target Database (TTD),"7-Methyl-[1,4]thiazepan-(5E)-ylideneamine",D01EHS,"7-Methyl-[1,4]thiazepan-(5E)-ylideneamine",https://idrblab.net/ttd/data/drug/details/D01EHS,T16117,Nitric-oxide synthase brain (NOS1),https://idrblab.net/ttd/data/target/details/T16117,P29475,"Nitric oxide synthase, brain",4842.0,NOS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
583,2009935,15552206,Therapeutic Target Database (TTD),"7-Methyl-[1,4]thiazepan-(5E)-ylideneamine",D01EHS,"7-Methyl-[1,4]thiazepan-(5E)-ylideneamine",https://idrblab.net/ttd/data/drug/details/D01EHS,T02703,Nitric-oxide synthase inducible (NOS2),https://idrblab.net/ttd/data/target/details/T02703,P35228,"Nitric oxide synthase, inducible",4843.0,NOS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
584,2009936,15552206,Therapeutic Target Database (TTD),"7-Methyl-[1,4]thiazepan-(5E)-ylideneamine",D01EHS,"7-Methyl-[1,4]thiazepan-(5E)-ylideneamine",https://idrblab.net/ttd/data/drug/details/D01EHS,T06046,Nitric-oxide synthase endothelial (NOS3),https://idrblab.net/ttd/data/target/details/T06046,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
585,2009937,15561101,BindingDB,Quinoline-3-carboxamide,60924,quinoline 3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60924,8295,Nicotinamide N-methyltransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8295,P40261,Nicotinamide N-methyltransferase,4837.0,NNMT,9606.0,Homo sapiens (human),,Ki (nM),97000000,PMID:27570878|DOI:10.1021/acs.biochem.6b00733,https://www.ncbi.nlm.nih.gov/pubmed/27570878|https://doi.org/10.1021/acs.biochem.6b00733,27570878,10.1021/acs.biochem.6b00733,
586,2009938,15604547,BindingDB,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,16978,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16978,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3.4,PMID:16603355|DOI:10.1016/j.bmcl.2006.03.041,https://www.ncbi.nlm.nih.gov/pubmed/16603355|https://doi.org/10.1016/j.bmcl.2006.03.041,16603355,10.1016/j.bmcl.2006.03.041,
587,2009939,15604547,BindingDB,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,16978,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16978,527,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),,IC50 (nM),21,PMID:16603355|DOI:10.1016/j.bmcl.2006.03.041,https://www.ncbi.nlm.nih.gov/pubmed/16603355|https://doi.org/10.1016/j.bmcl.2006.03.041,16603355,10.1016/j.bmcl.2006.03.041,
588,2009940,15604547,BindingDB,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,16978,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16978,1612,RAC-gamma serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1612,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),,IC50 (nM),76,PMID:16603355|DOI:10.1016/j.bmcl.2006.03.041,https://www.ncbi.nlm.nih.gov/pubmed/16603355|https://doi.org/10.1016/j.bmcl.2006.03.041,16603355,10.1016/j.bmcl.2006.03.041,
589,2009941,15604547,BindingDB,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,16978,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16978,448,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),8,PMID:16603355|DOI:10.1016/j.bmcl.2006.03.041,https://www.ncbi.nlm.nih.gov/pubmed/16603355|https://doi.org/10.1016/j.bmcl.2006.03.041,16603355,10.1016/j.bmcl.2006.03.041,
590,2009942,15604547,BindingDB,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,16978,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16978,602,Protein kinase C gamma type,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=602,P05129,Protein kinase C gamma type,5582.0,PRKCG,9606.0,Homo sapiens (human),,IC50 (nM),31,PMID:16603355|DOI:10.1016/j.bmcl.2006.03.041,https://www.ncbi.nlm.nih.gov/pubmed/16603355|https://doi.org/10.1016/j.bmcl.2006.03.041,16603355,10.1016/j.bmcl.2006.03.041,
591,2009943,15604547,BindingDB,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,16978,6-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16978,606,Protein kinase C zeta type,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=606,Q05513,Protein kinase C zeta type,5590.0,PRKCZ,9606.0,Homo sapiens (human),,IC50 (nM),8300,PMID:16603355|DOI:10.1016/j.bmcl.2006.03.041,https://www.ncbi.nlm.nih.gov/pubmed/16603355|https://doi.org/10.1016/j.bmcl.2006.03.041,16603355,10.1016/j.bmcl.2006.03.041,
592,2009668,15663667,Therapeutic Target Database (TTD),3-(Tetrazol-2-yl)-1-azabicyclo[2.2.2]octane,D0OE0K,3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane,https://idrblab.net/ttd/data/drug/details/D0OE0K,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
593,2009669,15663667,Therapeutic Target Database (TTD),3-(Tetrazol-2-yl)-1-azabicyclo[2.2.2]octane,D0OE0K,3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane,https://idrblab.net/ttd/data/drug/details/D0OE0K,T46185,Muscarinic acetylcholine receptor M2 (CHRM2),https://idrblab.net/ttd/data/target/details/T46185,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
594,2009670,15663667,Therapeutic Target Database (TTD),3-(Tetrazol-2-yl)-1-azabicyclo[2.2.2]octane,D0OE0K,3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane,https://idrblab.net/ttd/data/drug/details/D0OE0K,T28893,Muscarinic acetylcholine receptor M1 (CHRM1),https://idrblab.net/ttd/data/target/details/T28893,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
595,2009671,15669672,Therapeutic Target Database (TTD),1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,D02PFJ,1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,https://idrblab.net/ttd/data/drug/details/D02PFJ,T79961,Muscarinic acetylcholine receptor M5 (CHRM5),https://idrblab.net/ttd/data/target/details/T79961,P08912,Muscarinic acetylcholine receptor M5,1133.0,CHRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
596,2009672,15669672,Therapeutic Target Database (TTD),1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,D02PFJ,1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,https://idrblab.net/ttd/data/drug/details/D02PFJ,T20709,Muscarinic acetylcholine receptor M4 (CHRM4),https://idrblab.net/ttd/data/target/details/T20709,P08173,Muscarinic acetylcholine receptor M4,1132.0,CHRM4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
597,2009673,15669672,Therapeutic Target Database (TTD),1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,D02PFJ,1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,https://idrblab.net/ttd/data/drug/details/D02PFJ,T46185,Muscarinic acetylcholine receptor M2 (CHRM2),https://idrblab.net/ttd/data/target/details/T46185,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
598,2009674,15669672,Therapeutic Target Database (TTD),1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,D02PFJ,1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,https://idrblab.net/ttd/data/drug/details/D02PFJ,T28893,Muscarinic acetylcholine receptor M1 (CHRM1),https://idrblab.net/ttd/data/target/details/T28893,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
599,2009675,15669672,Therapeutic Target Database (TTD),1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,D02PFJ,1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea,https://idrblab.net/ttd/data/drug/details/D02PFJ,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
600,2009944,15685977,Therapeutic Target Database (TTD),3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,D06VST,3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,https://idrblab.net/ttd/data/drug/details/D06VST,T46185,Muscarinic acetylcholine receptor M2 (CHRM2),https://idrblab.net/ttd/data/target/details/T46185,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
601,2009945,15685977,Therapeutic Target Database (TTD),3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,D06VST,3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,https://idrblab.net/ttd/data/drug/details/D06VST,T28893,Muscarinic acetylcholine receptor M1 (CHRM1),https://idrblab.net/ttd/data/target/details/T28893,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
602,2009946,15685977,Therapeutic Target Database (TTD),3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,D06VST,3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,https://idrblab.net/ttd/data/drug/details/D06VST,T20709,Muscarinic acetylcholine receptor M4 (CHRM4),https://idrblab.net/ttd/data/target/details/T20709,P08173,Muscarinic acetylcholine receptor M4,1132.0,CHRM4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
603,2009676,15691791,Therapeutic Target Database (TTD),Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester,D0C1XI,Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester,https://idrblab.net/ttd/data/drug/details/D0C1XI,T00140,Arachidonate 5-lipoxygenase (5-LOX),https://idrblab.net/ttd/data/target/details/T00140,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
604,2009677,15691792,Therapeutic Target Database (TTD),Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester,D0G3VE,Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester,https://idrblab.net/ttd/data/drug/details/D0G3VE,T00140,Arachidonate 5-lipoxygenase (5-LOX),https://idrblab.net/ttd/data/target/details/T00140,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
605,2009810,15691796,Therapeutic Target Database (TTD),"Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester",D0T8TS,"Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester",https://idrblab.net/ttd/data/drug/details/D0T8TS,T00140,Arachidonate 5-lipoxygenase (5-LOX),https://idrblab.net/ttd/data/target/details/T00140,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
606,2009811,15691812,Therapeutic Target Database (TTD),5-Methyl-2-p-tolyl-thiazol-4-ol,D04IFV,5-Methyl-2-p-tolyl-thiazol-4-ol,https://idrblab.net/ttd/data/drug/details/D04IFV,T00140,Arachidonate 5-lipoxygenase (5-LOX),https://idrblab.net/ttd/data/target/details/T00140,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
607,2009812,15730767,BindingDB,Methyl 2-amino-4-(S-methylsulfonimidoyl)butanoate,85320,"GlcN-6-P synthase inhibitor, 13 (racemic mixture)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85320,5017,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5017,P53704,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],3636557.0,GFA1,237561.0,Candida albicans SC5314,,Ki (nM),1500000,,,,,
608,2009813,15731470,Therapeutic Target Database (TTD),6-Nitroflavone,D0W3FQ,6-Nitro-2-phenyl-chromen-4-one,https://idrblab.net/ttd/data/drug/details/D0W3FQ,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
609,2009814,15779398,Toxin and Toxin Target Database (T3DB),Copper ethanoate,T3D1204,Copper(II) acetate,http://www.t3db.ca/toxins/T3D1204,BE0001089,Glucose-6-phosphate 1-dehydrogenase,http://www.t3db.ca/biodb/bio_entities/BE0001089,P11413,Glucose-6-phosphate 1-dehydrogenase,2539.0,G6PD,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
610,2009815,15779398,Toxin and Toxin Target Database (T3DB),Copper ethanoate,T3D1204,Copper(II) acetate,http://www.t3db.ca/toxins/T3D1204,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
611,2009816,15779398,Toxin and Toxin Target Database (T3DB),Copper ethanoate,T3D1204,Copper(II) acetate,http://www.t3db.ca/toxins/T3D1204,BE0000930,Serum paraoxonase/arylesterase 1,http://www.t3db.ca/biodb/bio_entities/BE0000930,P27169,Serum paraoxonase/arylesterase 1,5444.0,PON1,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
612,2009592,16736221,BindingDB,"Methyl 2-{7-oxo-7-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptyl}benzoate",23055,"alpha-ketooxazole, 5aa",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23055,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
613,2009593,16736226,BindingDB,3-(4-(Phenoxymethyl)phenyl)-1-(5-(pyridin-2-yl)oxazol-2-yl)propan-1-one,23073,"3-[4-(phenoxymethyl)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23073,2330,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2330,,,,,,,,IC50 (nM),2000,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
614,2009594,16736226,BindingDB,3-(4-(Phenoxymethyl)phenyl)-1-(5-(pyridin-2-yl)oxazol-2-yl)propan-1-one,23073,"3-[4-(phenoxymethyl)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23073,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,Ki (nM),5,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
615,2009595,16736226,BindingDB,3-(4-(Phenoxymethyl)phenyl)-1-(5-(pyridin-2-yl)oxazol-2-yl)propan-1-one,23073,"3-[4-(phenoxymethyl)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23073,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
616,2009596,16736227,BindingDB,"3-[4-(Phenylamino)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",23075,"3-[4-(phenylamino)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23075,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),2,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
617,2009597,16736227,BindingDB,"3-[4-(Phenylamino)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",23075,"3-[4-(phenylamino)phenyl]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23075,2330,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2330,,,,,,,,IC50 (nM),600,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
618,2009598,16736417,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(3-pyridyl)hept-6-yne,23081,"1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]-7-(pyridin-3-yl)hept-6-yn-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23081,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),300,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
619,2009599,16736418,BindingDB,"tert-butyl N-(4-{7-oxo-7-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]hept-1-yn-1-yl}phenyl)carbamate",23085,"alpha-ketooxazole, 4p",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23085,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),23,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
620,2009802,16736419,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(3-fluorophenyl)hept-6-yne,23087,"7-(3-fluorophenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]hept-6-yn-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23087,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),3.2,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
621,2009803,16736420,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(2-nitrophenyl)hept-6-yne,23089,"7-(2-nitrophenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]hept-6-yn-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23089,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),17,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
622,2009804,16736427,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(3-(methoxycarbonyl)phenyl)hept-6-yne,23096,"alpha-ketooxazole, 4bb",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23096,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),30,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
623,2009805,16736428,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(2-chlorophenyl)hept-6-yne,23098,"7-(2-chlorophenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]hept-6-yn-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23098,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),13,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
624,2009806,16736437,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(3-methoxyphenyl)heptane,23039,"7-(3-methoxyphenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23039,2330,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2330,,,,,,,,IC50 (nM),1000,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
625,2009807,16736437,BindingDB,1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-(3-methoxyphenyl)heptane,23039,"7-(3-methoxyphenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23039,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),2.5,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
626,2009808,16736438,BindingDB,"7-(3-Aminophenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one",23041,"7-(3-aminophenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23041,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),30,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
627,2009809,16736439,BindingDB,"tert-butyl N-(3-{7-oxo-7-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptyl}phenyl)carbamate",23043,"alpha-ketooxazole, 5o",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23043,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),2.4,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
628,2009633,18452323,BindingDB,"4-[(4-chlorophenyl)methyl]-6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",25062,"4-[(4-chlorophenyl)methyl]-6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25062,200,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform/Phosphoinositide 3-kinase regulatory subunit 5",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=200,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,IC50 (nM),7.16,PMID:17095227|DOI:10.1016/j.bmcl.2006.10.080,https://www.ncbi.nlm.nih.gov/pubmed/17095227|https://doi.org/10.1016/j.bmcl.2006.10.080,17095227,10.1016/j.bmcl.2006.10.080,
629,2009634,18452350,BindingDB,"4-benzyl-6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",25059,"4-benzyl-6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25059,200,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform/Phosphoinositide 3-kinase regulatory subunit 5",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=200,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,IC50 (nM),23,PMID:17095227|DOI:10.1016/j.bmcl.2006.10.080,https://www.ncbi.nlm.nih.gov/pubmed/17095227|https://doi.org/10.1016/j.bmcl.2006.10.080,17095227,10.1016/j.bmcl.2006.10.080,
630,2009635,18452409,BindingDB,"4-[2-(4-methylphenyl)ethyl]-6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",25072,"4-[2-(4-methylphenyl)ethyl]-6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25072,200,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform/Phosphoinositide 3-kinase regulatory subunit 5",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=200,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,IC50 (nM),8.83,PMID:17095227|DOI:10.1016/j.bmcl.2006.10.080,https://www.ncbi.nlm.nih.gov/pubmed/17095227|https://doi.org/10.1016/j.bmcl.2006.10.080,17095227,10.1016/j.bmcl.2006.10.080,
631,2009636,18452424,BindingDB,"6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-4-{[4-(trifluoromethyl)phenyl]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",25064,"6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-4-{[4-(trifluoromethyl)phenyl]methyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25064,200,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform/Phosphoinositide 3-kinase regulatory subunit 5",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=200,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,IC50 (nM),27.5,PMID:17095227|DOI:10.1016/j.bmcl.2006.10.080,https://www.ncbi.nlm.nih.gov/pubmed/17095227|https://doi.org/10.1016/j.bmcl.2006.10.080,17095227,10.1016/j.bmcl.2006.10.080,
632,2009637,18452430,BindingDB,"6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-4-(2-phenylethyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",25067,"6-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}-4-(2-phenylethyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25067,200,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform/Phosphoinositide 3-kinase regulatory subunit 5",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=200,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,IC50 (nM),24.5,PMID:17095227|DOI:10.1016/j.bmcl.2006.10.080,https://www.ncbi.nlm.nih.gov/pubmed/17095227|https://doi.org/10.1016/j.bmcl.2006.10.080,17095227,10.1016/j.bmcl.2006.10.080,
633,2010340,18464794,Therapeutic Target Database (TTD),2-(3-(4-Chlorophenyl)pyrrolidin-3-YL)ethanol,D0Z2QR,DS-7250,https://idrblab.net/ttd/data/drug/details/D0Z2QR,T16688,Diacylglycerol acyltransferase 1 (DGAT1),https://idrblab.net/ttd/data/target/details/T16688,O75907,Diacylglycerol O-acyltransferase 1,8694.0,DGAT1,9606.0,Homo sapiens (human),Modulator,,,,,,,
634,2010341,18522047,BindingDB,"N-aryl-4-aryl-1,3-thiazole-2-amine, 29",91672,"N-aryl-4-aryl-1,3-thiazole-2-amine, 29",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=91672,2259,Polyunsaturated fatty acid 5-lipoxygenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2259,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),,IC50 (nM),421,PMID:22404847|DOI:10.1111/j.1747-0285.2012.01371.x,https://www.ncbi.nlm.nih.gov/pubmed/22404847|https://doi.org/10.1111/j.1747-0285.2012.01371.x,22404847,10.1111/j.1747-0285.2012.01371.x,
635,2010342,18601660,ChEMBL,Dihydrocodeine tartrate,CHEMBL2062266,DIHYDROCODEINE BITARTRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2062266/,CHEMBL233,Mu opioid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL233/,P35372,Mu-type opioid receptor,4988.0,OPRM1,9606.0,Homo sapiens (human),Mu opioid receptor agonist,,,PMID:11762966,https://www.ncbi.nlm.nih.gov/pubmed/11762966,11762966,,
636,2010343,18604758,Comparative Toxicogenomics Database (CTD),"(2S,3S)-2-Amino-3-methyl-N-(2-morpholinoethyl)pentanamide",C575077,LM11A-31,https://ctdbase.org/detail.go?type=chem&acc=C575077,4804,NGFR,https://ctdbase.org/detail.go?type=gene&acc=4804,,,4804.0,NGFR,9606.0,Homo sapiens (human),LM11A-31 binds to NGFR protein,,,PMID:25277379,https://www.ncbi.nlm.nih.gov/pubmed/25277379,25277379,,
637,2010344,18604758,Comparative Toxicogenomics Database (CTD),"(2S,3S)-2-Amino-3-methyl-N-(2-morpholinoethyl)pentanamide",C575077,LM11A-31,https://ctdbase.org/detail.go?type=chem&acc=C575077,5781,PTPN11,https://ctdbase.org/detail.go?type=gene&acc=5781,,,5781.0,PTPN11,10090.0,Mus musculus (house mouse),LM11A-31 inhibits the reaction [cisplatin results in decreased phosphorylation of PTPN11 protein]|lm11a-31 inhibits the reaction [calpeptin results in decreased phosphorylation of PTPN11 protein],,,PMID:25277379,https://www.ncbi.nlm.nih.gov/pubmed/25277379,25277379,,
638,2010345,18604758,Comparative Toxicogenomics Database (CTD),"(2S,3S)-2-Amino-3-methyl-N-(2-morpholinoethyl)pentanamide",C575077,LM11A-31,https://ctdbase.org/detail.go?type=chem&acc=C575077,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10090.0,Mus musculus (house mouse),LM11A-31 inhibits the reaction [cisplatin results in increased activity of RHOA protein]|lm11a-31 inhibits the reaction [calpeptin results in increased activity of RHOA protein],,,PMID:25277379,https://www.ncbi.nlm.nih.gov/pubmed/25277379,25277379,,
639,2010346,18632368,Drug Gene Interaction database (DGIdb),L-4-Thioproline,,CHEMBL:CHEMBL1800368,https://www.dgidb.org/drugs/chembl:CHEMBL1800368,,HIF1AN,https://www.dgidb.org/genes/hgnc:17113,,,55662.0,HIF1AN,9606.0,Homo sapiens (human),,,,,,,,
640,2010347,18642481,Drug Gene Interaction database (DGIdb),Cevimeline [vandf],,CEVIMELINE,https://www.dgidb.org/drugs/rxcui:44281,,CHRM3,https://www.dgidb.org/genes/hgnc:1952,,,1131.0,CHRM3,9606.0,Homo sapiens (human),,,,,,,,
641,2010348,18642481,Drug Gene Interaction database (DGIdb),Cevimeline [vandf],,CEVIMELINE,https://www.dgidb.org/drugs/rxcui:44281,,CHRM3,https://www.dgidb.org/genes/hgnc:1952,,,1131.0,CHRM3,9606.0,Homo sapiens (human),,,,,,,,
642,2010349,18642481,Drug Gene Interaction database (DGIdb),Cevimeline [vandf],,CEVIMELINE,https://www.dgidb.org/drugs/rxcui:44281,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
643,2010350,18646248,Therapeutic Target Database (TTD),(R/R)Befloxatone,D0M0XR,(R/R)BEFLOXATONE,https://idrblab.net/ttd/data/drug/details/D0M0XR,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
644,2010351,18646248,Therapeutic Target Database (TTD),(R/R)Befloxatone,D0M0XR,(R/R)BEFLOXATONE,https://idrblab.net/ttd/data/drug/details/D0M0XR,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
645,2009730,20587845,BindingDB,"6-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one",18518,"6-(1-Pyrrolidine)quinolin-2(1H)-one, 4c",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18518,1924,Androgen receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1924,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),,Ki (nM),19,PMID:17887661|DOI:10.1021/jm070231h,https://www.ncbi.nlm.nih.gov/pubmed/17887661|https://doi.org/10.1021/jm070231h,17887661,10.1021/jm070231h,
646,2009729,20587865,BindingDB,"rac-6-(trans-2,5-dimethylpyrrolidin-1-yl)-4-trifluoromethyl-1H-quinolin-2-one",18519,"6-(1-Pyrrolidine)quinolin-2(1H)-one, 4d (+/-)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18519,1924,Androgen receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1924,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),,Ki (nM),43,PMID:17887661|DOI:10.1021/jm070231h,https://www.ncbi.nlm.nih.gov/pubmed/17887661|https://doi.org/10.1021/jm070231h,17887661,10.1021/jm070231h,
647,2009615,21133161,Comparative Toxicogenomics Database (CTD),Emeramide,C000629929,"N,N'-Bis(2-mercaptoethyl)isophthalamide",https://ctdbase.org/detail.go?type=chem&acc=C000629929,30061,SLC40A1,https://ctdbase.org/detail.go?type=gene&acc=30061,,,30061.0,SLC40A1,9606.0,Homo sapiens (human),"N,N'-bis(2-mercaptoethyl)isophthalamide results in increased expression of SLC40A1 protein|[lead co-treated with N,N'-bis(2-mercaptoethyl)isophthalamide] results in increased expression of SLC40A1 protein",,,PMID:34165617,https://www.ncbi.nlm.nih.gov/pubmed/34165617,34165617,,
648,2009610,21302490,Drug Gene Interaction database (DGIdb),Lumateperone,,LUMATEPERONE,https://www.dgidb.org/drugs/rxcui:2275602,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
649,2009611,21302490,Drug Gene Interaction database (DGIdb),Lumateperone,,LUMATEPERONE,https://www.dgidb.org/drugs/rxcui:2275602,,SLC6A4,https://www.dgidb.org/genes/hgnc:11050,,,6532.0,SLC6A4,9606.0,Homo sapiens (human),,,,,,,,
650,2009612,21302490,Drug Gene Interaction database (DGIdb),Lumateperone,,LUMATEPERONE,https://www.dgidb.org/drugs/rxcui:2275602,,SLC6A4,https://www.dgidb.org/genes/hgnc:11050,,,6532.0,SLC6A4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
651,2009613,21302490,Drug Gene Interaction database (DGIdb),Lumateperone,,LUMATEPERONE,https://www.dgidb.org/drugs/rxcui:2275602,,HTR2A,https://www.dgidb.org/genes/hgnc:5293,,,3356.0,HTR2A,9606.0,Homo sapiens (human),,,,,,,,
652,2009614,21302490,Drug Gene Interaction database (DGIdb),Lumateperone,,LUMATEPERONE,https://www.dgidb.org/drugs/rxcui:2275602,,HTR2A,https://www.dgidb.org/genes/hgnc:5293,,,3356.0,HTR2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
653,2009616,21466113,BindingDB,"4,6-Dimethoxypyrimidine-2-carbonitrile",496398,AAR-RCN-748c104b-1,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496398,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99500,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
654,2009617,21580417,Drug Gene Interaction database (DGIdb),Berkeleydione,,BERKELEYDIONE,https://www.dgidb.org/drugs/chembl:CHEMBL400514,,MMP3,https://www.dgidb.org/genes/hgnc:7173,,,4314.0,MMP3,9606.0,Homo sapiens (human),,,,,,,,
655,2009731,21596158,Drug Gene Interaction database (DGIdb),30-Norhederagenin,,CHEMBL:CHEMBL1081326,https://www.dgidb.org/drugs/chembl:CHEMBL1081326,,GSK3B,https://www.dgidb.org/genes/hgnc:4617,,,2932.0,GSK3B,9606.0,Homo sapiens (human),,,,,,,,
656,2009618,21603517,Drug Gene Interaction database (DGIdb),Dolastatin 12,,DOLASTATIN 12,https://www.dgidb.org/drugs/chembl:CHEMBL448114,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
657,2009619,21603517,Drug Gene Interaction database (DGIdb),Dolastatin 12,,DOLASTATIN 12,https://www.dgidb.org/drugs/chembl:CHEMBL448114,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
658,2009732,21637679,Therapeutic Target Database (TTD),kazinol C,D0D5OG,Kazinol C,https://idrblab.net/ttd/data/drug/details/D0D5OG,T97035,Tyrosinase (TYR),https://idrblab.net/ttd/data/target/details/T97035,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
659,2009733,21637704,Comparative Toxicogenomics Database (CTD),Ganoderic Acid T,C550530,ganoderic acid T,https://ctdbase.org/detail.go?type=chem&acc=C550530,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),CAT protein inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]|diphenyleneiodonium inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]|ganoderic acid T analog results in increased activity of CASP3 protein|cat protein inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein]|acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein]|acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]|ganoderic acid T results in increased activity of CASP3 protein|diphenyleneiodonium inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein],,,PMID:26282491,https://www.ncbi.nlm.nih.gov/pubmed/26282491,26282491,,
660,2009734,21637704,Comparative Toxicogenomics Database (CTD),Ganoderic Acid T,C550530,ganoderic acid T,https://ctdbase.org/detail.go?type=chem&acc=C550530,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein]|ganoderic acid T results in increased activity of CASP9 protein|diphenyleneiodonium inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]|acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]|diphenyleneiodonium inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein]|ganoderic acid T analog results in increased activity of CASP9 protein|cat protein inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]|cat protein inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein],,,PMID:26282491,https://www.ncbi.nlm.nih.gov/pubmed/26282491,26282491,,
661,2009735,21637704,Comparative Toxicogenomics Database (CTD),Ganoderic Acid T,C550530,ganoderic acid T,https://ctdbase.org/detail.go?type=chem&acc=C550530,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),CAT protein inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]|cat protein inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein]|cat protein inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]|cat protein inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein],,,PMID:26282491,https://www.ncbi.nlm.nih.gov/pubmed/26282491,26282491,,
662,2009620,21678144,IUPHAR/BPS Guide to PHARMACOLOGY,"[[(1S,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene",11207,DPO-1,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11207,542,Kv1.5,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=542,P22460,Potassium voltage-gated channel subfamily A member 5,3741.0,KCNA5,9606.0,Homo sapiens (human),,pIC50,7.3,PMID:20304642,https://www.ncbi.nlm.nih.gov/pubmed/20304642,20304642,,
663,2009736,21775681,Therapeutic Target Database (TTD),Anthoptilide C,D0XE8T,Anthoptilide C,https://idrblab.net/ttd/data/drug/details/D0XE8T,T92072,Adenosine A1 receptor (ADORA1),https://idrblab.net/ttd/data/target/details/T92072,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
664,2009607,22464113,Drug Gene Interaction database (DGIdb),4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine,,CHEMBL:CHEMBL95207,https://www.dgidb.org/drugs/chembl:CHEMBL95207,,YES1,https://www.dgidb.org/genes/hgnc:12841,,,7525.0,YES1,9606.0,Homo sapiens (human),,,,,,,,
665,2009754,23396230,BindingDB,"3-[2-(2,4-dichlorophenyl)ethoxy]-4-methyl-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide",13642,3-Oxybenzamide 28,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13642,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),37,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
666,2009755,23396232,BindingDB,"3-[2-(2,4-dichlorophenyl)ethoxy]-5-methoxy-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide",13655,3-Oxybenzamide 41,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13655,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),125,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
667,2009879,23396254,BindingDB,3-[2-(3-chlorophenyl)ethoxy]-4-fluoro-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13634,3-Oxybenzamide 20,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13634,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),712,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
668,2009876,23396255,BindingDB,3-[2-(4-bromophenyl)ethoxy]-4-chloro-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13619,3-Oxybenzamide 5,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13619,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),4726,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
669,2009877,23396255,BindingDB,3-[2-(4-bromophenyl)ethoxy]-4-chloro-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13619,3-Oxybenzamide 5,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13619,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),36,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
670,2009756,23396256,BindingDB,3-[2-(4-bromophenyl)ethoxy]-4-fluoro-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13629,3-Oxybenzamide 15,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13629,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),71,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
671,2009757,23396258,BindingDB,3-[2-(4-chlorophenyl)ethoxy]-4-methoxy-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13665,3-Oxybenzamide 51,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13665,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),41,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
672,2009758,23396258,BindingDB,3-[2-(4-chlorophenyl)ethoxy]-4-methoxy-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13665,3-Oxybenzamide 51,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13665,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),5271,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
673,2009759,23396259,BindingDB,3-[2-(4-cyanophenyl)ethoxy]-4-fluoro-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13633,3-Oxybenzamide 19,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13633,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),4605,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
674,2009760,23396282,BindingDB,4-chloro-3-[2-(3-chlorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13624,3-Oxybenzamide 10,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13624,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1931,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
675,2009761,23396283,BindingDB,4-chloro-3-[2-(3-methoxyphenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13625,3-Oxybenzamide 11,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13625,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2494,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
676,2009762,23396286,BindingDB,4-chloro-3-[2-(4-cyanophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13623,3-Oxybenzamide 9,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13623,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1552,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
677,2009763,23396287,BindingDB,4-chloro-3-[2-(4-fluorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13620,3-Oxybenzamide 6,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13620,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),102,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
678,2009764,23396288,BindingDB,4-chloro-3-[2-(4-methylphenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13621,3-Oxybenzamide 7,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13621,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),124,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
679,2009765,23396289,BindingDB,4-fluoro-3-[2-(3-methoxyphenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13635,3-Oxybenzamide 21,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13635,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),3348,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
680,2009766,23396290,BindingDB,4-fluoro-3-[2-(4-fluorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13630,3-Oxybenzamide 16,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13630,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),203,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
681,2009767,23396291,BindingDB,4-fluoro-3-[2-(4-methoxyphenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13632,3-Oxybenzamide 18,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13632,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),307,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
682,2009768,23396292,BindingDB,4-fluoro-3-[2-(4-methylphenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13631,3-Oxybenzamide 17,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13631,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),206,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
683,2009769,23396298,BindingDB,"7-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}-2H-1,3-benzodioxole-5-carboxamide",13658,3-Oxybenzamide 44,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13658,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),39,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
684,2009875,23396298,BindingDB,"7-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}-2H-1,3-benzodioxole-5-carboxamide",13658,3-Oxybenzamide 44,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13658,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),1677,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
685,2009878,23452327,Therapeutic Target Database (TTD),3-Hydroxy-3-methyl-6-phosphonohexanoic acid,D08QCI,3-hydroxy-3-methyl-6-phosphohexanoic acid,https://idrblab.net/ttd/data/drug/details/D08QCI,T53892,Phosphomevalonate kinase (PMVK),https://idrblab.net/ttd/data/target/details/T53892,Q15126,Phosphomevalonate kinase,10654.0,PMVK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
686,2009600,23460501,BindingDB,"1,3-dioxo-2,4-dimethyl-8-bromo-2H-pyrrolo[3,4-c]quinoline",10380,"12-bromo-4,7-dimethyl-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10380,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),1580,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
687,2009601,23577110,IUPHAR/BPS Guide to PHARMACOLOGY,"(2E)-3-{3-chloro-4-[3-(3,5-dimethyladamantan-1-yl)-4-hydroxyphenyl]phenyl}prop-2-enoic acid",8838,compound 10 [PMID: 18759424],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8838,636,SHP,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=636,Q15466,Nuclear receptor subfamily 0 group B member 2,8431.0,NR0B2,9606.0,Homo sapiens (human),Binding,pIC50,6.3,PMID:18759424,https://www.ncbi.nlm.nih.gov/pubmed/18759424,18759424,,
688,2009880,23581792,Drug Gene Interaction database (DGIdb),IRINOTECAN HCl)trihydrate),,IRINOTECAN HYDROCHLORIDE HYDRATE,https://www.dgidb.org/drugs/chembl:CHEMBL1200512,,PAX8,https://www.dgidb.org/genes/hgnc:8622,,,7849.0,PAX8,9606.0,Homo sapiens (human),,,,,,,,
689,2009608,23602318,Drug Gene Interaction database (DGIdb),"2-[4-(4-Fluorophenyl)piperazin-1-YL]-2-oxo-N-{12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-B]quinazolin-2-YL}acetamide",,CHEMBL:CHEMBL548629,https://www.dgidb.org/drugs/chembl:CHEMBL548629,,PLK1,https://www.dgidb.org/genes/hgnc:9077,,,5347.0,PLK1,9606.0,Homo sapiens (human),,,,,,,,
690,2009609,23602318,Drug Gene Interaction database (DGIdb),"2-[4-(4-Fluorophenyl)piperazin-1-YL]-2-oxo-N-{12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-B]quinazolin-2-YL}acetamide",,CHEMBL:CHEMBL548629,https://www.dgidb.org/drugs/chembl:CHEMBL548629,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
691,2009881,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,HGF,https://www.dgidb.org/genes/hgnc:4893,,,3082.0,HGF,9606.0,Homo sapiens (human),,,,,,,,
692,2009882,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,HRAS,https://www.dgidb.org/genes/hgnc:5173,,,3265.0,HRAS,9606.0,Homo sapiens (human),,,,,,,,
693,2009883,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,HRAS,https://www.dgidb.org/genes/hgnc:5173,,,3265.0,HRAS,9606.0,Homo sapiens (human),,,,,,,,
694,2009884,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,BCL2,https://www.dgidb.org/genes/hgnc:990,,,596.0,BCL2,9606.0,Homo sapiens (human),,,,,,,,
695,2009885,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,MT1H,https://www.dgidb.org/genes/hgnc:7400,,,4496.0,MT1H,9606.0,Homo sapiens (human),,,,,,,,
696,2009886,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,UCP1,https://www.dgidb.org/genes/hgnc:12517,,,7350.0,UCP1,9606.0,Homo sapiens (human),,,,,,,,
697,2009887,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,SST,https://www.dgidb.org/genes/hgnc:11329,,,6750.0,SST,9606.0,Homo sapiens (human),,,,,,,,
698,2009955,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,SSTR1,https://www.dgidb.org/genes/hgnc:11330,,,6751.0,SSTR1,9606.0,Homo sapiens (human),,,,,,,,
699,2009956,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,SULT1A2,https://www.dgidb.org/genes/hgnc:11454,,,6799.0,SULT1A2,9606.0,Homo sapiens (human),,,,,,,,
700,2009957,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,IGFBP1,https://www.dgidb.org/genes/hgnc:5469,,,3484.0,IGFBP1,9606.0,Homo sapiens (human),,,,,,,,
701,2009958,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,CTSD,https://www.dgidb.org/genes/hgnc:2529,,,1509.0,CTSD,9606.0,Homo sapiens (human),,,,,,,,
702,2009959,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
703,2009602,23618032,Drug Gene Interaction database (DGIdb),Puromycin monohydrochloride,,CHEMBL:CHEMBL531268,https://www.dgidb.org/drugs/chembl:CHEMBL531268,,PAX8,https://www.dgidb.org/genes/hgnc:8622,,,7849.0,PAX8,9606.0,Homo sapiens (human),,,,,,,,
704,2009960,23624983,BindingDB,"3-[(4S,6R)-4,9-diamino-6-hydroxynonyl]-1-nitroguanidine",21970,"3-[(4S,6R)-4,9-diamino-6-hydroxynonyl]-1-nitroguanidine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21970,2224,"Nitric oxide synthase, endothelial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2224,P29473,"Nitric oxide synthase, endothelial",,,9913.0,Bos taurus (cattle),,IC50 (nM),1529000,PMID:17614291|DOI:10.1016/j.bmc.2007.06.038,https://www.ncbi.nlm.nih.gov/pubmed/17614291|https://doi.org/10.1016/j.bmc.2007.06.038,17614291,10.1016/j.bmc.2007.06.038,
705,2009961,23624983,BindingDB,"3-[(4S,6R)-4,9-diamino-6-hydroxynonyl]-1-nitroguanidine",21970,"3-[(4S,6R)-4,9-diamino-6-hydroxynonyl]-1-nitroguanidine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21970,2225,"Nitric oxide synthase, inducible",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2225,P29477,"Nitric oxide synthase, inducible",18126.0,Nos2,10090.0,Mus musculus (house mouse),,IC50 (nM),313000,PMID:17614291|DOI:10.1016/j.bmc.2007.06.038,https://www.ncbi.nlm.nih.gov/pubmed/17614291|https://doi.org/10.1016/j.bmc.2007.06.038,17614291,10.1016/j.bmc.2007.06.038,
706,2009962,23624983,BindingDB,"3-[(4S,6R)-4,9-diamino-6-hydroxynonyl]-1-nitroguanidine",21970,"3-[(4S,6R)-4,9-diamino-6-hydroxynonyl]-1-nitroguanidine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21970,2223,"Nitric oxide synthase, brain",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2223,P29476,"Nitric oxide synthase, brain ",24598.0,Nos1,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),830,PMID:17614291|DOI:10.1016/j.bmc.2007.06.038,https://www.ncbi.nlm.nih.gov/pubmed/17614291|https://doi.org/10.1016/j.bmc.2007.06.038,17614291,10.1016/j.bmc.2007.06.038,
707,2009603,23625310,BindingDB,"3-[3-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",81735,PPY-B,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81735,5221,Tyrosine-protein kinase ABL1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5221,P00519,Tyrosine-protein kinase ABL1,25.0,ABL1,9606.0,Homo sapiens (human),,IC50 (nM),7,PMID:17718712|DOI:10.1111/j.1747-0285.2007.00556.x,https://www.ncbi.nlm.nih.gov/pubmed/17718712|https://doi.org/10.1111/j.1747-0285.2007.00556.x,17718712,10.1111/j.1747-0285.2007.00556.x,
708,2009604,23625310,BindingDB,"3-[3-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",81735,PPY-B,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81735,195,Tyrosine-protein kinase ABL1 [T315I],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=195,P00519,Tyrosine-protein kinase ABL1,25.0,ABL1,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:17718712|DOI:10.1111/j.1747-0285.2007.00556.x,https://www.ncbi.nlm.nih.gov/pubmed/17718712|https://doi.org/10.1111/j.1747-0285.2007.00556.x,17718712,10.1111/j.1747-0285.2007.00556.x,
709,2009605,23625458,BindingDB,"N-[3-[3-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]phenyl]acetamide",81736,PPY-C,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81736,195,Tyrosine-protein kinase ABL1 [T315I],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=195,P00519,Tyrosine-protein kinase ABL1,25.0,ABL1,9606.0,Homo sapiens (human),,IC50 (nM),41,PMID:17718712|DOI:10.1111/j.1747-0285.2007.00556.x,https://www.ncbi.nlm.nih.gov/pubmed/17718712|https://doi.org/10.1111/j.1747-0285.2007.00556.x,17718712,10.1111/j.1747-0285.2007.00556.x,
710,2009606,23625458,BindingDB,"N-[3-[3-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]phenyl]acetamide",81736,PPY-C,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81736,5221,Tyrosine-protein kinase ABL1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5221,P00519,Tyrosine-protein kinase ABL1,25.0,ABL1,9606.0,Homo sapiens (human),,IC50 (nM),1.1e+2,PMID:17718712|DOI:10.1111/j.1747-0285.2007.00556.x,https://www.ncbi.nlm.nih.gov/pubmed/17718712|https://doi.org/10.1111/j.1747-0285.2007.00556.x,17718712,10.1111/j.1747-0285.2007.00556.x,
711,2009770,23625933,BindingDB,"Bipiperidinyl carboxylic acid amide, 3",81830,"Bipiperidinyl carboxylic acid amide, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81830,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),2.5e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
712,2009773,23625934,BindingDB,"Bipiperidinyl carboxylic acid amide, 5",81833,"Bipiperidinyl carboxylic acid amide, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81833,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),7.4e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
713,2009774,23625935,BindingDB,"Bipiperidinyl carboxylic acid amide, 7",81834,"Bipiperidinyl carboxylic acid amide, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81834,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),2.3e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
714,2009775,23626092,BindingDB,"Bipiperidinyl carboxylic acid amide, 12",81840,"Bipiperidinyl carboxylic acid amide, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81840,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),5.3e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
715,2009771,23626093,BindingDB,"Bipiperidinyl carboxylic acid amide, 14",81842,"Bipiperidinyl carboxylic acid amide, 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81842,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),5.2e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
716,2009772,23626094,BindingDB,"Bipiperidinyl carboxylic acid amide, 16",81844,"Bipiperidinyl carboxylic acid amide, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81844,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),6.3e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
717,2009776,23626235,BindingDB,"Bipiperidinyl carboxylic acid amide, 18",81846,"Bipiperidinyl carboxylic acid amide, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81846,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
718,2009888,23626236,BindingDB,"Bipiperidinyl carboxylic acid amide, 20",81848,"Bipiperidinyl carboxylic acid amide, 20",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81848,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),2e+2,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
719,2009952,23626237,BindingDB,"Bipiperidinyl carboxylic acid amide, 22",81850,"Bipiperidinyl carboxylic acid amide, 22",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81850,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),7.7e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
720,2009953,23626238,BindingDB,"Bipiperidinyl carboxylic acid amide, 24",81852,"Bipiperidinyl carboxylic acid amide, 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81852,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),5.2e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
721,2009777,23626239,BindingDB,"Bipiperidinyl carboxylic acid amide, 25",81854,"Bipiperidinyl carboxylic acid amide, 25",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81854,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
722,2009954,23626394,BindingDB,"Bipiperidinyl carboxylic acid amide, 27",81856,"Bipiperidinyl carboxylic acid amide, 27",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81856,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),6.9e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
723,2009889,23626395,BindingDB,"Bipiperidinyl carboxylic acid amide, 29",81858,"Bipiperidinyl carboxylic acid amide, 29",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81858,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
724,2009890,23626397,BindingDB,"Bipiperidinyl carboxylic acid amide, 2",81829,"Bipiperidinyl carboxylic acid amide, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81829,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),5.9e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
725,2009891,23626398,BindingDB,"Bipiperidinyl carboxylic acid amide, 4",81831,"Bipiperidinyl carboxylic acid amide, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81831,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
726,2009892,23626552,BindingDB,"Bipiperidinyl carboxylic acid amide, 6",81832,"Bipiperidinyl carboxylic acid amide, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81832,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),3.7e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
727,2009893,23626553,BindingDB,"Bipiperidinyl carboxylic acid amide, 8",81835,"Bipiperidinyl carboxylic acid amide, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81835,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
728,2009894,23626555,BindingDB,"Bipiperidinyl carboxylic acid amide, 13",81841,"Bipiperidinyl carboxylic acid amide, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81841,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),5.1e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
729,2009895,23626556,BindingDB,"Bipiperidinyl carboxylic acid amide, 15",81843,"Bipiperidinyl carboxylic acid amide, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81843,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
730,2009642,23626706,BindingDB,"Trifluoroethylamine inhibitor, 6",19496,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19496,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),1.8,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
731,2009643,23626706,BindingDB,"Trifluoroethylamine inhibitor, 6",19496,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19496,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1104,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
732,2009947,23626725,BindingDB,"Bipiperidinyl carboxylic acid amide, 19",81847,"Bipiperidinyl carboxylic acid amide, 19",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81847,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
733,2009948,23626726,BindingDB,"Bipiperidinyl carboxylic acid amide, 21",81849,"Bipiperidinyl carboxylic acid amide, 21",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81849,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),7.9e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
734,2009949,23626727,BindingDB,"Bipiperidinyl carboxylic acid amide, 23",81851,"Bipiperidinyl carboxylic acid amide, 23",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81851,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),9.8e+3,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
735,2009950,23626728,BindingDB,"Bipiperidinyl carboxylic acid amide, 17",81845,"Bipiperidinyl carboxylic acid amide, 17",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81845,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
736,2009951,23626729,BindingDB,"Bipiperidinyl carboxylic acid amide, 26",81855,"Bipiperidinyl carboxylic acid amide, 26",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81855,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
737,2010142,23626870,BindingDB,"N-Substituted indole-2-and 3-carboxamide derivative, 7",81864,"N-Substituted indole-2- and 3-carboxamide derivative, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81864,49001145,Hyaluronidase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=49001145,Q12794,Hyaluronidase-1,3373.0,HYAL1,9606.0,Homo sapiens (human),,IC50 (nM),3.304e+4,PMID:17986205|DOI:10.1111/j.1747-0285.2007.00590.x,https://www.ncbi.nlm.nih.gov/pubmed/17986205|https://doi.org/10.1111/j.1747-0285.2007.00590.x,17986205,10.1111/j.1747-0285.2007.00590.x,
738,2010143,23626884,BindingDB,"Bipiperidinyl carboxylic acid amide, 28",81857,"Bipiperidinyl carboxylic acid amide, 28",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81857,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
739,2010144,23626885,BindingDB,"Bipiperidinyl carboxylic acid amide, 30",81859,"Bipiperidinyl carboxylic acid amide, 30",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81859,7517,C-C chemokine receptor type 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7517,P51679,C-C chemokine receptor type 4,1233.0,CCR4,9606.0,Homo sapiens (human),,IC50 (nM),>1.0e+4,PMID:17718722|DOI:10.1111/j.1747-0285.2007.00551.x,https://www.ncbi.nlm.nih.gov/pubmed/17718722|https://doi.org/10.1111/j.1747-0285.2007.00551.x,17718722,10.1111/j.1747-0285.2007.00551.x,
740,2009644,23627929,BindingDB,3-(2-Ethoxy-propyl)-2-thioxanthine,119872,"3&#8208;(2&#8208;ethoxypropyl)&#8208;2&#8208;sulfanylidene&#8208;1,9&#8208; dihydropurin&#8208;6&#8208;one (A)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=119872,5152,Myeloperoxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5152,P05164,Myeloperoxidase,4353.0,MPO,9606.0,Homo sapiens (human),,Ki (nM),413,PMID:24320749|DOI:10.1021/bi401354d,https://www.ncbi.nlm.nih.gov/pubmed/24320749|https://doi.org/10.1021/bi401354d,24320749,10.1021/bi401354d,
741,2009979,23628221,BindingDB,"6-Ethyl-5-[1-(3-methoxypropyl)-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",18037,"6-ethyl-2,4-diaminopyrimidine-based compound, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18037,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),691,PMID:17113558|DOI:10.1016/j.ab.2006.10.017,https://www.ncbi.nlm.nih.gov/pubmed/17113558|https://doi.org/10.1016/j.ab.2006.10.017,17113558,10.1016/j.ab.2006.10.017,
742,2009980,23628221,BindingDB,"6-Ethyl-5-[1-(3-methoxypropyl)-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",18037,"6-ethyl-2,4-diaminopyrimidine-based compound, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18037,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),650,PMID:17482464|DOI:10.1016/j.bmcl.2007.04.052,https://www.ncbi.nlm.nih.gov/pubmed/17482464|https://doi.org/10.1016/j.bmcl.2007.04.052,17482464,10.1016/j.bmcl.2007.04.052,
743,2009981,23628222,BindingDB,"N-{2-[7-(2,4-diamino-6-ethylpyrimidin-5-yl)-1,2,3,4-tetrahydroquinolin-1-yl]ethyl}acetamide",18020,"6-ethyl-2,4-diaminopyrimidine-based compound, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18020,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),178,PMID:17482464|DOI:10.1016/j.bmcl.2007.04.052,https://www.ncbi.nlm.nih.gov/pubmed/17482464|https://doi.org/10.1016/j.bmcl.2007.04.052,17482464,10.1016/j.bmcl.2007.04.052,
744,2009982,23629654,DrugBank,(S)-N-(4-Carbamimidoylbenzyl)-1-(2-(Cyclopentylamino)ethanoyl)pyrrolidine-2-Carboxamide,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,https://www.drugbank.ca/drugs/DB06845,BE0001739,Trypsin-1,https://www.drugbank.ca/bio_entities/BE0001739,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
745,2009983,23629654,DrugBank,(S)-N-(4-Carbamimidoylbenzyl)-1-(2-(Cyclopentylamino)ethanoyl)pyrrolidine-2-Carboxamide,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,https://www.drugbank.ca/drugs/DB06845,BE0000048,Prothrombin,https://www.drugbank.ca/bio_entities/BE0000048,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
746,2009963,23634407,Comparative Toxicogenomics Database (CTD),"1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl)methyl)urea",C561944,EMD 534085,https://ctdbase.org/detail.go?type=chem&acc=C561944,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),EMD 534085 results in increased expression of H2AX protein modified form,,,PMID:18451153,https://www.ncbi.nlm.nih.gov/pubmed/18451153,18451153,,
747,2009964,23634407,Comparative Toxicogenomics Database (CTD),"1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl)methyl)urea",C561944,EMD 534085,https://ctdbase.org/detail.go?type=chem&acc=C561944,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),EMD 534085 results in increased expression of TP53 protein modified form,,,PMID:18451153,https://www.ncbi.nlm.nih.gov/pubmed/18451153,18451153,,
748,2009965,23634407,Comparative Toxicogenomics Database (CTD),"1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl)methyl)urea",C561944,EMD 534085,https://ctdbase.org/detail.go?type=chem&acc=C561944,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),EMD 534085 results in decreased expression of XIAP protein,,,PMID:18451153,https://www.ncbi.nlm.nih.gov/pubmed/18451153,18451153,,
749,2010003,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0002217,Egl nine homolog 1,https://www.drugbank.ca/bio_entities/BE0002217,Q9GZT9,Egl nine homolog 1,54583.0,EGLN1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31477256,https://www.ncbi.nlm.nih.gov/pubmed/31477256,31477256,,
750,2010004,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0002211,Egl nine homolog 2,https://www.drugbank.ca/bio_entities/BE0002211,Q96KS0,Prolyl hydroxylase EGLN2,112398.0,EGLN2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31477256,https://www.ncbi.nlm.nih.gov/pubmed/31477256,31477256,,
751,2010005,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0002219,Egl nine homolog 3,https://www.drugbank.ca/bio_entities/BE0002219,Q9H6Z9,Prolyl hydroxylase EGLN3,112399.0,EGLN3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31477256,https://www.ncbi.nlm.nih.gov/pubmed/31477256,31477256,,
752,2010006,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0002374,Hypoxia-inducible factor 1-alpha,https://www.drugbank.ca/bio_entities/BE0002374,Q16665,Hypoxia-inducible factor 1-alpha,3091.0,HIF1A,9606.0,Homo sapiens (human),Stabilization,,,PMID:31477256,https://www.ncbi.nlm.nih.gov/pubmed/31477256,31477256,,
753,2010007,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0009679,Endothelial PAS domain-containing protein 1,https://www.drugbank.ca/bio_entities/BE0009679,Q99814,Endothelial PAS domain-containing protein 1,2034.0,EPAS1,9606.0,Homo sapiens (human),Stabilization,,,PMID:31477256,https://www.ncbi.nlm.nih.gov/pubmed/31477256,31477256,,
754,2010008,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0003541,UDP-glucuronosyltransferase 1-1,https://www.drugbank.ca/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),Substrate|Inducer,,,,,,,
755,2010009,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0004695,UDP-glucuronosyltransferase 1-7,https://www.drugbank.ca/bio_entities/BE0004695,Q9HAW7,UDP-glucuronosyltransferase 1A7,54577.0,UGT1A7,9606.0,Homo sapiens (human),Substrate,,,,,,,
756,2010010,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0003682,UDP-glucuronosyltransferase 1-8,https://www.drugbank.ca/bio_entities/BE0003682,Q9HAW9,UDP-glucuronosyltransferase 1A8,54576.0,UGT1A8,9606.0,Homo sapiens (human),Substrate,,,,,,,
757,2010011,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0003538,UDP-glucuronosyltransferase 1-9,https://www.drugbank.ca/bio_entities/BE0003538,O60656,UDP-glucuronosyltransferase 1A9,54600.0,UGT1A9,9606.0,Homo sapiens (human),Substrate,,,,,,,
758,2010012,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0003679,UDP-glucuronosyltransferase 2B7,https://www.drugbank.ca/bio_entities/BE0003679,P16662,UDP-glucuronosyltransferase 2B7,7364.0,UGT2B7,9606.0,Homo sapiens (human),Substrate,,,,,,,
759,2010013,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0003549,Cytochrome P450 2B6,https://www.drugbank.ca/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),Inducer,,,,,,,
760,2010014,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
761,2009984,23642301,Therapeutic Target Database (TTD),Elacestrant,D07KUN,Elacestrant,https://idrblab.net/ttd/data/drug/details/D07KUN,T89534,Estrogen receptor (ESR),https://idrblab.net/ttd/data/target/details/T89534,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Modulator,,,,,,,
762,2009985,23644579,DrugBank,"(2s,3s)-3-(4-Fluorophenyl)-2,3-Dihydroxypropanoic Acid",DB06946,"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",https://www.drugbank.ca/drugs/DB06946,BE0003755,"MIO-dependent tyrosine 2,3-aminomutase",https://www.drugbank.ca/bio_entities/BE0003755,Q8GMG0,"MIO-dependent tyrosine 2,3-aminomutase",,,1908.0,Streptomyces globisporus,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
763,2009986,23644635,BindingDB,"2-{12-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]dodecyl}-2,3-dihydro-1H-isoindole-1,3-dione",10413,10-N-Demethyl-10-N-(12-phthalimidododecyl)-galanthamine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10413,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),1400,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
764,2009987,23644637,BindingDB,"(1S,12S,14R)-4-[12-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)dodecyl]-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",10418,"(1S,12S,14R)-4-[12-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)dodecyl]-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10418,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),130,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
765,2010024,23644639,BindingDB,"{12-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]dodecyl}trimethylazanium bromide",10423,10-N-Demethyl-10-N-(12 -trimethylammoniumdodecyl)galanthamine bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10423,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),80,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
766,2010025,23644640,BindingDB,"2-(12-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}dodecyl)-2,3-dihydro-1H-isoindole-1,3-dione",10427,"2-(12-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}dodecyl)-2,3-dihydro-1H-isoindole-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10427,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),4600,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
767,2010026,23644642,BindingDB,"(1S,12S,14R)-9-{[12-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)dodecyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",10431,"(1S,12S,14R)-9-{[12-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)dodecyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10431,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),320,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
768,2010027,23644644,BindingDB,"(12-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}dodecyl)trimethylazanium bromide",10434,"(12-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}dodecyl)trimethylazanium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10434,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),1300,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
769,2010028,23644648,BindingDB,"9-Ethyl-6,7,10,11-tetrahydro-12-{{8-[(1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",10582,"15-ethyl-N-[8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10582,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),5.55,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
770,2010029,23644648,BindingDB,"9-Ethyl-6,7,10,11-tetrahydro-12-{{8-[(1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",10582,"15-ethyl-N-[8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10582,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.82,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
771,2010076,23644650,BindingDB,"7-chloro-15-methyl-N-[8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10585,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{8-[(1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10585,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.33,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
772,2010077,23644650,BindingDB,"7-chloro-15-methyl-N-[8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10585,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{8-[(1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10585,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),4.74,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
773,2010078,23644652,BindingDB,"[3-({7-Chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)propyl](methyl)[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]amine trihydrochloride",10586,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{3-{N-{3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-N-methylamino}propyl}amino}-7,11-methanocycloocta[b]quinoline trihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10586,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),16.4,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
774,2010079,23644652,BindingDB,"[3-({7-Chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)propyl](methyl)[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]amine trihydrochloride",10586,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{3-{N-{3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-N-methylamino}propyl}amino}-7,11-methanocycloocta[b]quinoline trihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10586,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.32,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
775,2010080,23644654,BindingDB,"7-chloro-N-{8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10589,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10589,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),7.8,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
776,2010081,23644654,BindingDB,"7-chloro-N-{8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10589,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10589,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.4,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
777,2010115,23644656,BindingDB,"{3-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}[3-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)propyl]methylamine trihydrochloride",10590,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{3-{N-{3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-N-methylamino}propyl}amino}-7,11-methanocycloocta[b]quinoline trihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10590,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.29,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
778,2010116,23644656,BindingDB,"{3-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}[3-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)propyl]methylamine trihydrochloride",10590,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{3-{N-{3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-N-methylamino}propyl}amino}-7,11-methanocycloocta[b]quinoline trihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10590,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),31.1,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
779,2010117,23644657,BindingDB,"(9E)-N1-(7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)-9-ethylidene-4,4,7-trimethylbicyclo[3.3.1]non-6-ene-1,3-diamine",10593,"(9E)-N1-(7-(1,2,3,4-Tetrahydroacridin-9-ylamino)heptyl)-9-ethylidene-4,4,7-trimethylbicyclo[3.3.1]non-6-ene-1,3-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10593,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),16.5,PMID:16722663|DOI:10.1021/jm060257t,https://www.ncbi.nlm.nih.gov/pubmed/16722663|https://doi.org/10.1021/jm060257t,16722663,10.1021/jm060257t,
780,2010118,23644657,BindingDB,"(9E)-N1-(7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)-9-ethylidene-4,4,7-trimethylbicyclo[3.3.1]non-6-ene-1,3-diamine",10593,"(9E)-N1-(7-(1,2,3,4-Tetrahydroacridin-9-ylamino)heptyl)-9-ethylidene-4,4,7-trimethylbicyclo[3.3.1]non-6-ene-1,3-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10593,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),20.8,PMID:16722663|DOI:10.1021/jm060257t,https://www.ncbi.nlm.nih.gov/pubmed/16722663|https://doi.org/10.1021/jm060257t,16722663,10.1021/jm060257t,
781,2010119,23644658,BindingDB,Physovenine Carbamate 20a,10614,"(3aS)-3a,8-dimethyl-2H,3H,3aH,8H,8aH-furo[2,3-b]indol-5-yl N-methylcarbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10614,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),27,PMID:16570913|DOI:10.1021/jm050578p,https://www.ncbi.nlm.nih.gov/pubmed/16570913|https://doi.org/10.1021/jm050578p,16570913,10.1021/jm050578p,
782,2010120,23644658,BindingDB,Physovenine Carbamate 20a,10614,"(3aS)-3a,8-dimethyl-2H,3H,3aH,8H,8aH-furo[2,3-b]indol-5-yl N-methylcarbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10614,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),4,PMID:16570913|DOI:10.1021/jm050578p,https://www.ncbi.nlm.nih.gov/pubmed/16570913|https://doi.org/10.1021/jm050578p,16570913,10.1021/jm050578p,
783,2010121,23644716,BindingDB,"6-[(4-Fluorobenzene)sulfonamido]-2,3-dimethylbenzoic acid",17609,"5,6-disubstituted anthranilic acid sulfonamide, 9a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17609,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),78,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
784,2010138,23644717,BindingDB,"(2S)-2-amino-4-(methylsulfanyl)-1-(1,3-thiazol-2-yl)butan-1-one",17867,"(2S)-2-amino-4-(methylsulfanyl)-1-(1,3-thiazol-2-yl)butan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17867,1866,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1866,P0A079,Methionine aminopeptidase,,,196620.0,Staphylococcus aureus subsp. aureus MW2,,IC50 (nM),19000,PMID:14998322|DOI:10.1021/jm034188j,https://www.ncbi.nlm.nih.gov/pubmed/14998322|https://doi.org/10.1021/jm034188j,14998322,10.1021/jm034188j,
785,2010139,23644718,BindingDB,"tert-butyl N-[(1S)-2-[(1R,2S,5R)-2-[(1-carbamoyl-3-cyclobutyl-1-oxopropan-2-yl)carbamoyl]-7,7-dimethyl-6-oxa-3-azabicyclo[3.2.0]heptan-3-yl]-1-cyclohexyl-2-oxoethyl]carbamate",17874,"Ketoamide inhibitor, 36",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17874,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),1400,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
786,2010140,23644719,BindingDB,"N-{2-[(1R,5S)-2-[(1-carbamoyl-3-cyclopropyl-1-oxopropan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-cyclohexyl-2-oxoethyl}-2-acetamido-3-methylbutanamide",17897,"Ketoamide inhibitor, 34",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17897,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),68,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
787,2010141,23644720,BindingDB,"N-{1-[(1R,5S)-2-[(1-carbamoyl-3-cyclobutyl-1-oxopropan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}-2-acetamido-3-methylbutanamide",17898,"Ketoamide inhibitor, 35",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17898,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),38,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
788,2010145,23644721,BindingDB,"2-(4-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17921,"2-(4-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17921,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.6,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
789,2010160,23644722,BindingDB,"2-(4-{[(2S,4S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-(naphthalen-2-yloxy)pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17928,"2-(4-{[(2S,4S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-(naphthalen-2-yloxy)pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17928,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.4,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
790,2010161,23644723,BindingDB,"2-(4-{[(2S,3S)-3-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17929,"2-(4-{[(2S,3S)-3-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17929,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.3,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
791,2010162,23644724,BindingDB,"2-(4-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)propanoic acid",17939,"2-(4-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17939,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),231,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
792,2010163,23644725,BindingDB,"Ketopiperazine-based inhibitor, 2",18022,"Ketopiperazine-based inhibitor, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18022,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),4.0,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
793,2010164,23644726,BindingDB,"3-[2-(7-{[(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-oxopiperazin-2-yl]methoxy}-1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-1,3-oxazolidin-2-one",18024,"3-[2-(7-{[(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-oxopiperazin-2-yl]methoxy}-1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-1,3-oxazolidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18024,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),>1000,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
794,2010165,23644727,BindingDB,"Ketopiperazine-based inhibitor, 12",18032,"Ketopiperazine-based inhibitor, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18032,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),0.68,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
795,2010166,23645143,BindingDB,"1-methyl-2,3-dioxo-2,3-dihydro-1H-indole-5-carboxylate",10300,"1-methyl-2,3-dioxo-2,3-dihydro-1H-indole-5-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10300,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),>50000,PMID:11384246|DOI:10.1021/jm0100537,https://www.ncbi.nlm.nih.gov/pubmed/11384246|https://doi.org/10.1021/jm0100537,11384246,10.1021/jm0100537,
796,2010189,23645144,BindingDB,(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-4-[(2S)-2-acetamido-3-methylbutanamido]butanoic acid,10356,(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-4-[(2S)-2-acetamido-3-methylbutanamido]butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10356,120,Caspase-6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=120,P55212,Caspase-6,839.0,CASP6,9606.0,Homo sapiens (human),,IC50 (nM),60.5,PMID:16302804|DOI:10.1021/jm0506625,https://www.ncbi.nlm.nih.gov/pubmed/16302804|https://doi.org/10.1021/jm0506625,16302804,10.1021/jm0506625,
797,2010190,23645145,BindingDB,(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-hydroxypropyl]carbamoyl}-4-[(2S)-2-acetamido-3-methylpentanamido]butanoic acid,10357,(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-hydroxypropyl]carbamoyl}-4-[(2S)-2-acetamido-3-methylpentanamido]butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10357,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),4.7,PMID:16302804|DOI:10.1021/jm0506625,https://www.ncbi.nlm.nih.gov/pubmed/16302804|https://doi.org/10.1021/jm0506625,16302804,10.1021/jm0506625,
798,2010191,23645146,BindingDB,"12-Fluoro-7-methyl-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",10376,"12-fluoro-7-methyl-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10376,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),62800,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
799,2010192,23645147,BindingDB,"12-Bromo-7-methyl-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",10377,"12-bromo-7-methyl-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10377,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),37100,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
800,2010193,23645148,BindingDB,"Methyl 2-{12-fluoro-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}acetate",10383,"methyl 2-{12-fluoro-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}acetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10383,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),2500,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
801,2010194,23645149,BindingDB,"Methyl 2-{12-bromo-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}acetate",10384,"methyl 2-{12-bromo-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}acetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10384,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),460,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
802,2010195,23645150,BindingDB,"Methyl 3-{7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}propanoate",10386,"methyl 3-{7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}propanoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10386,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),23300,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
803,2010210,23645151,BindingDB,"Methyl 3-{12-fluoro-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}propanoate",10387,"methyl 3-{12-fluoro-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}propanoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10387,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),5500,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
804,2010211,23645152,BindingDB,"Methyl 3-{12-bromo-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}propanoate",10388,"methyl 3-{12-bromo-7-methyl-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl}propanoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10388,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),1080,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
805,2010212,23645153,BindingDB,"12-Bromo-7-methyl-4-(2-methylphenyl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",10391,"12-bromo-7-methyl-4-(2-methylphenyl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10391,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),2540,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
806,2010213,23645155,BindingDB,"7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-sulfonic acid",10395,"7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-sulfonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10395,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),90,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
807,2010214,23645156,BindingDB,"12-bromo-7-methyl-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",10394,"12-bromo-7-methyl-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10394,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),360,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
808,2010215,23645158,BindingDB,"7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-carbonitrile",10397,"7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10397,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),16,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
809,2010216,23645159,BindingDB,"7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-sulfonamide",10398,"7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10398,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),33,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
810,2010230,23645160,BindingDB,"Pyrrolo[3,4-c]quinoline 8b",10399,"2-hydroxy-N-[7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-12-yl]ethane-1-sulfonamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10399,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),20,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
811,2010231,23645161,BindingDB,"N-(2-methoxyethyl)-7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-sulfonamide",10400,"N-(2-methoxyethyl)-7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10400,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),21,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
812,2010232,23645162,BindingDB,"Pyrrolo[3,4-c]quinoline 8d",10401,"methyl (2S)-2-{[7-methyl-3,5-dioxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaene-12-]sulfonamido}-3-phenylpropanoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10401,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),23,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
813,2010233,23645163,BindingDB,"Pyrrolo[3,4-c]quinoline 8e",10402,"7-methyl-12-{[(2R)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),7,10,12-pentaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10402,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),55,PMID:15780618|DOI:10.1016/j.bmcl.2005.02.027,https://www.ncbi.nlm.nih.gov/pubmed/15780618|https://doi.org/10.1016/j.bmcl.2005.02.027,15780618,10.1016/j.bmcl.2005.02.027,
814,2010234,23645164,BindingDB,"(1S,12S,14R)-9-{[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6,8,10(17),15-pentaen-4-ium",10407,"(1S,12S,14R)-9-{[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6,8,10(17),15-pentaen-4-ium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10407,3621,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3621,O42275,Acetylcholinesterase,,,8005.0,Electrophorus electricus (electric eel),,IC50 (nM),203,PMID:15563167|DOI:10.1021/ja0466154,https://www.ncbi.nlm.nih.gov/pubmed/15563167|https://doi.org/10.1021/ja0466154,15563167,10.1021/ja0466154,
815,2010235,23645164,BindingDB,"(1S,12S,14R)-9-{[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6,8,10(17),15-pentaen-4-ium",10407,"(1S,12S,14R)-9-{[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6,8,10(17),15-pentaen-4-ium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10407,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),499,PMID:15563167|DOI:10.1021/ja0466154,https://www.ncbi.nlm.nih.gov/pubmed/15563167|https://doi.org/10.1021/ja0466154,15563167,10.1021/ja0466154,
816,2010243,23645164,BindingDB,"(1S,12S,14R)-9-{[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6,8,10(17),15-pentaen-4-ium",10407,"(1S,12S,14R)-9-{[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6,8,10(17),15-pentaen-4-ium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10407,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),70,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
817,2010244,23645165,BindingDB,"2-{4-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]butyl}-2,3-dihydro-1H-isoindole-1,3-dione",10409,10-N-Demethyl-10-N-(4-phthalimidobutyl)-galanthamine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10409,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),2000,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
818,2010245,23645166,BindingDB,"2-{6-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]hexyl}-2,3-dihydro-1H-isoindole-1,3-dione",10410,10-N-Demethyl-10-N-(6-phthalimidohexyl)-galanthamine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10410,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),990,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
819,2010246,23645167,BindingDB,"2-{10-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]decyl}-2,3-dihydro-1H-isoindole-1,3-dione",10412,10-N-Demethyl-10-N-(10-phthalimidodecyl)-galanthamine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10412,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),330,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
820,2010247,23645169,BindingDB,"(1S,12S,14R)-4-[4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)butyl]-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium; 2,2,2-trifluoroacetate",10414,"(1S,12S,14R)-4-[4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)butyl]-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10414,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),470,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
821,2010248,23645171,BindingDB,"(1S,12S,14R)-4-[6-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)hexyl]-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium; 2,2,2-trifluoroacetate",10415,"(1S,12S,14R)-4-[6-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)hexyl]-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10415,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),40,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
822,2010255,23645173,BindingDB,"{3-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]propyl}trimethylazanium bromide",10419,10-N-Demethyl-10-N-(3-trimethylammoniumpropyl) galanthamine bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10419,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),12400,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
823,2010256,23645175,BindingDB,"{6-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]hexyl}trimethylazanium bromide",10420,10-N-Demethyl-10-N-(6-trimethylammoniumhexyl) galanthamine bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10420,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),1700,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
824,2010257,23645177,BindingDB,"{8-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]octyl}trimethylazanium bromide",10421,10-N-Demethyl-10-N-(8-trimethylammoniumoctyl) galanthamine bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10421,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),310,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
825,2010258,23645179,BindingDB,"{10-[(1S,12S,14R)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-4-yl]decyl}trimethylazanium bromide",10422,10-N-Demethyl-10-N-(10-trimethylammoniumdecyl) galanthamine bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10422,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),120,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
826,2010259,23645180,BindingDB,"2-(4-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}butyl)-2,3-dihydro-1H-isoindole-1,3-dione",10424,"2-(4-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}butyl)-2,3-dihydro-1H-isoindole-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10424,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),16100,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
827,2010260,23645181,BindingDB,"2-(8-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}octyl)-2,3-dihydro-1H-isoindole-1,3-dione",10425,"2-(8-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}octyl)-2,3-dihydro-1H-isoindole-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10425,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),2500,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
828,2010275,23645182,BindingDB,"2-(10-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}decyl)-2,3-dihydro-1H-isoindole-1,3-dione",10426,"2-(10-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}decyl)-2,3-dihydro-1H-isoindole-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10426,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),4000,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
829,2010276,23645184,BindingDB,"(1S,12S,14R)-9-[4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)butoxy]-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",10428,"(1S,12S,14R)-9-[4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)butoxy]-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10428,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),2300,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
830,2010277,23645187,BindingDB,"(1S,12S,14R)-9-{[10-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)decyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",10430,"(1S,12S,14R)-9-{[10-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)decyl]oxy}-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-4,6(17),7,9,15-pentaen-4-ium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10430,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),50,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
831,2010278,23645189,BindingDB,"(8-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}octyl)trimethylazanium bromide",10432,"(8-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}octyl)trimethylazanium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10432,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),9700,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
832,2010279,23645191,BindingDB,"(10-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}decyl)trimethylazanium bromide",10433,"(10-{[(1S,12S,14R)-14-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-9-yl]oxy}decyl)trimethylazanium bromide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10433,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),4100,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
833,2010280,23645193,BindingDB,"[8-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)octyl]trimethylazanium bromide",10435,8-(Phthalimidooctyl)-trimethylammonium bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10435,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),900,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
834,2010288,23645195,BindingDB,"[10-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)decyl]trimethylazanium bromide",10436,10-(Phthalimidodecyl)-trimethylammonium bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10436,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),5270,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
835,2010289,23645197,BindingDB,"[12-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)dodecyl]trimethylazanium bromide",10437,12-(Phthalimidododecyl)-trimethylammonium bromide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10437,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,IC50 (nM),3030,PMID:9839013|DOI:10.1016/s0968-0896(98)00133-3,https://www.ncbi.nlm.nih.gov/pubmed/9839013|https://doi.org/10.1016/s0968-0896(98)00133-3,9839013,10.1016/s0968-0896(98)00133-3,
836,2010290,23645204,BindingDB,N-heptylquinolin-4-amine hydrochloride,10457,4-Aminoquinoline 8,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10457,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),5950,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
837,2010291,23645204,BindingDB,N-heptylquinolin-4-amine hydrochloride,10457,4-Aminoquinoline 8,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10457,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),33800,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
838,2010292,23645206,BindingDB,Bivalent 4-Aminopyridine 12e,10459,Bivalent 4-Aminopyridine 12e,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10459,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),20000,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
839,2010293,23645206,BindingDB,Bivalent 4-Aminopyridine 12e,10459,Bivalent 4-Aminopyridine 12e,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10459,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),7850,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
840,2010294,23645208,BindingDB,Bivalent 4-Aminopyridine 12f,10460,Bivalent 4-Aminopyridine 12f,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10460,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),809,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
841,2010295,23645208,BindingDB,Bivalent 4-Aminopyridine 12f,10460,Bivalent 4-Aminopyridine 12f,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10460,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),10700,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
842,2010296,23645210,BindingDB,Bivalent 4-Aminopyridine 12g,10461,Bivalent 4-Aminopyridine 12g,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10461,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),9220,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
843,2010297,23645210,BindingDB,Bivalent 4-Aminopyridine 12g,10461,Bivalent 4-Aminopyridine 12g,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10461,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),908,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
844,2010298,23645212,BindingDB,Bivalent 4-Aminopyridine 12h,10462,Bivalent 4-Aminopyridine 12h,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10462,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),364,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
845,2010299,23645212,BindingDB,Bivalent 4-Aminopyridine 12h,10462,Bivalent 4-Aminopyridine 12h,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10462,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),7940,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
846,2010300,23645216,BindingDB,Bivalent 4-Aminopyridine 12k,10465,Bivalent 4-Aminopyridine 12k,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10465,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),14400,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
847,2010301,23645216,BindingDB,Bivalent 4-Aminopyridine 12k,10465,Bivalent 4-Aminopyridine 12k,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10465,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),403,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
848,2010302,23645223,BindingDB,"5-(1,2-dithiolan-3-yl)-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]pentanamide",10509,"5-(1,2-dithiolan-3-yl)-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10509,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),38.4,PMID:15658850|DOI:10.1021/jm049112h,https://www.ncbi.nlm.nih.gov/pubmed/15658850|https://doi.org/10.1021/jm049112h,15658850,10.1021/jm049112h,
849,2010303,23645223,BindingDB,"5-(1,2-dithiolan-3-yl)-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]pentanamide",10509,"5-(1,2-dithiolan-3-yl)-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10509,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),1.48,PMID:15658850|DOI:10.1021/jm049112h,https://www.ncbi.nlm.nih.gov/pubmed/15658850|https://doi.org/10.1021/jm049112h,15658850,10.1021/jm049112h,
850,2010304,23645224,BindingDB,"N-(3-aminopropyl)-6-chloro-1,2,3,4-tetrahydroacridin-9-amine",10514,CHEMBL191758,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10514,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),21.5,PMID:15658850|DOI:10.1021/jm049112h,https://www.ncbi.nlm.nih.gov/pubmed/15658850|https://doi.org/10.1021/jm049112h,15658850,10.1021/jm049112h,
851,2010305,23645224,BindingDB,"N-(3-aminopropyl)-6-chloro-1,2,3,4-tetrahydroacridin-9-amine",10514,CHEMBL191758,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10514,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),2580,PMID:15658850|DOI:10.1021/jm049112h,https://www.ncbi.nlm.nih.gov/pubmed/15658850|https://doi.org/10.1021/jm049112h,15658850,10.1021/jm049112h,
852,2010306,23645225,BindingDB,"N-{7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]heptyl}-1,2,3,4-tetrahydroacridin-9-amine",10522,"N-{7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]heptyl}-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10522,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),290,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
853,2010307,23645225,BindingDB,"N-{7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]heptyl}-1,2,3,4-tetrahydroacridin-9-amine",10522,"N-{7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]heptyl}-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10522,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,Ki (nM),80,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
854,2010308,23645226,BindingDB,"6,8-dichloro-N-[7-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)heptyl]-1,2,3,4-tetrahydroacridin-9-amine",10523,"6,8-dichloro-N-[7-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)heptyl]-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10523,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,Ki (nM),250,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
855,2010309,23645226,BindingDB,"6,8-dichloro-N-[7-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)heptyl]-1,2,3,4-tetrahydroacridin-9-amine",10523,"6,8-dichloro-N-[7-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)heptyl]-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10523,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),41,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
856,2010310,23645227,BindingDB,"N-{6-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]hexyl}-1,2,3,4-tetrahydroacridin-9-amine",10524,"N-{6-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]hexyl}-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10524,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),120,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
857,2010333,23645227,BindingDB,"N-{6-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]hexyl}-1,2,3,4-tetrahydroacridin-9-amine",10524,"N-{6-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]hexyl}-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10524,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,Ki (nM),45,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
858,2010334,23645228,BindingDB,"N-[6-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)hexyl]-1,2,3,4-tetrahydroacridin-9-amine",10525,"N-[6-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)hexyl]-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10525,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,Ki (nM),30,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
859,2010335,23645228,BindingDB,"N-[6-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)hexyl]-1,2,3,4-tetrahydroacridin-9-amine",10525,"N-[6-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)hexyl]-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10525,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),100,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
860,2010336,23645229,BindingDB,"N-[4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl]-1,2,3,4-tetrahydroacridin-9-amine",10526,"N-[4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl]-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10526,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),650,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
861,2010337,23645229,BindingDB,"N-[4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl]-1,2,3,4-tetrahydroacridin-9-amine",10526,"N-[4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl]-1,2,3,4-tetrahydroacridin-9-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10526,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,Ki (nM),40,PMID:11425559|DOI:10.1016/s0960-894x(01)00294-3,https://www.ncbi.nlm.nih.gov/pubmed/11425559|https://doi.org/10.1016/s0960-894x(01)00294-3,11425559,10.1016/s0960-894x(01)00294-3,
862,2009747,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),17.7,PMID:15115390|DOI:10.1021/jm0305523,https://www.ncbi.nlm.nih.gov/pubmed/15115390|https://doi.org/10.1021/jm0305523,15115390,10.1021/jm0305523,
863,2009748,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),3100,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294,10.1016/j.bmcl.2003.10.064,
864,2009749,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),60,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294,10.1016/j.bmcl.2003.10.064,
865,2010338,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),18,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
866,2010339,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),18,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
867,2010372,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),284,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
868,2010373,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),3040,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
869,2010374,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),1890,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
870,2010375,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),285,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
871,2010376,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),3050,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
872,2010377,23645230,BindingDB,Bromomethoxyphenyl inhibitor,10527,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10527,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),1885,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
873,2010378,23645231,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,10528,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10528,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),5380,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
874,2010379,23645231,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,10528,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10528,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
875,2010380,23645231,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,10528,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10528,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),3690,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
876,2010381,23645231,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,10528,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10528,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),176,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
877,2010382,23645232,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,10529,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10529,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),274,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
878,2010383,23645232,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,10529,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10529,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),5300,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
879,2010384,23645232,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,10529,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10529,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
880,2010385,23645232,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,10529,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10529,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),4505,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
881,2010401,23645233,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,10530,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10530,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),5830,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
882,2010402,23645233,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,10530,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10530,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),5810,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
883,2010403,23645233,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,10530,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10530,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),4200,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
884,2010404,23645233,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,10530,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10530,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),181,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
885,2010405,23645234,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10531,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10531,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),9445,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
886,2010406,23645234,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10531,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10531,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
887,2010407,23645234,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10531,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10531,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
888,2010416,23645234,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10531,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10531,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),1320,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
889,2010417,23645235,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,10532,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10532,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
890,2010418,23645235,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,10532,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10532,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
891,2010419,23645235,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,10532,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10532,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
892,2010420,23645235,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,10532,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10532,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),323,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
893,2010421,23645236,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,10533,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10533,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),80,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
894,2010422,23645236,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,10533,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10533,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),2215,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
895,2010431,23645236,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,10533,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10533,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),6505,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
896,2010432,23645236,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,10533,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10533,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),1625,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
897,2010433,23645237,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10534,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10534,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),4470,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
898,2010434,23645237,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10534,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10534,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
899,2010435,23645237,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10534,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10534,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),3625,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
900,2010436,23645237,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10534,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10534,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),341,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
901,2010437,23645238,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10535,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10535,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),17,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
902,2010438,23645238,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10535,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10535,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),139,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
903,2010439,23645238,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10535,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10535,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),1030,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
904,2010440,23645238,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,10535,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10535,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),92,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
905,2009750,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),22000,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294,10.1016/j.bmcl.2003.10.064,
906,2009751,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),8400,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294,10.1016/j.bmcl.2003.10.064,
907,2009752,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),22500,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294,10.1016/j.bmcl.2003.10.064,
908,2009753,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),750,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294,10.1016/j.bmcl.2003.10.064,
909,2010441,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),22050,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
910,2010442,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),21200,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
911,2010443,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),8360,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
912,2010444,23645239,BindingDB,Valine aspartyl ketone 15,10536,(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10536,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),746,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
913,2010445,23645240,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10537,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10537,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),41,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
914,2010446,23645240,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10537,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10537,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),1050,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
915,2010447,23645240,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10537,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10537,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),4160,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
916,2010448,23645240,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10537,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10537,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),1150,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
917,2010449,23645241,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10538,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10538,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),3650,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
918,2010450,23645241,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10538,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10538,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),4060,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
919,2010451,23645241,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10538,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10538,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),10860,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
920,2010452,23645241,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10538,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10538,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
921,2010453,23645242,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10539,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10539,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),330,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
922,2010454,23645242,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10539,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10539,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
923,2010455,23645242,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10539,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10539,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
924,2010456,23645242,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10539,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10539,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),7270,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
925,2010457,23645243,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10540,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10540,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),7340,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
926,2010458,23645243,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10540,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10540,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),3015,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
927,2010459,23645243,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10540,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10540,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),3405,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
928,2010460,23645243,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,10540,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10540,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),118,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
929,2010461,23645244,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10541,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10541,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),425,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
930,2010462,23645244,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10541,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10541,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
931,2010463,23645244,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10541,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10541,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),9175,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
932,2010464,23645244,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10541,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10541,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
933,2010465,23645245,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10542,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10542,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),18900,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
934,2010466,23645245,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10542,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10542,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),8000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
935,2010467,23645245,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10542,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10542,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),2760,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
936,2010468,23645245,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10542,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10542,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),85,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
937,2010469,23645246,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",10543,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10543,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),1295,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
938,2010470,23645246,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",10543,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10543,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
939,2010471,23645246,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",10543,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10543,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
940,2010472,23645246,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",10543,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10543,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
941,2010473,23645247,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,10544,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10544,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
942,2010474,23645247,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,10544,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10544,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
943,2010475,23645247,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,10544,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10544,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),9580,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
944,2010476,23645247,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,10544,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10544,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),2020,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
945,2010477,23645248,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10545,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10545,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),467,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
946,2010478,23645248,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10545,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10545,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),13800,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
947,2010479,23645248,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10545,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10545,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),18400,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
948,2010480,23645248,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,10545,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10545,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),10860,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
949,2010481,23645249,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,10546,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10546,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),9590,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
950,2010482,23645249,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,10546,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10546,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),5095,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
951,2010483,23645249,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,10546,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10546,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),12300,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
952,2010484,23645249,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,10546,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10546,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),160,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
953,2010485,23645250,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",10547,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10547,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),146,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
954,2010486,23645250,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",10547,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10547,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
955,2010487,23645250,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",10547,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10547,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
956,2010488,23645250,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",10547,"(3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10547,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
957,2010489,23645251,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",10549,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10549,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),29,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
958,2010490,23645251,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",10549,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10549,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),545,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
959,2010491,23645251,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",10549,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10549,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),975,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
960,2010492,23645251,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",10549,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10549,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),4490,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
961,2010493,23645252,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10551,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10551,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),1540,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
962,2010494,23645252,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10551,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10551,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),91,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
963,2010495,23645252,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10551,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10551,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),104,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
964,2010496,23645252,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10551,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10551,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),5,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
965,2010497,23645253,BindingDB,Valine aspartyl ketone 31,10552,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-acetyl-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10552,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),13,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
966,2010498,23645253,BindingDB,Valine aspartyl ketone 31,10552,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-acetyl-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10552,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),3880,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
967,2010499,23645253,BindingDB,Valine aspartyl ketone 31,10552,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-acetyl-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10552,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),555,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
968,2010500,23645253,BindingDB,Valine aspartyl ketone 31,10552,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-acetyl-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10552,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),6190,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
969,2010501,23645254,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10553,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10553,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),4850,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
970,2010502,23645254,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10553,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10553,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),290,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
971,2010503,23645254,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10553,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10553,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),635,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
972,2010504,23645254,BindingDB,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,10553,(3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-acetyl-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10553,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),16,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
973,2010505,23645255,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",10555,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10555,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),63,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
974,2010506,23645255,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",10555,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10555,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),280,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
975,2010507,23645255,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",10555,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10555,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),2460,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
976,2010508,23645255,BindingDB,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",10555,"(3S)-5-(benzylsulfanyl)-3-[(2S)-2-{2-hydroxy-2-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetamido}-3-methylbutanamido]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10555,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:16023344|DOI:10.1016/j.bmcl.2005.05.116,https://www.ncbi.nlm.nih.gov/pubmed/16023344|https://doi.org/10.1016/j.bmcl.2005.05.116,16023344,10.1016/j.bmcl.2005.05.116,
977,2010509,23645256,BindingDB,(3S)-4-oxo-3-(phenylformamido)butanoic acid,10557,(3S)-4-oxo-3-(phenylformamido)butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10557,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),23000,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
978,2010510,23645257,BindingDB,(3S)-4-oxo-3-(pyridin-2-ylformamido)butanoic acid,10558,(3S)-4-oxo-3-(pyridin-2-ylformamido)butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10558,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),55000,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
979,2010511,23645258,BindingDB,(3S)-4-oxo-3-(pyridin-4-ylformamido)butanoic acid,10560,(3S)-4-oxo-3-(pyridin-4-ylformamido)butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10560,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),>200000,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
980,2010512,23645259,BindingDB,(3S)-3-[(5-bromopyridin-3-yl)formamido]-4-oxo-9-phenylnonanoic acid,10564,(3S)-3-[(5-bromopyridin-3-yl)formamido]-4-oxo-9-phenylnonanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10564,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),96900,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
981,2010513,23645260,BindingDB,(3S)-3-[(5-bromopyridin-3-yl)formamido]-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10567,(3S)-3-[(5-bromopyridin-3-yl)formamido]-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10567,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),1200,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
982,2010514,23645261,BindingDB,(3S)-3-{[5-(dipropylcarbamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10569,(3S)-3-{[5-(dipropylcarbamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10569,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),410,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
983,2010515,23645262,BindingDB,(3S)-3-({5-[ethyl(propan-2-yl)carbamoyl]pyridin-3-yl}formamido)-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10570,(3S)-3-({5-[ethyl(propan-2-yl)carbamoyl]pyridin-3-yl}formamido)-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10570,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),250,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
984,2010516,23645263,BindingDB,(3S)-3-({5-[bis(2-methylpropyl)carbamoyl]pyridin-3-yl}formamido)-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10571,(3S)-3-({5-[bis(2-methylpropyl)carbamoyl]pyridin-3-yl}formamido)-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10571,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),130,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
985,2010517,23645264,BindingDB,(3S)-3-{[5-(dimethylsulfamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10572,(3S)-3-{[5-(dimethylsulfamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10572,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
986,2010518,23645265,BindingDB,(3S)-3-{[5-(dipropylsulfamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10574,(3S)-3-{[5-(dipropylsulfamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10574,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),170,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
987,2010519,23645266,BindingDB,(3S)-3-{[5-(benzylsulfamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,10577,(3S)-3-{[5-(benzylsulfamoyl)pyridin-3-yl]formamido}-5-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxopentanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10577,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),340,PMID:12798321|DOI:10.1016/s0960-894x(03)00390-1,https://www.ncbi.nlm.nih.gov/pubmed/12798321|https://doi.org/10.1016/s0960-894x(03)00390-1,12798321,10.1016/s0960-894x(03)00390-1,
988,2010520,23645268,BindingDB,"7-chloro-15-methyl-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10583,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{6-[(1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10583,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),7.69,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
989,2010521,23645268,BindingDB,"7-chloro-15-methyl-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10583,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{6-[(1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10583,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.5,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
990,2010522,23645270,BindingDB,"7-chloro-15-methyl-N-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10584,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{7-[(1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10584,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.34,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
991,2010523,23645270,BindingDB,"7-chloro-15-methyl-N-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl]-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10584,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{7-[(1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10584,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),6.70,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
992,2010524,23645272,BindingDB,"7-chloro-N-{6-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10587,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{6-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10587,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),14.0,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
993,2010525,23645272,BindingDB,"7-chloro-N-{6-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10587,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{6-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10587,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.45,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
994,2010526,23645274,BindingDB,"7-chloro-N-{7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine dihydrochloride",10588,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}amino}-7,11-methanocycloocta[b]quinoline dihydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10588,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),0.33,PMID:15771413|DOI:10.1021/jm0496741,https://www.ncbi.nlm.nih.gov/pubmed/15771413|https://doi.org/10.1021/jm0496741,15771413,10.1021/jm0496741,
995,2009705,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),3.7,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
996,2009706,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),37,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
997,2009707,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),5,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
998,2009708,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),6.4,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
999,2009709,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),>200,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1000,2009710,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),>200,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1001,2009711,23645537,BindingDB,Hydroxamate 43,11362,"2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11362,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),>200,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1002,2009712,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),>200,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1003,2009827,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),>200,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1004,2009828,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),>200,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1005,2009829,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),27,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1006,2009830,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),31,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1007,2009831,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),53,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1008,2009832,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),12,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1009,2009833,23645538,BindingDB,Hydroxamate 45,11364,2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11364,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),22,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1010,2009834,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),62000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1011,2009905,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),19000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1012,2009906,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),74000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1013,2009907,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),21000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1014,2009908,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),25000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1015,2009909,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),27,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1016,2009910,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),15,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1017,2009911,23645539,BindingDB,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",11368,"1,1,2,2,3,3,4,4,4-nonafluoro-N-hydroxybutane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11368,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),1800,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1018,2009912,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),1600,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1019,2009972,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),9,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1020,2009973,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),21,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1021,2009974,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),23000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1022,2009975,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),21000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1023,2009976,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),70000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1024,2009977,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),14000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1025,2009978,23645540,BindingDB,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",11369,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-hydroxyoctane-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11369,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),55000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1026,2010015,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),80000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1027,2010016,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),73000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1028,2010017,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),95000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1029,2010018,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),83000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1030,2010019,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),76000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1031,2010020,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),460,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1032,2010021,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),190,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1033,2010022,23645541,BindingDB,N-Benzylsulfonylhydroxylamin,11371,Hydroxysulfonamide 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11371,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),19000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1034,2010023,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),57000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1035,2010067,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),9,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1036,2010068,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),70,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1037,2010069,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),15000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1038,2010070,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),14000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1039,2010071,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),42000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1040,2010072,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),21000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1041,2010073,23645542,BindingDB,N-Hydroxy-4-nitrobenzene-1-sulfonamide,11378,Hydroxysulfonamide 59,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11378,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),36000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1042,2010074,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),32000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1043,2010075,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),23000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1044,2010098,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),37000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1045,2010099,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),13000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1046,2010100,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),16000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1047,2010101,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),24,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1048,2010102,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),5,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1049,2010103,23645543,BindingDB,N-hydroxy-3-nitrobenzene-1-sulfonamide,11379,Hydroxysulfonamide 60,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11379,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),17000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1050,2010104,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),15000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1051,2010105,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),5,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1052,2010106,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),13,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1053,2010107,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),24000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1054,2010108,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),23000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1055,2010109,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),59000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1056,2010110,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),38000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1057,2010111,23645544,BindingDB,N-Hydroxy-2-nitrobenzenesulfonamide,11380,Hydroxysulfonamide 61,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11380,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),62000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1058,2010112,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),29000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1059,2010113,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),14000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1060,2010114,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),30000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1061,2010152,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),13000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1062,2010153,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),16000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1063,2010154,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),12,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1064,2010155,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),4,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1065,2010156,23645545,BindingDB,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,11381,3-chloro-N-hydroxy-4-nitrobenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11381,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),17000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1066,2010157,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),41000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1067,2010158,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),44,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1068,2010159,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),136,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1069,2010173,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),10000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1070,2010174,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),9000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1071,2010175,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),30000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1072,2010176,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),11000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1073,2010177,23645546,BindingDB,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,11384,3-amino-N-hydroxy-4-methoxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11384,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),13000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1074,2010178,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),500,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1075,2010179,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),900,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1076,2010180,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),400,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1077,2010181,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),1300,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1078,2010182,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),1000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1079,2010183,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),13,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1080,2010184,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.8,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1081,2010185,23645547,BindingDB,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",11387,"2,3,4,5,6-pentafluoro-N-hydroxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11387,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),30000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1082,2010186,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),25000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1083,2010187,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),12,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1084,2010188,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.9,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1085,2010202,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,1250,Neutrophil collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1250,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,Ki (nM),120,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1086,2010203,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,6143,Matrix metalloproteinase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6143,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,Ki (nM),100,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1087,2010204,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,111,Interstitial collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=111,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,Ki (nM),80,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1088,2010205,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606.0,Homo sapiens (human),,Ki (nM),90,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1089,2010206,23645548,BindingDB,2-(Hydroxysulfamoyl)benzoic acid,11389,2-(hydroxysulfamoyl)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11389,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),7000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
1090,2010207,23645549,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 8",11398,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11398,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.15,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1091,2010208,23645549,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 8",11398,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11398,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.17,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1092,2010209,23645551,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 9",11399,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11399,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.11,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1093,2010223,23645551,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 9",11399,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11399,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.1,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1094,2010224,23645551,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 9",11399,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11399,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),,IC50 (nM),16.9,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1095,2010225,23645553,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 12",11405,"2-Ethyl-3-[[bis(2-hydroxyethyl)amino]methyl]-2H-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11405,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.33,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1096,2010226,23645553,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 12",11405,"2-Ethyl-3-[[bis(2-hydroxyethyl)amino]methyl]-2H-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11405,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),0.96,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1097,2010227,23645555,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 14",11407,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11407,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.48,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1098,2010228,23645555,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 14",11407,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11407,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.15,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1099,2010229,23645556,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 20",11413,"2-Cyclohexyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11413,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),0.79,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1100,2010268,23645556,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 20",11413,"2-Cyclohexyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11413,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.31,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1101,2010269,23645556,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 20",11413,"2-Cyclohexyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11413,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),,IC50 (nM),49.5,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1102,2010270,23645559,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 24",11417,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11417,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.26,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1103,2010271,23645559,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 24",11417,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11417,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),3.12,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1104,2010272,23645560,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 25",11418,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 25",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11418,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),2.23,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1105,2010273,23645560,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 25",11418,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 25",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11418,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.12,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1106,2010274,23645562,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 28",11421,"2-(3-Methoxyphenyl)-3-[(2-hydroxyethylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11421,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.16,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1107,2010311,23645562,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 28",11421,"2-(3-Methoxyphenyl)-3-[(2-hydroxyethylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11421,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.11,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1108,2010312,23645564,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 29",11422,"2-(3,4-Dimethoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11422,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.08,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1109,2010313,23645564,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 29",11422,"2-(3,4-Dimethoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11422,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.05,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1110,2010314,23645564,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 29",11422,"2-(3,4-Dimethoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11422,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),,IC50 (nM),10.1,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1111,2010315,23645565,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 31",11424,"2-(3-Hydroxypropyl)-3-(4-morpholinylmethyl)-2H-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11424,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.62,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1112,2010316,23645565,BindingDB,"2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 31",11424,"2-(3-Hydroxypropyl)-3-(4-morpholinylmethyl)-2H-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11424,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),0.2,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
1113,2010317,23645566,BindingDB,"4-({5-[(4-aminocyclohexyl)amino]-3-cyclopentylpyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11429,"4-({5-[(4-aminocyclohexyl)amino]-3-cyclopentylpyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11429,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),4,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1114,2010352,23645567,BindingDB,"4-({5-[(4-aminocyclohexyl)amino]-3-chloropyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11431,"4-({5-[(4-aminocyclohexyl)amino]-3-chloropyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11431,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),8,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1115,2010353,23645568,BindingDB,"4-[(5-{[4-(ethylamino)cyclohexyl]amino}-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzene-1-sulfonamide",11433,"4-[(5-{[4-(ethylamino)cyclohexyl]amino}-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11433,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),61,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1116,2010354,23645569,BindingDB,"4-[(5-{[4-(diethylamino)cyclohexyl]amino}-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzene-1-sulfonamide",11434,"4-[(5-{[4-(diethylamino)cyclohexyl]amino}-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11434,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),92,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1117,2010355,23645570,BindingDB,"4-({5-[(4-aminocyclohexyl)oxy]-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11435,"4-({5-[(4-aminocyclohexyl)oxy]-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11435,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),17,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1118,2010356,23645571,BindingDB,"4-({5-[(3-aminocyclohexyl)amino]-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11436,"4-({5-[(3-aminocyclohexyl)amino]-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11436,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),2100,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1119,2010357,23645572,BindingDB,"N,N-dimethyl-4-{[5-(2-methylpropoxy)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide",11437,"N,N-dimethyl-4-{[5-(2-methylpropoxy)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11437,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1200,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1120,2010358,23645573,BindingDB,"Pyrazolo[1,5-a]pyrimidine 9k",11438,"N-(4-methanesulfonylphenyl)-5-(2-methylpropoxy)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11438,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1200,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1121,2010359,23645574,BindingDB,"4-({5-[(4-aminocyclohexyl)amino]-3-bromopyrazolo[1,5-a]pyrimidin-7-yl}amino)-2-chloro-N,N-dimethylbenzene-1-sulfonamide",11439,"4-({5-[(4-aminocyclohexyl)amino]-3-bromopyrazolo[1,5-a]pyrimidin-7-yl}amino)-2-chloro-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11439,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1122,2010360,23645575,BindingDB,"5-chloro-N-(4-methanesulfonylphenyl)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-amine",11443,"5-chloro-N-(4-methanesulfonylphenyl)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11443,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),230,PMID:15686876|DOI:10.1016/j.bmcl.2004.12.073,https://www.ncbi.nlm.nih.gov/pubmed/15686876|https://doi.org/10.1016/j.bmcl.2004.12.073,15686876,10.1016/j.bmcl.2004.12.073,
1123,2010361,23645576,BindingDB,"4-({5-[(4-Hydroxycyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)benzene-1-sulfonamide",11450,"4-({5-[(4-hydroxycyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11450,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),7400,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1124,2010362,23645577,BindingDB,"4-(5-Diethylamino-[1,2,4]triazolo[1,5-a]pyrimidine-7-ylamino)-benzenesulfonamide",11451,"4-{[5-(diethylamino)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11451,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),400,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1125,2010363,23645577,BindingDB,"4-(5-Diethylamino-[1,2,4]triazolo[1,5-a]pyrimidine-7-ylamino)-benzenesulfonamide",11451,"4-{[5-(diethylamino)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11451,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),3400,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1126,2010364,23645577,BindingDB,"4-(5-Diethylamino-[1,2,4]triazolo[1,5-a]pyrimidine-7-ylamino)-benzenesulfonamide",11451,"4-{[5-(diethylamino)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11451,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),11000,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1127,2010394,23645578,BindingDB,"4-({5-[(4-Aminocyclohexyl)amino][1,2,4]triazolo[1,5-A]pyrimidin-7-YL}amino)benzenesulfonamide",11452,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11452,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),780,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1128,2010395,23645578,BindingDB,"4-({5-[(4-Aminocyclohexyl)amino][1,2,4]triazolo[1,5-A]pyrimidin-7-YL}amino)benzenesulfonamide",11452,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11452,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),270,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1129,2010396,23645579,BindingDB,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11453,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11453,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1130,2010397,23645579,BindingDB,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11453,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11453,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),5600,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1131,2010398,23645579,BindingDB,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",11453,"4-({5-[(4-aminocyclohexyl)amino]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)-N,N-dimethylbenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11453,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),20000,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1132,2010399,23645580,BindingDB,"Triazolo[1,5-a]pyrimidine 16",11454,"5-N-(4-aminocyclohexyl)-7-N-(4-methanesulfonylphenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11454,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),43000,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1133,2010400,23645580,BindingDB,"Triazolo[1,5-a]pyrimidine 16",11454,"5-N-(4-aminocyclohexyl)-7-N-(4-methanesulfonylphenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11454,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),16000,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1134,2010423,23645580,BindingDB,"Triazolo[1,5-a]pyrimidine 16",11454,"5-N-(4-aminocyclohexyl)-7-N-(4-methanesulfonylphenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11454,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),250,PMID:16325401|DOI:10.1016/j.bmcl.2005.11.048,https://www.ncbi.nlm.nih.gov/pubmed/16325401|https://doi.org/10.1016/j.bmcl.2005.11.048,16325401,10.1016/j.bmcl.2005.11.048,
1135,2009638,23645673,BindingDB,"(2S,3S)-2-amino-1-[(3S)-3-fluoropyrrolidin-1-yl]-3-{4-[3-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}butan-1-one (12)",123777,"(2S,3S)-2-amino-1-[(3S)-3-fluoropyrrolidin-1-yl]-3- {4-[3-(1H-1,2,3,4-tetrazol-5- yl)phenyl]phenyl}butan-1-one (12)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=123777,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:24674599|DOI:10.1111/cbdd.12327,https://www.ncbi.nlm.nih.gov/pubmed/24674599|https://doi.org/10.1111/cbdd.12327,24674599,10.1111/cbdd.12327,
1136,2009639,23645685,BindingDB,2-Cyanopyrrolidine 1,11644,(2S)-1-[(2S)-2-amino-2-cyclopentylacetyl]pyrrolidine-2-carbonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11644,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,Ki (nM),3,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1137,2009640,23645685,BindingDB,2-Cyanopyrrolidine 1,11644,(2S)-1-[(2S)-2-amino-2-cyclopentylacetyl]pyrrolidine-2-carbonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11644,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,Ki (nM),4,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1138,2009641,23645685,BindingDB,2-Cyanopyrrolidine 1,11644,(2S)-1-[(2S)-2-amino-2-cyclopentylacetyl]pyrrolidine-2-carbonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11644,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1139,2010002,23646127,BindingDB,N-[(3S)-1-[2-(azepan-1-yl)-2-oxoethyl]-2-oxopyrrolidin-3-yl]-6-chloro-N-methylnaphthalene-2-sulfonamide,12554,N-[(3S)-1-[2-(azepan-1-yl)-2-oxoethyl]-2-oxopyrrolidin-3-yl]-6-chloro-N-methylnaphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12554,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),60,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1140,2010030,23646128,BindingDB,6-chloro-N-methyl-N-[(3S)-2-oxo-1-[2-oxo-2-(piperidin-1-yl)ethyl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,12555,6-chloro-N-methyl-N-[(3S)-2-oxo-1-[2-oxo-2-(piperidin-1-yl)ethyl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12555,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),72,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1141,2010031,23646129,BindingDB,6-chloro-N-[(3S)-2-oxo-1-[2-oxo-2-(piperidin-1-yl)ethyl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,12556,6-chloro-N-[(3S)-2-oxo-1-[2-oxo-2-(piperidin-1-yl)ethyl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12556,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),63,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1142,2009778,23646130,BindingDB,6-chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide,12557,6-chloro-N-[(3S)-2-oxo-1-[(2S)-1-oxo-1-(piperidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12557,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1143,2009779,23646131,BindingDB,6-Chloro-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide,12558,6-chloro-N-methyl-N-[(3S)-2-oxo-1-[(2S)-1-oxo-1-(piperidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12558,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1144,2009780,23646132,BindingDB,6-chloro-N-{1-[2-methyl-1-oxo-1-(piperidin-1-yl)propan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide,12559,6-chloro-N-{1-[2-methyl-1-oxo-1-(piperidin-1-yl)propan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12559,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),10600,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1145,2009781,23646133,BindingDB,6-chloro-N-[(3S)-2-oxo-1-[(2S)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,12560,6-chloro-N-[(3S)-2-oxo-1-[(2S)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12560,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),50,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1146,2009782,23646134,BindingDB,6-chloro-N-[(3S)-2-oxo-1-[(2S)-1-oxo-1-(piperazin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,12563,6-chloro-N-[(3S)-2-oxo-1-[(2S)-1-oxo-1-(piperazin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12563,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),320,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1147,2009783,23646135,BindingDB,6-chloro-N-[(3S)-1-[(2S)-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]naphthalene-2-sulfonamide,12564,6-chloro-N-[(3S)-1-[(2S)-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12564,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2060,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1148,2009784,23646136,BindingDB,6-Chloro-N-{(3S)-1-[(1R)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide,12572,6-chloro-N-[(3S)-1-[(2R)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12572,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),160,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1149,2009868,23646137,BindingDB,6-chloro-N-[(3R)-2-oxo-1-[(2R)-1-oxo-1-(piperidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,12573,6-chloro-N-[(3R)-2-oxo-1-[(2R)-1-oxo-1-(piperidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12573,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),40,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1150,2009869,23646138,BindingDB,6-Chloro-N-{(3S)-1-[(1R)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide,12575,6-chloro-N-[(3S)-2-oxo-1-[(2R)-1-oxo-1-(piperidin-1-yl)propan-2-yl]pyrrolidin-3-yl]naphthalene-2-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12575,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),82,PMID:16697194|DOI:10.1016/j.bmcl.2006.04.053,https://www.ncbi.nlm.nih.gov/pubmed/16697194|https://doi.org/10.1016/j.bmcl.2006.04.053,16697194,10.1016/j.bmcl.2006.04.053,
1151,2009870,23646140,BindingDB,"(2S,5S)-1-((2S)-2-amino-2-cyclopentylethanoyl)-5-methylpyrrolidine-2-carbonitrile",12629,"(2S,5S)-1-((2S)-2-amino-2-cyclopentylethanoyl)-5-methylpyrrolidine-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12629,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),97,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1152,2009871,23646141,BindingDB,"(2S,5S)-1-[(2R,3R)-2-amino-3-methylpentanoyl]-5-phenylpyrrolidine-2-carbonitrile",12634,"(2S,5S)-1-[(2R,3R)-2-amino-3-methylpentanoyl]-5-phenylpyrrolidine-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12634,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1153,2009872,23646142,BindingDB,"(2S,5R)-5-ethynyl-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile",12642,"(2S,5R)-5-ethynyl-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12642,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),62,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1154,2009873,23646142,BindingDB,"(2S,5R)-5-ethynyl-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile",12642,"(2S,5R)-5-ethynyl-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12642,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1155,2009874,23646142,BindingDB,"(2S,5R)-5-ethynyl-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile",12642,"(2S,5R)-5-ethynyl-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12642,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1156,2009913,23646143,BindingDB,6-{[4-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)cyclohexyl]oxy}pyridine-3-carbonitrile,12643,6-{[4-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)cyclohexyl]oxy}pyridine-3-carbonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12643,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,Ki (nM),110,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1157,2009914,23646143,BindingDB,6-{[4-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)cyclohexyl]oxy}pyridine-3-carbonitrile,12643,6-{[4-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)cyclohexyl]oxy}pyridine-3-carbonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12643,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,Ki (nM),10,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1158,2009915,23646143,BindingDB,6-{[4-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)cyclohexyl]oxy}pyridine-3-carbonitrile,12643,6-{[4-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)cyclohexyl]oxy}pyridine-3-carbonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12643,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),4,PMID:17034148|DOI:10.1021/jm060777o,https://www.ncbi.nlm.nih.gov/pubmed/17034148|https://doi.org/10.1021/jm060777o,17034148,10.1021/jm060777o,
1159,2009916,23646153,BindingDB,Aminobenzisoxazole 44,12668,"1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-5-[[(2,4-bis-(2-methylimidazol-1-yl)phenyl]aminocarbonyl]pyrazole, Bis(trifluoroacetic acid) Salt",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12668,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),800,PMID:15771420|DOI:10.1021/jm0497949,https://www.ncbi.nlm.nih.gov/pubmed/15771420|https://doi.org/10.1021/jm0497949,15771420,10.1021/jm0497949,
1160,2009917,23646153,BindingDB,Aminobenzisoxazole 44,12668,"1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-5-[[(2,4-bis-(2-methylimidazol-1-yl)phenyl]aminocarbonyl]pyrazole, Bis(trifluoroacetic acid) Salt",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12668,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1.6,PMID:15771420|DOI:10.1021/jm0497949,https://www.ncbi.nlm.nih.gov/pubmed/15771420|https://doi.org/10.1021/jm0497949,15771420,10.1021/jm0497949,
1161,2009918,23646154,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(dimethylamino)methyl]phenyl}-2-fluorophenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12682,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(dimethylamino)methyl]phenyl}-2-fluorophenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12682,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.13,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1162,2009919,23646155,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(diethylamino)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12689,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(diethylamino)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12689,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.11,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1163,2009966,23646156,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-(2-{[ethyl(methyl)amino]methyl}phenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12690,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-(2-{[ethyl(methyl)amino]methyl}phenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12690,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),<0.1,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1164,2009967,23646157,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(methylamino)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12691,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(methylamino)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12691,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.34,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1165,2009968,23646158,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-(2-{[(3S)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12694,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-(2-{[(3S)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12694,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.12,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1166,2009969,23646159,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(4-hydroxypiperidin-1-yl)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12695,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(4-hydroxypiperidin-1-yl)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12695,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.22,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1167,2009970,23646160,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-{4-[2-(piperazin-1-ylmethyl)phenyl]phenyl}-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12697,"1-(3-amino-1,2-benzoxazol-5-yl)-6-{4-[2-(piperazin-1-ylmethyl)phenyl]phenyl}-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12697,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.64,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1168,2009971,23646161,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(4-methylpiperazin-1-yl)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12698,"1-(3-amino-1,2-benzoxazol-5-yl)-6-(4-{2-[(4-methylpiperazin-1-yl)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12698,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.71,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1169,2009997,23646162,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-{2-fluoro-4-[2-(pyrrolidin-1-ylmethyl)phenyl]phenyl}-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12699,"1-(3-amino-1,2-benzoxazol-5-yl)-6-{2-fluoro-4-[2-(pyrrolidin-1-ylmethyl)phenyl]phenyl}-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12699,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.24,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1170,2009998,23646163,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[2-fluoro-4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12700,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[2-fluoro-4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12700,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.16,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1171,2009999,23646164,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12703,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12703,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.27,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1172,2010000,23646165,BindingDB,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[2-fluoro-4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12704,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[2-fluoro-4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12704,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.34,PMID:16730984|DOI:10.1016/j.bmcl.2006.02.069,https://www.ncbi.nlm.nih.gov/pubmed/16730984|https://doi.org/10.1016/j.bmcl.2006.02.069,16730984,10.1016/j.bmcl.2006.02.069,
1173,2010001,23646166,BindingDB,N-arylpyrazole carboxamide 12,12706,4-amino-3-cyano-N-[2-fluoro-4-(2-methanesulfonylphenyl)phenyl]-1-(4-methoxyphenyl)-1H-pyrazole-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12706,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),8.4,PMID:16682200|DOI:10.1016/j.bmcl.2006.04.044,https://www.ncbi.nlm.nih.gov/pubmed/16682200|https://doi.org/10.1016/j.bmcl.2006.04.044,16682200,10.1016/j.bmcl.2006.04.044,
1174,2010032,23646167,BindingDB,"ethyl 6-{4-[2-(hydroxymethyl)phenyl]phenyl}-1-(4-methoxyphenyl)-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxylate",12718,"ethyl 6-{4-[2-(hydroxymethyl)phenyl]phenyl}-1-(4-methoxyphenyl)-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12718,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),45,PMID:16682200|DOI:10.1016/j.bmcl.2006.04.044,https://www.ncbi.nlm.nih.gov/pubmed/16682200|https://doi.org/10.1016/j.bmcl.2006.04.044,16682200,10.1016/j.bmcl.2006.04.044,
1175,2010033,23646168,BindingDB,"6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-1-(4-methoxyphenyl)-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide",12721,"6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-1-(4-methoxyphenyl)-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12721,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1.5,PMID:16682200|DOI:10.1016/j.bmcl.2006.04.044,https://www.ncbi.nlm.nih.gov/pubmed/16682200|https://doi.org/10.1016/j.bmcl.2006.04.044,16682200,10.1016/j.bmcl.2006.04.044,
1176,2010034,23646169,BindingDB,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(4-methoxyphenyl)-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carbonitrile",12723,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(4-methoxyphenyl)-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12723,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.1,PMID:16682200|DOI:10.1016/j.bmcl.2006.04.044,https://www.ncbi.nlm.nih.gov/pubmed/16682200|https://doi.org/10.1016/j.bmcl.2006.04.044,16682200,10.1016/j.bmcl.2006.04.044,
1177,2010035,23646170,BindingDB,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(4-methoxyphenyl)-5-methyl-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carbonitrile",12724,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(4-methoxyphenyl)-5-methyl-7-oxo-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12724,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1.8,PMID:16682200|DOI:10.1016/j.bmcl.2006.04.044,https://www.ncbi.nlm.nih.gov/pubmed/16682200|https://doi.org/10.1016/j.bmcl.2006.04.044,16682200,10.1016/j.bmcl.2006.04.044,
1178,2010036,23646171,BindingDB,"2-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]benzene-1-sulfonamide",12730,"2-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12730,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.82,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1179,2010082,23646172,BindingDB,"2-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]benzamide",12731,"2-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12731,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.70,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1180,2010083,23646173,BindingDB,"3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]benzonitrile",12732,"3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]benzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12732,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),12,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1181,2010084,23646174,BindingDB,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(3-nitrophenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12734,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(3-nitrophenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12734,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),20.0,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1182,2010085,23646175,BindingDB,"1-(3-aminophenyl)-6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12735,"1-(3-aminophenyl)-6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12735,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.00,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1183,2010086,23646176,BindingDB,"N-{3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]phenyl}acetamide",12736,"N-{3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]phenyl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12736,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),88,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1184,2010087,23646177,BindingDB,"{3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]phenyl}urea",12737,dihydropyrazolopyridinone analogue 6h,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12737,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),54,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1185,2010088,23646178,BindingDB,"N-{3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]phenyl}methanesulfonamide",12738,"N-{3-[6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl]phenyl}methanesulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12738,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),47,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1186,2010122,23646179,BindingDB,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(4-ethylphenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12739,"6-(4-{2-[(dimethylamino)methyl]phenyl}phenyl)-1-(4-ethylphenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12739,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.6,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1187,2010123,23646180,BindingDB,"2-{6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}benzene-1-sulfonamide",12741,"2-{6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12741,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1.2,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1188,2010124,23646181,BindingDB,"6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12743,"6-[4-(2-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}phenyl)phenyl]-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12743,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.76,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1189,2010125,23646182,BindingDB,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}benzene-1-sulfonamide",12744,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12744,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.74,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1190,2010126,23646183,BindingDB,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}benzamide",12745,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12745,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.0,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1191,2010127,23646184,BindingDB,"6-[4-(2-methanesulfonylphenyl)phenyl]-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12746,"6-[4-(2-methanesulfonylphenyl)phenyl]-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12746,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.18,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1192,2010146,23646185,BindingDB,"2-[6-(2'-Methanesulfonyl-biphenyl-4-yl)-7-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[3,4-c]pyridin-1-yl]-5-methoxy-benzamide",12747,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}-5-methoxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12747,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.18,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1193,2010147,23646186,BindingDB,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}-5-methoxybenzene-1-sulfonamide",12748,"2-{6-[4-(2-methanesulfonylphenyl)phenyl]-7-oxo-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-1-yl}-5-methoxybenzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12748,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.12,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1194,2010148,23646187,BindingDB,"1-(2-amino-4-methoxyphenyl)-6-[4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",12749,"1-(2-amino-4-methoxyphenyl)-6-[4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12749,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.2,PMID:16963264|DOI:10.1016/j.bmcl.2006.08.027,https://www.ncbi.nlm.nih.gov/pubmed/16963264|https://doi.org/10.1016/j.bmcl.2006.08.027,16963264,10.1016/j.bmcl.2006.08.027,
1195,2010149,23646188,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12752,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12752,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.094,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1196,2010150,23646188,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12752,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12752,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1197,2010151,23646189,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-b]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12754,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-b]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12754,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),7.9,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1198,2010167,23646189,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-b]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12754,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-b]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12754,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.024,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1199,2010168,23646190,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-c]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12755,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-c]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12755,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.036,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1200,2010169,23646190,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-c]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12755,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{1H-imidazo[4,5-c]pyridin-1-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12755,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),8,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1201,2010170,23646191,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-c]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12756,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-c]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12756,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),7.9,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1202,2010171,23646191,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-c]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12756,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-c]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12756,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.044,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1203,2010172,23646192,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-b]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12757,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-b]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12757,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.028,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1204,2010196,23646192,BindingDB,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-b]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12757,"1-(3-carbamimidoylphenyl)-N-(2-fluoro-4-{3H-imidazo[4,5-b]pyridin-3-yl}phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12757,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),13,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1205,2010197,23646193,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12758,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12758,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),4.2,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1206,2010198,23646193,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12758,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12758,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.42,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1207,2010199,23646194,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(6-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12759,"1-(3-carbamimidoylphenyl)-N-[4-(6-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12759,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.25,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1208,2010200,23646194,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(6-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12759,"1-(3-carbamimidoylphenyl)-N-[4-(6-chloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12759,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),5.1,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1209,2010201,23646195,BindingDB,"1-(3-carbamimidoylphenyl)-N-{2-fluoro-4-[5-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]phenyl}-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12760,"1-(3-carbamimidoylphenyl)-N-{2-fluoro-4-[5-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]phenyl}-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12760,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),6.4,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1210,2010217,23646195,BindingDB,"1-(3-carbamimidoylphenyl)-N-{2-fluoro-4-[5-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]phenyl}-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12760,"1-(3-carbamimidoylphenyl)-N-{2-fluoro-4-[5-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]phenyl}-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12760,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.29,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1211,2010218,23646196,BindingDB,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-methyl-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12761,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-methyl-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12761,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.27,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1212,2010219,23646196,BindingDB,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-methyl-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12761,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-methyl-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12761,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),10,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1213,2010220,23646197,BindingDB,"N-[4-(5-amino-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12762,"N-[4-(5-amino-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12762,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1214,2010221,23646197,BindingDB,"N-[4-(5-amino-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12762,"N-[4-(5-amino-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12762,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.12,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1215,2010222,23646198,BindingDB,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-nitro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12763,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-nitro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12763,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.08,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1216,2010236,23646198,BindingDB,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-nitro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12763,"1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(5-nitro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12763,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1217,2010237,23646199,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12764,"1-(3-carbamimidoylphenyl)-N-[4-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12764,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),26,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1218,2010238,23646199,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",12764,"1-(3-carbamimidoylphenyl)-N-[4-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12764,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.27,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1219,2010239,23646200,BindingDB,1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(1H-indol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide,12765,1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(1H-indol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12765,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),5.4,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1220,2010240,23646200,BindingDB,1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(1H-indol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide,12765,1-(3-carbamimidoylphenyl)-N-[2-fluoro-4-(1H-indol-1-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12765,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),1700,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1221,2010241,23646202,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-imidazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",12768,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-imidazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12768,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),120,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1222,2010242,23646202,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-imidazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",12768,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-imidazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12768,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.58,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1223,2010249,23646203,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrazole-5-carboxamide",12769,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12769,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.19,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1224,2010250,23646203,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrazole-5-carboxamide",12769,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12769,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),44,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1225,2010251,23646204,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3-triazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",12770,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3-triazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12770,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),20,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1226,2010252,23646204,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3-triazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",12770,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3-triazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12770,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.26,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1227,2010253,23646205,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3,4-tetrazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",12771,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3,4-tetrazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12771,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.31,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1228,2010254,23646205,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3,4-tetrazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",12771,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(1H-1,2,3,4-tetrazol-1-ylmethyl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12771,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1229,2010261,23646206,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",12772,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12772,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),5.5,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1230,2010262,23646206,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",12772,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-1-(3-carbamimidoylphenyl)-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12772,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.20,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1231,2010263,23646207,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",12773,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12773,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.65,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1232,2010264,23646207,BindingDB,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",12773,"1-(3-carbamimidoylphenyl)-N-[4-(5-chloro-1H-1,3-benzodiazol-1-yl)phenyl]-3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12773,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),15,PMID:15454208|DOI:10.1016/j.bmcl.2004.08.034,https://www.ncbi.nlm.nih.gov/pubmed/15454208|https://doi.org/10.1016/j.bmcl.2004.08.034,15454208,10.1016/j.bmcl.2004.08.034,
1233,2010265,23646208,BindingDB,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(2-sulfamoylphenyl)phenyl]propanamide,12776,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(2-sulfamoylphenyl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12776,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.63,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1234,2010266,23646208,BindingDB,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(2-sulfamoylphenyl)phenyl]propanamide,12776,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(2-sulfamoylphenyl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12776,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),660,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1235,2010267,23646209,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12777,5-amidinoindole 13a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12777,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),63,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1236,2010281,23646209,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12777,5-amidinoindole 13a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12777,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.5,PMID:15582405|DOI:10.1016/j.bmcl.2004.10.045,https://www.ncbi.nlm.nih.gov/pubmed/15582405|https://doi.org/10.1016/j.bmcl.2004.10.045,15582405,10.1016/j.bmcl.2004.10.045,
1237,2010282,23646209,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12777,5-amidinoindole 13a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12777,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),63,PMID:15582405|DOI:10.1016/j.bmcl.2004.10.045,https://www.ncbi.nlm.nih.gov/pubmed/15582405|https://doi.org/10.1016/j.bmcl.2004.10.045,15582405,10.1016/j.bmcl.2004.10.045,
1238,2010283,23646209,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12777,5-amidinoindole 13a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12777,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.5,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1239,2010284,23646210,BindingDB,"(2R)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12778,"(2R)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12778,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1.3,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1240,2010285,23646210,BindingDB,"(2R)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12778,"(2R)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12778,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),19,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1241,2010286,23646211,BindingDB,"(2S)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12779,"(2S)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12779,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),820,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1242,2010287,23646211,BindingDB,"(2S)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12779,"(2S)-N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12779,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),26,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1243,2010318,23646212,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12780,5-amidinoindole 14,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12780,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),3,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1244,2010319,23646212,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12780,5-amidinoindole 14,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12780,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),480,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1245,2010320,23646213,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-2-methylpropanamide",12781,5-amidinoindole 15,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12781,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),750,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1246,2010321,23646213,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-2-methylpropanamide",12781,5-amidinoindole 15,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12781,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.2,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1247,2010322,23646214,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)butanamide",12782,5-amidinoindole 16,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12782,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.8,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1248,2010323,23646214,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)butanamide",12782,5-amidinoindole 16,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12782,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),160,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1249,2010324,23646215,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-cyclopropylpropanamide",12783,5-amidinoindole 17,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12783,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),3800,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1250,2010325,23646215,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-cyclopropylpropanamide",12783,5-amidinoindole 17,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12783,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1251,2010326,23646216,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-4-phenylbutanamide",12784,5-amidinoindole 18,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12784,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),6.1,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1252,2010327,23646216,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-4-phenylbutanamide",12784,5-amidinoindole 18,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12784,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),240,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1253,2010328,23646217,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-(naphthalen-2-yl)propanamide",12785,5-amidinoindole 19,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12785,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),98,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1254,2010329,23646217,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-(naphthalen-2-yl)propanamide",12785,5-amidinoindole 19,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12785,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),28,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1255,2010330,23646218,BindingDB,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12787,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12787,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),4,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1256,2010331,23646218,BindingDB,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12787,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12787,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),75,PMID:15582405|DOI:10.1016/j.bmcl.2004.10.045,https://www.ncbi.nlm.nih.gov/pubmed/15582405|https://doi.org/10.1016/j.bmcl.2004.10.045,15582405,10.1016/j.bmcl.2004.10.045,
1257,2010332,23646218,BindingDB,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12787,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12787,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),75,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1258,2010365,23646218,BindingDB,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12787,"3-(4-aminophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12787,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),4,PMID:15582405|DOI:10.1016/j.bmcl.2004.10.045,https://www.ncbi.nlm.nih.gov/pubmed/15582405|https://doi.org/10.1016/j.bmcl.2004.10.045,15582405,10.1016/j.bmcl.2004.10.045,
1259,2010366,23646219,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-(pyridin-3-yl)propanamide",12788,5-amidinoindole 22,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12788,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),1200,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1260,2010367,23646219,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)-3-(pyridin-3-yl)propanamide",12788,5-amidinoindole 22,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12788,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),7,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1261,2010368,23646220,BindingDB,"N-[4-(2-{[4-(1H-1,3-benzodiazol-1-yl)phenyl]carbamoyl}-2-(5-carbamimidoyl-1H-indol-3-yl)ethyl)phenyl]benzamide",12789,5-amidinoindole 23,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12789,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),18,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1262,2010369,23646220,BindingDB,"N-[4-(2-{[4-(1H-1,3-benzodiazol-1-yl)phenyl]carbamoyl}-2-(5-carbamimidoyl-1H-indol-3-yl)ethyl)phenyl]benzamide",12789,5-amidinoindole 23,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12789,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),270,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1263,2010370,23646221,BindingDB,"3-(4-benzenesulfonamidophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12790,"3-(4-benzenesulfonamidophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12790,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),130,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1264,2010371,23646221,BindingDB,"3-(4-benzenesulfonamidophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",12790,"3-(4-benzenesulfonamidophenyl)-N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-(5-carbamimidoyl-1H-indol-3-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12790,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),19,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1265,2010386,23646222,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(6-carbamimidoyl-1H-indol-1-yl)-3-phenylpropanamide",12791,6-amidinoindole 25,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12791,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),5.6,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1266,2010387,23646222,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(6-carbamimidoyl-1H-indol-1-yl)-3-phenylpropanamide",12791,6-amidinoindole 25,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12791,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),300,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1267,2010388,23646223,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1-methyl-1H-indol-3-yl)-3-phenylpropanamide",12792,5-amidinoindole 26,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12792,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),360,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1268,2010389,23646223,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1-methyl-1H-indol-3-yl)-3-phenylpropanamide",12792,5-amidinoindole 26,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12792,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),160,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1269,2010390,23646224,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-[(5-carbamimidoyl-1H-indol-3-yl)methyl]-3-phenylpropanamide",12793,5-amidinoindole 27,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12793,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),45,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1270,2010391,23646224,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-2-[(5-carbamimidoyl-1H-indol-3-yl)methyl]-3-phenylpropanamide",12793,5-amidinoindole 27,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12793,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),130,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1271,2010392,23646225,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-3-(5-carbamimidoyl-1H-indol-3-yl)-4-phenylbutanamide",12794,5-amidinoindole 28,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12794,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),250,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1272,2010393,23646225,BindingDB,"N-[4-(1H-1,3-benzodiazol-1-yl)phenyl]-3-(5-carbamimidoyl-1H-indol-3-yl)-4-phenylbutanamide",12794,5-amidinoindole 28,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12794,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),36,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1273,2010408,23646226,BindingDB,"N-{[4-(1H-1,3-benzodiazol-1-yl)phenyl]methyl}-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12795,5-amidinoindole 29,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12795,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),72,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1274,2010409,23646226,BindingDB,"N-{[4-(1H-1,3-benzodiazol-1-yl)phenyl]methyl}-2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamide",12795,5-amidinoindole 29,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12795,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),310,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1275,2010410,23646227,BindingDB,"N-(1H-1,3-benzodiazol-2-yl)-4-{[2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamido]methyl}benzamide",12796,5-amidinoindole 30,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12796,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),930,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1276,2010411,23646227,BindingDB,"N-(1H-1,3-benzodiazol-2-yl)-4-{[2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamido]methyl}benzamide",12796,5-amidinoindole 30,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12796,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),810,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1277,2010412,23646228,BindingDB,"N-(1H-1,3-benzodiazol-2-yl)-3-{[2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamido]methyl}benzamide",12797,5-amidinoindole 31,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12797,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2600,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1278,2010413,23646228,BindingDB,"N-(1H-1,3-benzodiazol-2-yl)-3-{[2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenylpropanamido]methyl}benzamide",12797,5-amidinoindole 31,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12797,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),1900,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1279,2010414,23646229,BindingDB,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(4-phenyl-1H-imidazol-1-yl)phenyl]propanamide,12798,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(4-phenyl-1H-imidazol-1-yl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12798,1345,Coagulation factor IX,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1345,P00740,Coagulation factor IX,2158.0,F9,9606.0,Homo sapiens (human),,Ki (nM),270,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1280,2010415,23646229,BindingDB,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(4-phenyl-1H-imidazol-1-yl)phenyl]propanamide,12798,2-(5-carbamimidoyl-1H-indol-3-yl)-3-phenyl-N-[4-(4-phenyl-1H-imidazol-1-yl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12798,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),79,PMID:15454209|DOI:10.1016/j.bmcl.2004.08.037,https://www.ncbi.nlm.nih.gov/pubmed/15454209|https://doi.org/10.1016/j.bmcl.2004.08.037,15454209,10.1016/j.bmcl.2004.08.037,
1281,2010424,23647689,Therapeutic Target Database (TTD),"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",D0T6TW,GSK642444,https://idrblab.net/ttd/data/drug/details/D0T6TW,T52522,Adrenergic receptor beta-2 (ADRB2),https://idrblab.net/ttd/data/target/details/T52522,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),Agonist,,,,,,,
1282,2010425,23647691,BindingDB,"Phenylalanine derived inhibitor, 3",11140,"(1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11140,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),69000,PMID:15908206|DOI:10.1016/j.bmcl.2005.04.028,https://www.ncbi.nlm.nih.gov/pubmed/15908206|https://doi.org/10.1016/j.bmcl.2005.04.028,15908206,10.1016/j.bmcl.2005.04.028,
1283,2010426,23647691,BindingDB,"Phenylalanine derived inhibitor, 3",11140,"(1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11140,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:15908206|DOI:10.1016/j.bmcl.2005.04.028,https://www.ncbi.nlm.nih.gov/pubmed/15908206|https://doi.org/10.1016/j.bmcl.2005.04.028,15908206,10.1016/j.bmcl.2005.04.028,
1284,2010427,23647692,BindingDB,"Phenylalanine derived inhibitor, 4",11189,"(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11189,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),86000,PMID:15908206|DOI:10.1016/j.bmcl.2005.04.028,https://www.ncbi.nlm.nih.gov/pubmed/15908206|https://doi.org/10.1016/j.bmcl.2005.04.028,15908206,10.1016/j.bmcl.2005.04.028,
1285,2010428,23647692,BindingDB,"Phenylalanine derived inhibitor, 4",11189,"(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11189,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),87000,PMID:15908206|DOI:10.1016/j.bmcl.2005.04.028,https://www.ncbi.nlm.nih.gov/pubmed/15908206|https://doi.org/10.1016/j.bmcl.2005.04.028,15908206,10.1016/j.bmcl.2005.04.028,
1286,2009713,23648449,BindingDB,4-(3-{1-[(Cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,19866,4-(3-{1-[(cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19866,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:12904076|DOI:10.1021/jm0301078,https://www.ncbi.nlm.nih.gov/pubmed/12904076|https://doi.org/10.1021/jm0301078,12904076,10.1021/jm0301078,
1287,2009714,23648449,BindingDB,4-(3-{1-[(Cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,19866,4-(3-{1-[(cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19866,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),1373,PMID:12904076|DOI:10.1021/jm0301078,https://www.ncbi.nlm.nih.gov/pubmed/12904076|https://doi.org/10.1021/jm0301078,12904076,10.1021/jm0301078,
1288,2009715,23648449,BindingDB,4-(3-{1-[(Cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,19866,4-(3-{1-[(cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19866,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:12904076|DOI:10.1021/jm0301078,https://www.ncbi.nlm.nih.gov/pubmed/12904076|https://doi.org/10.1021/jm0301078,12904076,10.1021/jm0301078,
1289,2009716,23648449,BindingDB,4-(3-{1-[(Cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,19866,4-(3-{1-[(cyanomethyl)carbamoyl]-3-methylbutyl}phenyl)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19866,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,IC50 (nM),1015,PMID:12904076|DOI:10.1021/jm0301078,https://www.ncbi.nlm.nih.gov/pubmed/12904076|https://doi.org/10.1021/jm0301078,12904076,10.1021/jm0301078,
1290,2009717,23648450,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-(4-{4-[(fluoromethyl)sulfanyl]phenyl}pyridin-3-yl)cyclohexane-1-carboxamide",19901,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-(4-{4-[(fluoromethyl)sulfanyl]phenyl}pyridin-3-yl)cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19901,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),2,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1291,2009718,23648450,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-(4-{4-[(fluoromethyl)sulfanyl]phenyl}pyridin-3-yl)cyclohexane-1-carboxamide",19901,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-(4-{4-[(fluoromethyl)sulfanyl]phenyl}pyridin-3-yl)cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19901,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),2,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1292,2009719,23648451,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]pyridin-4-yl}cyclohexane-1-carboxamide",19902,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]pyridin-4-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19902,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1293,2009835,23648451,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]pyridin-4-yl}cyclohexane-1-carboxamide",19902,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]pyridin-4-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19902,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1294,2009836,23648452,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{2-[4-(methylsulfanyl)phenyl]pyridin-3-yl}cyclohexane-1-carboxamide",19903,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{2-[4-(methylsulfanyl)phenyl]pyridin-3-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19903,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1295,2009837,23648452,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{2-[4-(methylsulfanyl)phenyl]pyridin-3-yl}cyclohexane-1-carboxamide",19903,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{2-[4-(methylsulfanyl)phenyl]pyridin-3-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19903,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1296,2009838,23648453,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",19905,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19905,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),8,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1297,2009839,23648453,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",19905,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{3-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19905,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),6,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1298,2009840,23648454,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{5-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",19906,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{5-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19906,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),5,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1299,2009841,23648454,BindingDB,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{5-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",19906,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{5-[4-(methylsulfanyl)phenyl]-2-oxo-1,2-dihydropyridin-4-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19906,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),4,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
1300,2010429,23649181,Drug Gene Interaction database (DGIdb),Crolibulin,,CROLIBULIN,https://www.dgidb.org/drugs/ncit:C66938,,TUBA3C,https://www.dgidb.org/genes/hgnc:12408,,,7278.0,TUBA3C,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1301,2010430,23649245,Therapeutic Target Database (TTD),Pavinetant,D02IWC,AZD2624,https://idrblab.net/ttd/data/drug/details/D02IWC,T29683,Neuromedin-K receptor (TACR3),https://idrblab.net/ttd/data/target/details/T29683,P29371,Neuromedin-K receptor,6870.0,TACR3,9606.0,Homo sapiens (human),Modulator,,,,,,,
1302,2009723,23655463,BindingDB,"Substituted phenylsulfonyltryptamine, 11g",21348,2-{1-[(4-iodobenzene)sulfonyl]-1H-indol-3-yl}ethan-1-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21348,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1303,2009724,23655464,BindingDB,"Substituted phenylsulfonyltryptamine, 11i",21350,2-{1-[(4-methoxybenzene)sulfonyl]-1H-indol-3-yl}ethan-1-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21350,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),47,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1304,2009728,23655465,BindingDB,"Substituted phenylsulfonyltryptamine, 11j",21351,4-{[3-(2-aminoethyl)-1H-indole-1-]sulfonyl}aniline,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21351,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1305,2009720,23655467,BindingDB,"Substituted phenylsulfonyltryptamine, 11l",21353,"2-{1-[(3,4-dimethoxybenzene)sulfonyl]-1H-indol-3-yl}ethan-1-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21353,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),7,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1306,2009721,23655468,BindingDB,"Thiophene sulfonyltryptamine, 11m",21354,2-{1-[(5-chlorothiophene-2-)sulfonyl]-1H-indol-3-yl}ethan-1-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21354,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),6,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1307,2009722,23655469,BindingDB,"Thiophene sulfonyltryptamine, 11n",21355,2-{1-[(5-bromothiophene-2-)sulfonyl]-1H-indol-3-yl}ethan-1-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21355,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),7,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1308,2010061,23655664,BindingDB,"Thiophene sulfonyltryptamine, 11o",21356,"2-{1-[(4,5-dichlorothiophene-2-)sulfonyl]-1H-indol-3-yl}ethan-1-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21356,2142,5-hydroxytryptamine receptor 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2142,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,Ki (nM),31,PMID:17948978|DOI:10.1021/jm070521y,https://www.ncbi.nlm.nih.gov/pubmed/17948978|https://doi.org/10.1021/jm070521y,17948978,10.1021/jm070521y,
1309,2009725,23658582,DrugBank,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",DB07326,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",https://www.drugbank.ca/drugs/DB07326,BE0000369,Vascular endothelial growth factor receptor 2,https://www.drugbank.ca/bio_entities/BE0000369,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1310,2009726,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRA6,https://www.dgidb.org/genes/hgnc:4080,,,2559.0,GABRA6,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
1311,2009727,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRB1,https://www.dgidb.org/genes/hgnc:4081,,,2560.0,GABRB1,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
1312,2010066,23661697,DrugBank,"(2r)-4-[(8r)-8-Methyl-2-(Trifluoromethyl)-5,6-Dihydro[1,2,4]triazolo[1,5-A]pyrazin-7(8h)-Yl]-4-Oxo-1-(2,4,5-Trifluorophenyl)butan-2-Amine",DB07081,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",https://www.drugbank.ca/drugs/DB07081,BE0000854,Dipeptidyl peptidase 4,https://www.drugbank.ca/bio_entities/BE0000854,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1313,2010053,23663991,Drug Gene Interaction database (DGIdb),Boniva,,IBANDRONATE SODIUM,https://www.dgidb.org/drugs/rxcui:236916,,FDPS,https://www.dgidb.org/genes/hgnc:3631,,,2224.0,FDPS,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1314,2010054,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYSLTR1,https://www.dgidb.org/genes/hgnc:17451,,,10800.0,CYSLTR1,9606.0,Homo sapiens (human),,,,,,,,
1315,2010055,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,LTA4H,https://www.dgidb.org/genes/hgnc:6710,,,4048.0,LTA4H,9606.0,Homo sapiens (human),,,,,,,,
1316,2010056,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYP2C8,https://www.dgidb.org/genes/hgnc:2622,,,1558.0,CYP2C8,9606.0,Homo sapiens (human),,,,,,,,
1317,2010057,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CA10,https://www.dgidb.org/genes/hgnc:1369,,,56934.0,CA10,9606.0,Homo sapiens (human),,,,,,,,
1318,2010058,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,ALOX5,https://www.dgidb.org/genes/hgnc:435,,,240.0,ALOX5,9606.0,Homo sapiens (human),,,,,,,,
1319,2010059,23665770,Comparative Toxicogenomics Database (CTD),Sodium tetradecyl sulfate,D012981,Sodium Tetradecyl Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D012981,389434,IYD,https://ctdbase.org/detail.go?type=gene&acc=389434,,,389434.0,IYD,9606.0,Homo sapiens (human),Sodium tetradecyl sulfate inhibits the reaction [IYD protein results in increased metabolism of monoiodotyrosine],,,PMID:33352258,https://www.ncbi.nlm.nih.gov/pubmed/33352258,33352258,,
1320,2010060,23665888,Drug Gene Interaction database (DGIdb),Menadione sodium bisulfite,,MENADIONE SODIUM BISULPHITE,https://www.dgidb.org/drugs/chembl:CHEMBL2358118,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
1321,2010062,23665997,Comparative Toxicogenomics Database (CTD),Sodium allylthiosulphate,C488464,2-propenyl thiosulfate,https://ctdbase.org/detail.go?type=chem&acc=C488464,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),2-propenyl thiosulfate results in increased expression of NQO1 mRNA,,,PMID:20650352,https://www.ncbi.nlm.nih.gov/pubmed/20650352,20650352,,
1322,2010063,23667300,Drug Gene Interaction database (DGIdb),Cefoxitin Sodium,,CEFOXITIN SODIUM,https://www.dgidb.org/drugs/rxcui:203118,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
1323,2010064,23667548,Drug Gene Interaction database (DGIdb),Sodium Ascorbate,,SODIUM ASCORBATE,https://www.dgidb.org/drugs/rxcui:267366,,G6PD,https://www.dgidb.org/genes/hgnc:4057,,,2539.0,G6PD,9606.0,Homo sapiens (human),,,,,,,,
1324,2010065,23669322,Drug Gene Interaction database (DGIdb),"Sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate",,TANSHINONE IIA SULFONATE,https://www.dgidb.org/drugs/chembl:CHEMBL1473252,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
1325,2010089,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,10090.0,Mus musculus (house mouse),Lactisole inhibits the reaction [fructose results in increased expression of PKLR mrna],,,PMID:17786952,https://www.ncbi.nlm.nih.gov/pubmed/17786952,17786952,,
1326,2010090,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,6518,SLC2A5,https://ctdbase.org/detail.go?type=gene&acc=6518,,,6518.0,SLC2A5,10090.0,Mus musculus (house mouse),Lactisole inhibits the reaction [fructose results in increased expression of SLC2A5 mrna],,,PMID:17786952,https://www.ncbi.nlm.nih.gov/pubmed/17786952,17786952,,
1327,2010091,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,6523,SLC5A1,https://ctdbase.org/detail.go?type=gene&acc=6523,,,6523.0,SLC5A1,10090.0,Mus musculus (house mouse),Lactisole inhibits the reaction [fructose results in increased expression of SLC5A1 mrna],,,PMID:17786952,https://www.ncbi.nlm.nih.gov/pubmed/17786952,17786952,,
1328,2010092,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,80835,TAS1R1,https://ctdbase.org/detail.go?type=gene&acc=80835,,,80835.0,TAS1R1,9606.0,Homo sapiens (human),Lactisole results in decreased activity of [TAS1R1 protein binds to TAS1R3 protein],,,PMID:15353592,https://www.ncbi.nlm.nih.gov/pubmed/15353592,15353592,,
1329,2010093,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,80834,TAS1R2,https://ctdbase.org/detail.go?type=gene&acc=80834,,,80834.0,TAS1R2,9606.0,Homo sapiens (human),Lactisole binds to [TAS1R2 protein binds to TAS1R3 protein],,,PMID:17168764,https://www.ncbi.nlm.nih.gov/pubmed/17168764,17168764,,
1330,2010094,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,80834,TAS1R2,https://ctdbase.org/detail.go?type=gene&acc=80834,,,80834.0,TAS1R2,9606.0,Homo sapiens (human),Lactisole inhibits the reaction [aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]|lactisole inhibits the reaction [cyclamates results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]|lactisole inhibits the reaction [neohesperidin dihydrochalcone results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]],,,PMID:17935609,https://www.ncbi.nlm.nih.gov/pubmed/17935609,17935609,,
1331,2010095,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,83756,TAS1R3,https://ctdbase.org/detail.go?type=gene&acc=83756,,,83756.0,TAS1R3,9606.0,Homo sapiens (human),Lactisole binds to [TAS1R2 protein binds to TAS1R3 protein],,,PMID:17168764,https://www.ncbi.nlm.nih.gov/pubmed/17168764,17168764,,
1332,2010096,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,83756,TAS1R3,https://ctdbase.org/detail.go?type=gene&acc=83756,,,83756.0,TAS1R3,9606.0,Homo sapiens (human),Lactisole inhibits the reaction [aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]|lactisole inhibits the reaction [neohesperidin dihydrochalcone results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]|lactisole inhibits the reaction [cyclamates results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]|lactisole binds to TAS1R3 protein,,,PMID:17935609,https://www.ncbi.nlm.nih.gov/pubmed/17935609,17935609,,
1333,2010097,23670520,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-methoxyphenoxy)propanoate,C495512,lactisole,https://ctdbase.org/detail.go?type=chem&acc=C495512,83756,TAS1R3,https://ctdbase.org/detail.go?type=gene&acc=83756,,,83756.0,TAS1R3,9606.0,Homo sapiens (human),Lactisole results in decreased activity of [TAS1R1 protein binds to TAS1R3 protein],,,PMID:15353592,https://www.ncbi.nlm.nih.gov/pubmed/15353592,15353592,,
1334,2009624,23676207,Therapeutic Target Database (TTD),Procylin (TN),D00QFY,YM533,https://idrblab.net/ttd/data/drug/details/D00QFY,T99954,Prostacyclin receptor (PTGIR),https://idrblab.net/ttd/data/target/details/T99954,P43119,Prostacyclin receptor,5739.0,PTGIR,9606.0,Homo sapiens (human),Modulator,,,,,,,
1335,2009625,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,P35498,Sodium channel protein type 1 subunit alpha,6323.0,SCN1A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1336,2009626,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,P35499,Sodium channel protein type 4 subunit alpha,6329.0,SCN4A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1337,2009627,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q01118,Sodium channel protein type 7 subunit alpha,6332.0,SCN7A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1338,2009628,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q14524,Sodium channel protein type 5 subunit alpha,6331.0,SCN5A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1339,2009629,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q15858,Sodium channel protein type 9 subunit alpha,6335.0,SCN9A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1340,2009630,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q99250,Sodium channel protein type 2 subunit alpha,6326.0,SCN2A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1341,2009631,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9NY46,Sodium channel protein type 3 subunit alpha,6328.0,SCN3A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1342,2009632,23679632,ChEMBL,Antisacer,CHEMBL1611,PHENYTOIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1611/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9UI33,Sodium channel protein type 11 subunit alpha,11280.0,SCN11A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15208697|PMID:23205958,https://www.ncbi.nlm.nih.gov/pubmed/15208697|https://www.ncbi.nlm.nih.gov/pubmed/23205958,15208697|23205958,,
1343,2009687,24779675,DrugBank,"2-(Cyclohexylmethylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile",DB08353,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",https://www.drugbank.ca/drugs/DB08353,BE0001209,Casein kinase II subunit alpha,https://www.drugbank.ca/bio_entities/BE0001209,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1344,2009688,24779676,DrugBank,"2-(4-Chlorobenzylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile",DB08354,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",https://www.drugbank.ca/drugs/DB08354,BE0001209,Casein kinase II subunit alpha,https://www.drugbank.ca/bio_entities/BE0001209,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1345,2009689,24779677,DrugBank,"2-(4-Ethylpiperazin-1-yl)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile",DB08360,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",https://www.drugbank.ca/drugs/DB08360,BE0001209,Casein kinase II subunit alpha,https://www.drugbank.ca/bio_entities/BE0001209,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1346,2009690,24779678,DrugBank,"4-(2-(1H-imidazol-4-yl)ethylamino)-2-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile",DB08345,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",https://www.drugbank.ca/drugs/DB08345,BE0001209,Casein kinase II subunit alpha,https://www.drugbank.ca/bio_entities/BE0001209,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1347,2009691,24779724,Drug Gene Interaction database (DGIdb),Sgx-523,,MET TYROSINE KINASE INHIBITOR SGX523,https://www.dgidb.org/drugs/ncit:C74062,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
1348,2009692,24779745,Drug Gene Interaction database (DGIdb),Sotrastaurin acetate,,SOTRASTAURIN ACETATE,https://www.dgidb.org/drugs/ncit:C80631,,GNAQ,https://www.dgidb.org/genes/hgnc:4390,,,2776.0,GNAQ,9606.0,Homo sapiens (human),,,,,,,,
1349,2009693,24779772,Therapeutic Target Database (TTD),AP-Cav,D01FMS,AP-Cav,https://idrblab.net/ttd/data/drug/details/D01FMS,T06046,Nitric-oxide synthase endothelial (NOS3),https://idrblab.net/ttd/data/target/details/T06046,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1350,2009694,24782016,Therapeutic Target Database (TTD),"2-(2,6-Dimethyl-benzyl)-4,5-dihydro-1H-imidazole",D02EPZ,"2-(2,6-Dimethyl-benzyl)-4,5-dihydro-1H-imidazole",https://idrblab.net/ttd/data/drug/details/D02EPZ,T11072,5-HT 1D receptor (HTR1D),https://idrblab.net/ttd/data/target/details/T11072,P28221,5-hydroxytryptamine receptor 1D,3352.0,HTR1D,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1351,2009695,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1352,2009696,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,AKT3,https://www.dgidb.org/genes/hgnc:393,,,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1353,2009697,24794466,ChEMBL,Difelikefalin,CHEMBL3989915,DIFELIKEFALIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989915/,CHEMBL237,Kappa opioid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL237/,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),Kappa opioid receptor agonist,,,PMID:31702883|PMID:32405581,https://www.ncbi.nlm.nih.gov/pubmed/31702883|https://www.ncbi.nlm.nih.gov/pubmed/32405581,31702883|32405581,,
1354,2009656,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,BRCA2,https://www.dgidb.org/genes/hgnc:1101,,,675.0,BRCA2,9606.0,Homo sapiens (human),,,,,,,,
1355,2009657,24958668,Therapeutic Target Database (TTD),"Urea, N-(2-((1-(2-chlorophenyl)-3-methyl-1H-pyrazol-5-yl)oxy)phenyl)-N'-(4-(trifluoromethoxy)phenyl)-",D0G8KA,PMID18445527C11,https://idrblab.net/ttd/data/drug/details/D0G8KA,T67818,P2Y purinoceptor 1 (P2RY1),https://idrblab.net/ttd/data/target/details/T67818,P47900,P2Y purinoceptor 1,5028.0,P2RY1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1356,2009658,24962989,BindingDB,1-(3-{[(2S)-2-aminopropanamido]methyl}phenyl)-N-benzyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide,27659,1-(3-{[(2S)-2-aminopropanamido]methyl}phenyl)-N-benzyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27659,3339,Histone-arginine methyltransferase CARM1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3339,Q9WVG6,Histone-arginine methyltransferase CARM1,59035.0,Carm1,10090.0,Mus musculus (house mouse),,IC50 (nM),80,PMID:19131248|DOI:10.1016/j.bmcl.2008.12.075,https://www.ncbi.nlm.nih.gov/pubmed/19131248|https://doi.org/10.1016/j.bmcl.2008.12.075,19131248,10.1016/j.bmcl.2008.12.075,
1357,2009659,24964624,IUPHAR/BPS Guide to PHARMACOLOGY,MK-2206,7945,MK-2206,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7945,1480,AKT serine/threonine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1480,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),Negative,pIC50,7.92,,,,,
1358,2009660,24964624,IUPHAR/BPS Guide to PHARMACOLOGY,MK-2206,7945,MK-2206,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7945,1479,AKT serine/threonine kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1479,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),Negative,pIC50,8.3,,,,,
1359,2009661,24969622,Drug Gene Interaction database (DGIdb),Vestipitant Mesylate,,VESTIPITANT MESYLATE,https://www.dgidb.org/drugs/ncit:C95195,,TACR1,https://www.dgidb.org/genes/hgnc:11526,,,6869.0,TACR1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1360,2009662,24970878,Therapeutic Target Database (TTD),Cl-amidine,D0YP0A,Cl-amidine,https://idrblab.net/ttd/data/drug/details/D0YP0A,T36612,Peptidyl arginine deiminase type III (PADI3),https://idrblab.net/ttd/data/target/details/T36612,Q9ULW8,Protein-arginine deiminase type-3,51702.0,PADI3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1361,2009663,24970878,Therapeutic Target Database (TTD),Cl-amidine,D0YP0A,Cl-amidine,https://idrblab.net/ttd/data/drug/details/D0YP0A,T50429,Peptidyl arginine deiminase type IV (PADI4),https://idrblab.net/ttd/data/target/details/T50429,Q9UM07,Protein-arginine deiminase type-4,23569.0,PADI4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1362,2009664,24978538,Drug Gene Interaction database (DGIdb),Navitoclax,,NAVITOCLAX,https://www.dgidb.org/drugs/ncit:C64776,,BCL2,https://www.dgidb.org/genes/hgnc:990,,,596.0,BCL2,9606.0,Homo sapiens (human),,,,,,,,
1363,2009665,24978538,Drug Gene Interaction database (DGIdb),Navitoclax,,NAVITOCLAX,https://www.dgidb.org/drugs/ncit:C64776,,POLI,https://www.dgidb.org/genes/hgnc:9182,,,11201.0,POLI,9606.0,Homo sapiens (human),,,,,,,,
1364,2009666,24978538,Drug Gene Interaction database (DGIdb),Navitoclax,,NAVITOCLAX,https://www.dgidb.org/drugs/ncit:C64776,,BCL2,https://www.dgidb.org/genes/hgnc:990,,,596.0,BCL2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1365,2009667,24986635,IUPHAR/BPS Guide to PHARMACOLOGY,4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide,9054,PF-04191834,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9054,1385,5-LOX,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1385,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibition,pIC50,6.64,PMID:20378715,https://www.ncbi.nlm.nih.gov/pubmed/20378715,20378715,,
1366,2009647,25114442,IUPHAR/BPS Guide to PHARMACOLOGY,PF-04418948,5817,PF-04418948,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5817,341,EP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,P43116,Prostaglandin E2 receptor EP2 subtype,5732.0,PTGER2,9606.0,Homo sapiens (human),Antagonist,pKB,8.3,PMID:21595651|PMID:22747912,https://www.ncbi.nlm.nih.gov/pubmed/21595651|https://www.ncbi.nlm.nih.gov/pubmed/22747912,21595651|22747912,,
1367,2009648,25114442,IUPHAR/BPS Guide to PHARMACOLOGY,PF-04418948,5817,PF-04418948,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5817,341,EP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,Q62053,Prostaglandin E2 receptor EP2 subtype,19217.0,Ptger2,10090.0,Mus musculus (house mouse),Antagonist,pKB,8.32,PMID:22747912,https://www.ncbi.nlm.nih.gov/pubmed/22747912,22747912,,
1368,2009646,25117126,Drug Gene Interaction database (DGIdb),Defactinib,,DEFACTINIB,https://www.dgidb.org/drugs/ncit:C79809,,PTK2,https://www.dgidb.org/genes/hgnc:9611,,,5747.0,PTK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1369,2009645,25129117,Therapeutic Target Database (TTD),3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine,D0Q5ZZ,3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine,https://idrblab.net/ttd/data/drug/details/D0Q5ZZ,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1370,2009649,25130517,Therapeutic Target Database (TTD),3-(3-Benzylnaphthalen-2-yl)pyridine,D05IXU,3-(3-Benzylnaphthalen-2-yl)pyridine,https://idrblab.net/ttd/data/drug/details/D05IXU,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1371,2009651,25130848,Therapeutic Target Database (TTD),3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine,D06JYY,3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine,https://idrblab.net/ttd/data/drug/details/D06JYY,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1372,2009652,25130848,Therapeutic Target Database (TTD),3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine,D06JYY,3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine,https://idrblab.net/ttd/data/drug/details/D06JYY,T37848,Albendazole monooxygenase (CYP3A4),https://idrblab.net/ttd/data/target/details/T37848,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1373,2009653,25137229,Therapeutic Target Database (TTD),"(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one",D0D2SE,"(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one",https://idrblab.net/ttd/data/drug/details/D0D2SE,T14834,Cytosolic phospholipase A2 (GIVA cPLA2),https://idrblab.net/ttd/data/target/details/T14834,P47712,Cytosolic phospholipase A2,5321.0,PLA2G4A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1374,2009650,25137230,Therapeutic Target Database (TTD),1-(Perfluoropropyl)-5-phenylpentanol,D0UV2N,"1,1,1,2,2,3,3-heptafluoro-8-phenyloctan-4-ol",https://idrblab.net/ttd/data/drug/details/D0UV2N,T14834,Cytosolic phospholipase A2 (GIVA cPLA2),https://idrblab.net/ttd/data/target/details/T14834,P47712,Cytosolic phospholipase A2,5321.0,PLA2G4A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1375,2009654,25139469,Therapeutic Target Database (TTD),"3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin",D0P4GF,"3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin",https://idrblab.net/ttd/data/drug/details/D0P4GF,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1376,2009655,25139469,Therapeutic Target Database (TTD),"3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin",D0P4GF,"3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin",https://idrblab.net/ttd/data/drug/details/D0P4GF,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1377,2009785,25139473,Therapeutic Target Database (TTD),"3,4-Benzo-7-acetonyloxy-8-methoxycoumarin",D0TL3S,"3,4-Benzo-7-acetonyloxy-8-methoxycoumarin",https://idrblab.net/ttd/data/drug/details/D0TL3S,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1378,2009798,25139473,Therapeutic Target Database (TTD),"3,4-Benzo-7-acetonyloxy-8-methoxycoumarin",D0TL3S,"3,4-Benzo-7-acetonyloxy-8-methoxycoumarin",https://idrblab.net/ttd/data/drug/details/D0TL3S,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1379,2009786,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,TAOK1,https://www.dgidb.org/genes/hgnc:29259,,,57551.0,TAOK1,9606.0,Homo sapiens (human),,,,,,,,
1380,2009787,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,AURKB,https://www.dgidb.org/genes/hgnc:11390,,,9212.0,AURKB,9606.0,Homo sapiens (human),,,,,,,,
1381,2009788,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,FLT4,https://www.dgidb.org/genes/hgnc:3767,,,2324.0,FLT4,9606.0,Homo sapiens (human),,,,,,,,
1382,2009789,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,JAK3,https://www.dgidb.org/genes/hgnc:6193,,,3718.0,JAK3,9606.0,Homo sapiens (human),,,,,,,,
1383,2009790,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
1384,2009791,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,FGFR1,https://www.dgidb.org/genes/hgnc:3688,,,2260.0,FGFR1,9606.0,Homo sapiens (human),,,,,,,,
1385,2009792,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,RET,https://www.dgidb.org/genes/hgnc:9967,,,5979.0,RET,9606.0,Homo sapiens (human),,,,,,,,
1386,2009793,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,LYN,https://www.dgidb.org/genes/hgnc:6735,,,4067.0,LYN,9606.0,Homo sapiens (human),,,,,,,,
1387,2009794,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK3,https://www.dgidb.org/genes/hgnc:8033,,,4916.0,NTRK3,9606.0,Homo sapiens (human),,,,,,,,
1388,2009795,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,JAK2,https://www.dgidb.org/genes/hgnc:6192,,,3717.0,JAK2,9606.0,Homo sapiens (human),,,,,,,,
1389,2009796,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815.0,KIT,9606.0,Homo sapiens (human),,,,,,,,
1390,2009797,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,CAMK1D,https://www.dgidb.org/genes/hgnc:19341,,,57118.0,CAMK1D,9606.0,Homo sapiens (human),,,,,,,,
1391,2009800,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,MAP4K2,https://www.dgidb.org/genes/hgnc:6864,,,5871.0,MAP4K2,9606.0,Homo sapiens (human),,,,,,,,
1392,2009801,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
1393,2009799,25147692,Therapeutic Target Database (TTD),"6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one",D03YHZ,"6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one",https://idrblab.net/ttd/data/drug/details/D03YHZ,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1394,2102665,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"SOD1 protein inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]|4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]|egfr protein affects the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]|cat protein inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:16908449,https://www.ncbi.nlm.nih.gov/pubmed/16908449,16908449,,
1395,2102666,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in decreased phosphorylation of MAPK3 protein",,,PMID:17191120|PMID:18314537,https://www.ncbi.nlm.nih.gov/pubmed/17191120|https://www.ncbi.nlm.nih.gov/pubmed/18314537,17191120|18314537,,
1396,2102667,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in increased phosphorylation of MAPK3 protein",,,PMID:16908449|PMID:16966607|PMID:21454801|PMID:21762757|PMID:22573546,https://www.ncbi.nlm.nih.gov/pubmed/16908449|https://www.ncbi.nlm.nih.gov/pubmed/16966607|https://www.ncbi.nlm.nih.gov/pubmed/21454801|https://www.ncbi.nlm.nih.gov/pubmed/21762757|https://www.ncbi.nlm.nih.gov/pubmed/22573546,16908449|16966607|21454801|21762757|22573546,,
1397,2102668,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"RTKI cpd inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:21762757,https://www.ncbi.nlm.nih.gov/pubmed/21762757,21762757,,
1398,2102669,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"U 0126 inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:21454801,https://www.ncbi.nlm.nih.gov/pubmed/21454801,21454801,,
1399,2102670,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10036.0,Mesocricetus auratus (golden hamster),"Asbestos, crocidolite results in increased phosphorylation of MAPK3 protein",,,PMID:16966607,https://www.ncbi.nlm.nih.gov/pubmed/16966607,16966607,,
1400,2102671,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]|src protein affects the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]|rtki cpd inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:14737115,https://www.ncbi.nlm.nih.gov/pubmed/14737115,14737115,,
1401,2102672,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"Antigens, polyomavirus transforming promotes the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:24130165,https://www.ncbi.nlm.nih.gov/pubmed/24130165,24130165,,
1402,2102673,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in increased expression of MAPK3 protein|asbestos, crocidolite affects the localization of MAPK3 protein modified form",,,PMID:12598305,https://www.ncbi.nlm.nih.gov/pubmed/12598305,12598305,,
1403,2102674,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in increased phosphorylation of and affects the localization of MAPK3 protein",,,PMID:15374964,https://www.ncbi.nlm.nih.gov/pubmed/15374964,15374964,,
1404,2102675,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in increased phosphorylation of MAPK3 protein",,,PMID:11306433|PMID:12598305|PMID:14737115|PMID:18192500|PMID:24130165,https://www.ncbi.nlm.nih.gov/pubmed/11306433|https://www.ncbi.nlm.nih.gov/pubmed/12598305|https://www.ncbi.nlm.nih.gov/pubmed/14737115|https://www.ncbi.nlm.nih.gov/pubmed/18192500|https://www.ncbi.nlm.nih.gov/pubmed/24130165,11306433|12598305|14737115|18192500|24130165,,
1405,2102676,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"MAP2K1 protein affects the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:18192500,https://www.ncbi.nlm.nih.gov/pubmed/18192500,18192500,,
1406,2102677,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),"ITGB1 protein affects the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]|arginyl-glycyl-aspartic acid inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK3 protein]",,,PMID:14627993,https://www.ncbi.nlm.nih.gov/pubmed/14627993,14627993,,
1407,2102678,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),"Asbestos, crocidolite results in increased phosphorylation of MAPK3 protein",,,PMID:12495932|PMID:14627993,https://www.ncbi.nlm.nih.gov/pubmed/12495932|https://www.ncbi.nlm.nih.gov/pubmed/14627993,12495932|14627993,,
1408,2102679,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),"[asbestos, crocidolite results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of ELK1 protein",,,PMID:12495932,https://www.ncbi.nlm.nih.gov/pubmed/12495932,12495932,,
1409,2102680,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5598,MAPK7,https://ctdbase.org/detail.go?type=gene&acc=5598,,,5598.0,MAPK7,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in increased phosphorylation of MAPK7 protein|mapk7 protein affects the reaction [asbestos, crocidolite results in increased expression of JUN mrna]|ag 1879 inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK7 protein]|cat protein inhibits the reaction [asbestos, crocidolite results in increased phosphorylation of MAPK7 protein]",,,PMID:14737115,https://www.ncbi.nlm.nih.gov/pubmed/14737115,14737115,,
1410,2102681,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of MAPK8 mRNA",,,PMID:25757056,https://www.ncbi.nlm.nih.gov/pubmed/25757056,25757056,,
1411,2102682,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in increased expression of MAPK8 mRNA",,,PMID:19446018,https://www.ncbi.nlm.nih.gov/pubmed/19446018,19446018,,
1412,2102683,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in decreased expression of and results in decreased phosphorylation of MAPK9 protein",,,PMID:17191120,https://www.ncbi.nlm.nih.gov/pubmed/17191120,17191120,,
1413,2102684,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of MAPKAPK2 mRNA",,,PMID:25757056,https://www.ncbi.nlm.nih.gov/pubmed/25757056,25757056,,
1414,2102685,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,8550,MAPKAPK5,https://ctdbase.org/detail.go?type=gene&acc=8550,,,8550.0,MAPKAPK5,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite inhibits the reaction [SPARC gene mutant form results in increased expression of MAPKAPK5 mrna]",,,PMID:19446018,https://www.ncbi.nlm.nih.gov/pubmed/19446018,19446018,,
1415,2102686,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,10982,MAPRE2,https://ctdbase.org/detail.go?type=gene&acc=10982,,,10982.0,MAPRE2,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in decreased expression of MAPRE2 mRNA",,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
1416,2102687,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,51257,MARCHF2,https://ctdbase.org/detail.go?type=gene&acc=51257,,,51257.0,MARCHF2,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in decreased expression of MARCHF2 mRNA",,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
1417,2102688,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,57574,MARCHF4,https://ctdbase.org/detail.go?type=gene&acc=57574,,,57574.0,MARCHF4,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of MARCHF4 mRNA",,,PMID:18687144,https://www.ncbi.nlm.nih.gov/pubmed/18687144,18687144,,
1418,2102689,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,54708,MARCHF5,https://ctdbase.org/detail.go?type=gene&acc=54708,,,54708.0,MARCHF5,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in decreased expression of MARCHF5 mRNA",,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
1419,2102690,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in decreased expression of MARCKS mRNA",,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
1420,2102717,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263.0,MCF2L,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in decreased methylation of MCF2L promoter",,,PMID:29626692,https://www.ncbi.nlm.nih.gov/pubmed/29626692,29626692,,
1421,2102718,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,4170,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170.0,MCL1,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of MCL1 mRNA",,,PMID:18687144|PMID:25757056,https://www.ncbi.nlm.nih.gov/pubmed/18687144|https://www.ncbi.nlm.nih.gov/pubmed/25757056,18687144|25757056,,
1422,2102719,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,84515,MCM8,https://ctdbase.org/detail.go?type=gene&acc=84515,,,84515.0,MCM8,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in decreased expression of MCM8 mRNA",,,PMID:29523930,https://www.ncbi.nlm.nih.gov/pubmed/29523930,29523930,,
1423,2102720,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,157777,MCMDC2,https://ctdbase.org/detail.go?type=gene&acc=157777,,,157777.0,MCMDC2,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in decreased expression of MCMDC2 mRNA",,,PMID:29523930,https://www.ncbi.nlm.nih.gov/pubmed/29523930,29523930,,
1424,2102721,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,79772,MCTP1,https://ctdbase.org/detail.go?type=gene&acc=79772,,,79772.0,MCTP1,9606.0,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of MCTP1 mRNA",,,PMID:18687144|PMID:25351596,https://www.ncbi.nlm.nih.gov/pubmed/18687144|https://www.ncbi.nlm.nih.gov/pubmed/25351596,18687144|25351596,,
1425,2102722,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,28985,MCTS1,https://ctdbase.org/detail.go?type=gene&acc=28985,,,28985.0,MCTS1,10090.0,Mus musculus (house mouse),"Asbestos, crocidolite results in decreased expression of MCTS1 mRNA",,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
